UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 20-F

(Mark One)

 

¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

¨ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ___________

 

OR

 

x SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of event requiring this shell company report: May 13, 2019

  

Commission file number: 001-38911

 

Clarivate Analytics Plc

 

 

 

(Exact Name of Registrant as Specified in Its Charter)

 

Not Applicable

(Translation of Registrant’s Name Into English)

 

Jersey, Channel Islands

(Jurisdiction of Incorporation or Organization)

 

4th Floor, St. Paul’s Gate, 22-24 New Street

St. Helier, Jersey JE1 4TR

 

 

 

(Address of Principal Executive Offices)

 

Mr. Stephen Hartman

General Counsel and Global Head of Corporate Development

Friars House

160 Blackfriars Road

London, SE1 8EZ, UK

Telephone: +44 207 433 4000

Fax: +44 207 433 4001

 

 

 

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbols   Name of Each Exchange on which Registered
Ordinary Shares   CCC   New York Stock Exchange
Ordinary Shares Underlying Warrants   CCC WS   New York Stock Exchange American

 

Securities registered or to be registered pursuant to Section 12(g) of the Act.

 

None

(Title of Class)

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.

 

None

(Title of Class)

 

On May 13, 2019 the issuer had 305,249,999 ordinary shares outstanding.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No x

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.  Yes ¨ No ¨

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ¨ No x

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer,” accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer  ¨ Accelerated Filer    ¨ Non-Accelerated Filer x
    Emerging Growth Company x

  

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. x

 

† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

 

U.S. GAAP x International Financial Reporting Standards as issued by the International Accounting Standards Board   ¨ Other ¨

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. o Item 17 o Item 18

 

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No o

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page
     
PART I 5
   
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 5
     
A. Directors and Senior Management 5
B. Advisers 5
C. Auditors 5
     
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 5
     
A. Offer Statistics 5
B. Method and Expected Timetable 5
     
ITEM 3. KEY INFORMATION 5
     
A. Selected Financial Data 5
B. Capitalization and Indebtedness 5
C. Reasons for the Offer and Use of Proceeds 5
D. Risk Factors 5
     
ITEM 4. INFORMATION ON THE COMPANY 5
     
A. History and Development of the Company 5
B. Business Overview 6
C. Organizational Structure 6
D. Property, Plants and Equipment 7
     
ITEM 4A. UNRESOLVED STAFF COMMENTS 7
     
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 7
     
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 7
     
A. Directors and Senior Management 7
B. Compensation 7

 

  2  

 

 

C. Board Practices 7
D. Employees 7
E. Share Ownership 7
     
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 7
     
A. Major Shareholders 7
B. Related Party Transactions 8
C. Interests of Experts and Counsel 8
     
ITEM 8. FINANCIAL INFORMATION 8
     
A. Consolidated Statements and Other Financial Information 8
B. Significant Changes 8
     
ITEM 9. THE OFFER AND LISTING 8
     
A. Offer and Listing Details 8
B. Plan of Distribution 8
C. Markets 8
D. Selling Shareholders 8
E. Dilution 9
F. Expenses of the Issue 9

 

ITEM 10. ADDITIONAL INFORMATION 9
     
A. Share Capital 9
B. Memorandum and Articles of Association 9
C. Material Contracts 11
D. Exchange Controls 11
E. Taxation 11
F. Dividends and Paying Agents 12
G. Statement by Experts 12
H. Documents on Display 12
I. Subsidiary Information 12
     
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 12
     
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 12
     
PART II 12
   
PART III 12
   
ITEM 17. FINANCIAL STATEMENTS 12
     
ITEM 18. FINANCIAL STATEMENTS 12
     
ITEM 19. EXHIBITS 12

 

  3  

 

 

INTRODUCTORY NOTES

 

Use of Certain Defined Terms

 

Except as otherwise indicated by the context and for the purpose of this report only, references in this report to:

 

· “Clarivate” are to Clarivate Analytics Plc, a public limited company incorporated under the laws of Jersey, Channel Islands; and

 

· “Transactions” are to the Mergers and other transactions contemplated by the Agreement and plan of Merger, dated as of January 14, 2019 (as amended by Amendment No. 1 to the Agreement and plan of Merger, dated February 26, 2019, and Amendment No. 2 to the Agreement and plan of Merger, dated March 29, 2019, the “Merger Agreement”), by and among Churchill, Clarivate, CCC Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Clarivate (“Delaware Merger Sub”), Camelot Merger Sub (Jersey) Limited, a private limited company organized under the laws of Jersey, Channel Islands and wholly owned subsidiary of Clarivate (“Jersey Merger Sub”), and Camelot Holdings (Jersey) limited, a private limited company organized under the laws of Jersey, Channel Islands (the “Company”), which, among other things, provides for (i) Jersey Merger Sub to be merged with and into the Company with the Company being the surviving company in the merger (the “Jersey Merger”) and (ii) Delaware Merger Sub to be merged with and into Churchill with Churchill being the surviving corporation in the merger (the “Delaware Merger”, and together with the Jersey Merger the “Mergers”).

 

Forward-Looking Information

 

This report includes statements that express Clarivate’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will” or “should” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this report and include statements regarding our intentions, beliefs or current expectations concerning, among other things, the Transactions, the benefits and synergies of the Transactions, including anticipated cost savings, results of operations, financial condition, liquidity, prospects, growth, strategies and the markets in which the Company operates. Such forward-looking statements are based on available current market material and management’s expectations, beliefs and forecasts concerning future events impacting Clarivate. You are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, as well as assumptions, which, if they were to ever materialize or prove incorrect, could cause the results of Clarivate to differ materially from those expressed or implied by such forward-looking statements. Potential risks and uncertainties include those generally set forth under Item 3 “Key information—D. Risk Factors” and elsewhere in this report.

 

Readers are urged to carefully review and consider the various disclosures made by us in this report and our other filings with the SEC. These reports attempt to advise interested parties of the risks and factors that may affect our business, financial condition and results of operations and prospects. The forward-looking statements made in this report speak only as of the date hereof and we disclaim any obligation, except as required by law, to provide updates, revisions or amendments to any forward-looking statements to reflect changes in our expectations or future events.

 

  4  

 

 

PART I

 

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

 

A. Directors and Senior Management

 

Clarivate’s directors and executive officers immediately following the consummation of the Transactions are described in Clarivate’s Registration Statement on Form F-4, as amended (Registration No. 333-229889) (the “F-4”) under the heading “ Information About Executive Officers, Directors and Nominees ” beginning on page 117, which is incorporated herein by reference.

 

B. Advisors

 

Ogier (44 Esplanade, St Helier, Jersey, JE4 9WG) acts as Jersey, Channel Islands counsel to Clarivate. Latham & Watkins LLP (555 11th Street NW, Suite 1000, Washington, D.C., USA, 20004) acts as United States counsel to Clarivate.

 

C. Auditors

 

From Clarivate’s inception through the consummation of the Transactions, PricewaterhouseCoopers LLP, an independent registered public accounting firm (2001 Market Street #1800, Philadelphia, PA 19103), has acted as the Company’s independent registered public accounting firm.

 

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

 

A. Offer Statistics

 

Not applicable.

 

B. Method and Expected Timetable

 

Not applicable.

 

ITEM 3. KEY INFORMATION

 

A. Selected Financial Data

 

Information regarding Clarivate’s selected financial data is described in Clarivate’s F-4 under the heading “ Selected Historical Financial Information ” beginning on page 160, which is incorporated herein by reference.

 

B. Capitalization and Indebtedness

 

Not applicable.

 

C. Reasons for the Offer and Use of Proceeds

 

Not applicable.

 

D. Risk Factors

 

The risks associated with our business are described in Clarivate’s F-4 under the heading “ Risk Factors ” beginning on page 32, which is incorporated herein by reference.

 

ITEM 4. INFORMATION ON THE COMPANY

 

A. History and Development of the Company

 

The history and development of Clarivate are described in Clarivate’s F-4 under the headings:

 

· Summary of the Material Terms of the Transaction ” beginning on page 5;
· The Business Combination Proposal ” beginning on page 74;

 

  5  

 

 

· Business of Clarivate—Our History ” on page 138; and
· Description of Clarivate’s Securities ” beginning on page 199.

 

These descriptions are incorporated herein by reference.

 

The U.S. Securities and Exchange Commission (“SEC”) maintains a website that contains reports, proxy and information statements, and other information regarding issuers (including Clarivate) that file electronically with the SEC at http://www.sec.gov . Clarivate also maintains a public website at http://www.clarivate.com .

 

B. Business Overview

 

The business of Clarivate is described in Clarivate’s F-4 under the heading “ Business of Clarivate ” beginning on page 137, which is incorporated herein by reference.

 

C. Organizational Structure

 

The chart below presents Clarivate’s simplified corporate structure as of the date of this report.

 

 

  6  

 

 

D. Property, Plants and Equipment

 

Information regarding Clarivate’s property, plants and equipment is described in Clarivate’s F-4 under the heading “ Business of Clarivate—Properties ” on page 147, which is incorporated herein by reference.

  

ITEM 4A. UNRESOLVED STAFF COMMENTS

 

Not required.

 

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

 

Reference is made to the disclosure contained in Clarivate’s F-4 under the heading “ Company’s Management’s Discussion and Analysis of Financial Condition and Results of Operations ” beginning on page 162 and that information is incorporated herein by reference.

 

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

 

A. Directors and Senior Management

 

Clarivate’s directors and executive officers immediately following the consummation of the Transactions are described in Clarivate’s F-4 under the heading “ Information About Executive Officers, Directors and Nominees ” beginning on page 117, which is incorporated herein by reference.

 

B. Compensation

 

The compensation of Clarivate’s executive officers and directors is described in Clarivate’s F-4 under the heading “ Director and Executive Compensation ” beginning on page 125, which is incorporated herein by reference.

 

C. Board Practices

 

Clarivate’s board practices immediately following the consummation of the Transactions are described in Clarivate’s F-4 under the heading “ Information About Executive Officers, Directors and Nominees ” beginning on page 117, which is incorporated herein by reference.

 

D. Employees

 

As of December 31, 2018, Clarivate had approximately 4,450 full-time and 130 part-time employees. The information in Clarivate’s F-4 under the heading “ Business of Clarivate—Employees ” on page 146 is incorporated herein by reference.

 

E. Share Ownership

 

Information regarding share ownership of Clarivate’s executive officers and directors is described in Clarivate’s F-4 under the heading “ Beneficial Ownership of Securities ” beginning on page 188, which is incorporated herein by reference. Information regarding arrangements for involving Clarivate employees in the capital of Clarivate is described in Clarivate’s F-4 under the heading “ Director and Executive Officer Compensation—Employee Share Plans ” beginning on page 125, which is incorporated herein by reference.

 

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

 

A. Major Shareholders

 

Please refer to Item 6 “Directors, Senior Management and Employees—E. Share Ownership.”

 

  7  

 

 

B. Related Party Transactions

 

Related party transactions are described in Clarivate’s F-4 under the heading “ Certain Relationships and Related Person Transactions ” beginning on page 194, which is incorporated herein by reference.

 

C. Interests of Experts and Counsel

 

Not applicable.

 

ITEM 8. FINANCIAL INFORMATION

 

A. Consolidated Statements and Other Financial Information

 

Financial Statements

 

Consolidated financial statements have been filed as part of this report. See Item 18 “Financial Statements.”

 

Legal Proceedings 

 

Legal or arbitration proceedings are described in Clarivate’s F-4 under the heading “ Business of Clarivate—Legal Proceedings ” on page 147 is incorporated herein by reference.

 

Dividend Policy

 

Clarivate’s policy on dividend distributions is described in Clarivate’s F-4 under the heading “ Price Range of Securities and Dividends—Dividend Policy ” on page 217 is incorporated herein by reference.

 

B. Significant Changes

 

Not applicable.

 

ITEM 9. THE OFFER AND LISTING

 

A. Offer and Listing Details

 

Offer and listing details of Clarivate’s securities are described in Clarivate’s F-4 under the headings:

 

· The Business Combination Proposal—Stock Symbols ” beginning on page 79;
· Description of Clarivate’s Securities ” beginning on page 199; and
· Price Range of Securities and Dividends ” beginning on page 216.

 

These descriptions are incorporated herein by reference.

 

B. Plan of Distribution

 

Not applicable.

 

C. Markets

 

See disclosures above under “—A. Offer and Listing Details.”

 

D. Selling Shareholders

 

Not applicable.

 

  8  

 

 

E. Dilution

 

Not applicable.

 

F. Expenses of the Issue

 

Not applicable.

 

ITEM 10. ADDITIONAL INFORMATION

 

A. Share Capital

 

Clarivate’s share capital is described in Clarivate’s F-4 under the headings:

 

· Description of Clarivate’s Securities—Shares ” beginning on page 199; and
· Description of Clarivate’s Securities—Description of Warrants ” beginning on page 201.

 

These descriptions are incorporated herein by reference.

 

B. Memorandum of Association and Articles of Association

 

The following represents a summary of certain key provisions of Clarivate’s memorandum of association and articles of association. The summary does not purport to be a summary of all of the provisions of Clarivate’s memorandum of association or articles of association. For more complete information you should read Clarivate’s amended and restated memorandum of association and articles of association which are listed as an exhibit to this report.

 

Clarivate was incorporated under the laws of Jersey, Channel Islands as a public limited company on January 7, 2019. Neither Clarivate’s memorandum of association nor the articles of association (the “Articles”) stipulate any particular objects or purposes of Clarivate and no objects or purposes are required to be stated by the Companies (Jersey) Law 1991 (the “Companies Law”).

 

Securities Registrar

 

Continental Stock Transfer & Trust Company is the transfer and registrar for the shares, with branch registers of transfers at 1 State Street 30 th Floor, New York, New York 10004.

 

Director’s Power to Vote on a Proposal, Arrangement or Contract in which the Director is Materially Interested

 

An interested director must disclose to Clarivate the nature and extent of any interest in a transaction with Clarivate, or one of its subsidiaries, which to a material extent conflicts or may conflict with its interests and of which the director is aware. Failure to disclose an interest entitles Clarivate or a shareholder to apply to the court for an order setting aside the transaction concerned and directing that the director account to Clarivate for any profit. A transaction is not voidable and a director is not accountable notwithstanding a failure to disclose an interest if the transaction is confirmed by special resolution and the nature and extent of the director’s interest in the transaction are disclosed in reasonable detail in the notice calling the meeting at which the resolution is passed.

 

Although it may still order that a director account for any profit, a court will not set aside a transaction unless it is satisfied that the interests of third parties who have acted in good faith would not thereby be unfairly prejudiced and the transaction was not reasonable and fair in Clarivate's interests at the time it was entered into.

 

Subject to the Articles and the Companies Law, a director may vote in respect of any contract or proposed contract or arrangement notwithstanding that he may be interested therein and if he does so his vote shall be counted and he may be counted in the quorum at any meeting of the directors at which any such contract or proposed contract or arrangement shall come before the meeting for consideration.

 

  9  

 

 

Directors’ Power, in the Absence of an Independent Quorum, to Vote Compensation to Themselves or Any Members of Their Body

 

The compensation of the directors is decided by the directors unless the board of directors specifically requests approval of the compensation from the shareholders. If the issuance of compensation to the directors is decided by the directors, a quorum is the majority of the directors in office. The Articles do not require that the compensation of any director be approved by disinterested directors.

 

Clarivate has a compensation committee which is currently composed of four independent directors and one non-independent director. The compensation committee makes recommendations to the board with respect to compensation.

 

Borrowing Powers Exercisable by the Directors and How Such Borrowing Powers May Be Varied

 

Subject to the Companies Law and any resolutions made in a general meeting, the board may exercise all Clarivate's powers to borrow money, to guarantee, to indemnify and to mortgage or charge all or any part of Clarivate's undertaking, property and assets (present and future).

 

Retirement and Non-Retirement of Directors Under an Age Limit Requirement

 

There are no such provisions applicable to Clarivate under the Articles or the Companies Law.

 

Number of Shares Required for a Director’s Qualification

 

Under the Articles, the directors are not required to hold any shares as qualification for service on the board.

 

Rights, Preferences and Restrictions Attaching to Each Class of Shares

 

No preference shares are currently issued and outstanding. Preference shares may be issued from time to time in one or more series composed of such number of shares with such voting powers (full or limited or without voting powers), designations, preferences and relative, participating, optional or other special rights and qualifications, limitations or restrictions thereof as may be determined by the board of directors of Clarivate .

 

The holders of ordinary shares of Clarivate are entitled to such dividends as may be declared by the board of directors of Clarivate, subject to the Companies Law and the Articles. Dividends and other distributions on issued and outstanding ordinary shares may be paid out of the funds of Clarivate lawfully available for such purpose, subject to any preference of any outstanding preferred shares of Clarivate. Dividends and other distributions will be distributed among the holders of ordinary shares of Clarivate on a pro rata basis.

 

Each ordinary share of Clarivate entitles the holder to one vote on all matters upon which the ordinary shares of Clarivate are entitled to vote. Voting at any shareholders’ meeting is by way of poll.

 

The holders of ordinary shares of Clarivate are also entitled to the distribution of the residual assets of Clarivate in the event of a liquidation, dissolution or winding up of Clarivate.

 

Clarivate's ordinary shares do not have pre-emptive rights to purchase additional shares.

 

Action Necessary to Change the Rights of Holders of the Stock, Indicating Where the Conditions Are More Significant Than Is Required by Law

 

The rights attached to any class of shares of Clarivate (unless otherwise provided by the terms of issue of that class), such as voting, dividends and the like, may be varied only with the sanction of a special resolution passed at a general meeting or by the written consent of the holders of two-thirds of the shares of that class or with the sanction of a resolution passed by a majority of not less than two-thirds of the votes cast at a separate meeting of the holders of the shares of that class. The rights conferred upon the holders of the shares of any class shall not (unless otherwise provided by the terms of issue of that class) be deemed to be varied by the creation or issue of further shares ranking in priority to or pari passu with such previously existing shares.

 

  10  

 

 

Meetings of Shareholders

 

The Articles require Clarivate to call an annual general meeting of shareholders within 18 months after holding the last preceding annual general meeting and permits Clarivate to call any other meeting of shareholders at any time. Clarivate is required to send a notice of meeting to registered shareholders not less than 14 clear days and not more than 60 days prior to the date of any annual or other general meeting of shareholders. The Articles provide that a quorum of shareholders in person or represented by proxy holding or representing by proxy not less than a simple majority of all voting share capital of Clarivate at the meeting is required to transact business at a general meeting, provided that the minimum quorum for any meeting shall be two shareholders entitled to vote. Shareholders, and their duly appointed proxies and corporate representatives, as well as Clarivate’s directors and auditors, are entitled to be admitted to Clarivate’s annual and other general meetings of shareholders.

 

Limitations on the Right to Own Securities

 

There are no limitations on the rights to own securities in Clarivate.

 

Limitations on Restructuring

 

There is no provision in the Articles that would have the effect of placing any limitations on any corporate restructuring in addition to what would otherwise be required by applicable law.

 

Disclosure of Share Ownership

 

There are no such provisions applicable to Clarivate under the Articles or the Companies Law.

 

C. Material Contracts

 

Information concerning Clarivate’s material contracts governing the business of Clarivate is included elsewhere in this report or in the information incorporated by reference herein.

 

D. Exchange Controls

 

Jersey Exchange Controls

 

There are no governmental laws, decrees or regulations existing in Jersey, Channel Islands, which restrict the export or import of capital, or the remittance of dividends, interest or other payments to non-resident holders of Clarivate's securities, nor does Jersey, Channel Islands have foreign exchange currency controls.

 

E. Taxation

 

The material United States federal income tax consequences of the Transactions are described in Clarivate’s F-4 under the headings:

 

· The Business Combination Proposal—Material United States Federal Income Tax Consequences of the Business Combination to Churchill Security Holders ” beginning on page 93;
· The Business Combination Proposal—U.S. Federal Income Tax Considerations of the Delaware Merger to U.S. Holders ” beginning on page 94;
· The Business Combination Proposal—U.S. Federal Income Tax Considerations of the Delaware Merger to Non-U.S. Holders ” on page 98; and
· The Business Combination Proposal—U.S. Federal Income Tax Consequences of the Ownership and Disposition of Clarivate Ordinary Shares and Warrants ” beginning on page 99.

 

These descriptions are incorporated herein by reference.

 

  11  

 

 

F. Dividends and Paying Agents

 

Information regarding Clarivate’s policy on dividends is described in Clarivate’s F-4 under the heading “ Price Range of Securities and Dividends ” beginning on page 216, which is incorporated herein by reference. Clarivate has not identified a paying agent.

 

G. Statement by Experts

 

Not applicable.

 

H. Documents on Display

 

Clarivate has filed this report on Form 20-F with the SEC under the Exchange Act. Statements made in this report as to the contents of any document referred to are not necessarily complete. With respect to each such document filed as an exhibit to this report, reference is made to the exhibit for a more complete description of the matter involved, and each such statement shall be deemed qualified in its entirety by such reference.

 

Clarivate is subject to the informational requirements of the Exchange Act as a foreign private issuer and file reports and other information with the SEC. Reports and other information filed by Clarivate with the SEC, including this report, may be obtained from the SEC’s Internet site at http://www.sec.gov. The SEC’s telephone number is 1-800-SEC-0330.

 

As a foreign private issuer, Clarivate is exempt from the rules under the Exchange Act prescribing the furnishing and content of quarterly reports and proxy statements, and officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.

 

I. Subsidiary Information

 

Not applicable.

 

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Quantitative and qualitative disclosures about Clarivate’s market risk are described in Clarivate’s F-4 under the heading “ Quantitative and Qualitative Disclosures About Market Risk ” beginning on page 186, which are incorporated herein by reference.

 

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

 

A description of the rights of Clarivate’s securities other than equity securities is included Clarivate’s F-4 under the heading “ Description of Clarivate’s Securities ” beginning on page 199, which is incorporated herein by reference.

 

PART II

 

Not Required.

PART III

 

ITEM 17. FINANCIAL STATEMENTS

 

Not applicable.

 

ITEM 18. FINANCIAL STATEMENTS

 

The financial statements are filed as part of this report beginning on page F-1.

 

ITEM 19. EXHIBITS

 

The list of exhibits in the Exhibit Index to this report is incorporated herein by reference.

 

  12  

 

 

SIGNATURE

 

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this report on its behalf.

 

 Date: May 16, 2019 CLARIVATE ANALYTICS PLC
   
  /s/ Jay Nadler
  Jay Nadler
  Chief Executive Officer

 

  13  

 

 

INDEX TO FINANCIAL STATEMENTS

 

CAMELOT HOLDINGS (JERSEY) LIMITED

 

 

 

  Page
Consolidated Financial Statements for the Years Ended December 31, 2018 and 2017  
Report  of Independent Registered Public Accounting  Firm F-2
Consolidated Balance Sheets as of December 31, 2018 and 2017 F-3
Consolidated Statements  of Operations for the years ended December 31, 2018 and 2017 F-4
Consolidated Statements  of Comprehensive  Income (Loss) for the years ended December 31, 2018 and 2017 F-5
Consolidated Statements  of Changes in Equity for the years ended December 31, 2018 and 2017 F-6
Consolidated Statements  of Cash Flows for the years ended December 31, 2018 and 2017 F-7
Notes to the Consolidated Financial  Statements F-8
 
Interim Condensed Consolidated Financial Statements (Unaudited) for the Three Months Ended March 31, 2019 and 2018  
Interim Condensed Consolidated Balance Sheets as of March 31, 2019 and December 31, 2018 F-49
Interim Condensed Consolidated Statements of Operations for the three months ended March 31, 2019 and 2018 F-50
Interim Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2019 and 2018 F-51
Interim Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2019 and 2018 F-52
Interim Condensed Consolidated Statements of Cash Flows or the three months ended March 31, 2019 and 2018 F-53
Notes to Interim Condensed Consolidated Financial Statements F-55
   
Unaudited Pro Forma Condensed Combined Financial Statements for the Year Ended December 31, 2018  
Unaudited Pro Forma Condensed Combined Financial Statements F-69
Unaudited Pro Forma Condensed Combined Balance Sheet F-72
Unaudited Pro Forma Condensed Combined Statement of Operations F-74
Notes to Unaudited Pro Forma Condensed Combined Financial Information F-75

 

 

F- 1  

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Shareholders of

Camelot Holdings (Jersey) Limited

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Camelot Holdings (Jersey) Limited and its subsidiaries (the “Company”) as of December 31, 2018 and 2017, and the related consolidated statements of operations, comprehensive income (loss), changes in equity and cash flows for the years then ended, including the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2018 and 2017, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/PricewaterhouseCoopers LLP  
Philadelphia, Pennsylvania  
February 26, 2019  

 

We have served as the Company’s or it predecessor’s auditor since 2016.

 

F- 2  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands except share and per share data)

 

    As of December 31,  
    2018     2017  
Assets                
Current  assets:                
Cash and cash equivalents   $ 25,575     $ 53,186  
Restricted cash     9       24,362  
Accounts receivable, less allowance for doubtful  accounts of $14,076 and $8,495 at December 31, 2018 and December 31, 2017, respectively     331,295       317,808  
Prepaid expenses     31,021       28,395  
Other current assets     20,712       20,157  
Total current assets     408,612       443,908  
Computer hardware and other property, net     20,641       23,010  
Identifiable intangible assets, net     1,958,520       2,160,087  
Goodwill     1,282,919       1,311,253  
Other non-current assets     26,556       60,029  
Deferred income taxes     12,426       6,824  
Total Assets   $ 3,709,674     $ 4,005,111  
                 
Liabilities and Shareholders’ Equity                
Current  liabilities:                
Accounts payable   $ 38,418     $ 60,758  
Accrued expenses and other current liabilities     153,849       193,710  
Current portion of deferred revenues     391,102       361,260  
Short-term debt, including current portion of long-term debt     60,345       45,345  
Total current liabilities     643,714       661,073  
Long-term debt     1,930,177       1,967,735  
Non-current portion of deferred revenues     17,112       15,796  
Other non-current liabilities     24,838       22,609  
Deferred income taxes     43,226       51,792  
Total liabilities     2,659,067       2,719,005  
                 
Commitments and Contingencies (Note 19)                
Shareholders’ equity:                
Share capital, $0.01 par value; 2,000,000 shares authorized at December 31, 2018 and December 31, 2017; 1,646,223 and 1,644,720 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively     16       16  
Additional paid-in capital     1,677,494       1,662,205  
Accumulated other comprehensive income     5,358       13,984  
Accumulated deficit     (632,261 )     (390,099 )
Total shareholders’ equity     1,050,607       1,286,106  
Total Liabilities and Shareholders’ Equity   $ 3,709,674     $ 4,005,111  

 

The accompanying notes are an integral part of these financial statements.

 

F- 3  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands)

 

    Years Ended December 31,  
    2018     2017  
Revenues, net   $ 968,468     $ 917,634  
Operating  costs and expenses:                
Cost of revenues, excluding depreciation and amortization     (396,499 )     (394,215 )
Selling, general and administrative costs, excluding depreciation and amortization     (369,377 )     (343,143 )
Share-based compensation expense     (13,715 )     (17,663 )
Depreciation     (9,422 )     (6,997 )
Amortization     (227,803 )     (221,466 )
Transaction expenses     (2,457 )     (2,245 )
Transition, integration and other     (61,282 )     (78,695 )
Other operating income (expense), net     6,379       (237 )
Total operating expenses     (1,074,176 )     (1,064,661 )
Loss from operations     (105,708 )     (147,027 )
Interest expense, net     (130,805 )     (138,196 )
Loss before income tax     (236,513 )     (285,223 )
Benefit (provision) for income taxes     (5,649 )     21,293  
Net loss   $ (242,162 )   $ (263,930 )
                 
Per share:                
Basic   $ (147.14 )   $ (160.83 )
Diluted   $ (147.14 )   $ (160.83 )
                 
Weighted-average shares outstanding:                
Basic     1,645,818       1,641,095  
Diluted     1,645,818       1,641,095  

 

The accompanying notes are an integral part of these financial statements.

 

F- 4  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In thousands)

 

    Years Ended December 31,  
    2018     2017  
Net loss   $ (242,162 )   $ (263,930 )
Other comprehensive income (loss):                
Interest rate swaps, net of $0 tax in all periods     2,537       1,107  
Defined benefit pension plans, net of tax (benefit) provision of ($91) and $430, respectively     (17 )     881  
Foreign currency translation adjustments     (11,146 )     15,466  
Total other comprehensive income (loss)     (8,626 )     17,454  
Comprehensive loss   $ (250,788 )   $ (246,476 )

 

The accompanying notes are an integral part of these financial statements.

 

F- 5  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Dollars in thousands except share data)

 

                      Accumulated              
        Additional     Other           Total  
    Share Capital     Paid-In     Comprehensive     Accumulated     Shareholders’  
    Shares     Amount     Capital     Income (Loss)     Deficit     Equity  
Balance at December 31, 2016     1,635,000     $ 16     $ 1,634,984     $ (3,470 )   $ (126,169 )   $ 1,505,361  
Issuance of common stock, net.     9,720             9,558                   9,558  
Share-based compensation                 17,663                   17,663  
Comprehensive  Income (loss)                       17,454       (263,930 )     (246,476 )
Balance at December 31, 2017     1,644,720       16       1,662,205       13,984       (390,099 )     1,286,106  
Issuance of common stock, net.     1,503             1,574                   1,574  
Share-based compensation                 13,715                   13,715  
Comprehensive loss                       (8,626 )     (242,162 )     (250,788 )
Balance at December 31, 2018     1,646,223     $ 16     $ 1,677,494     $ 5,358     $ (632,261 )   $ 1,050,607  

 

The accompanying notes are an integral part of these financial statements

 

F- 6  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

    Years Ended December 31,  
    2018     2017  
Cash Flows From Operating  Activities                
Net loss   $ (242,162 )   $ (263,930 )
Adjustments to reconcile net loss to net cash provided by operating activities:                
Depreciation and amortization     237,225       228,463  
Bad debt expense     6,507       6,505  
Deferred income tax benefit     (14,103 )     (36,272 )
Share-based compensation     13,715       17,663  
Gain on sale of IPM Product Line     (39,104 )      
Deferred finance charges     9,182       23,510  
Tax indemnity write-off     33,819        
Other operating activities     (3,979 )     2,548  
Changes in operating  assets and liabilities:                
Accounts receivable     (50,906 )     43,109  
Prepaid expenses     (2,936 )     (4,052 )
Other assets     578       10,799  
Accounts payable     (18,091 )     (39,660 )
Accrued expenses and other current liabilities     9,842       (6,038 )
Deferred revenues     33,539       18,751  
Other liabilities     774       5,271  
Net cash (used in) provided by operating activities     (26,100 )     6,667  
Cash Flows From Investing Activities                
Capital expenditures     (45,410 )     (37,804 )
Acquisitions, net of cash acquired     (23,539 )     (7,401 )
Proceeds from sale of Product Line, net of restricted cash     80,883        
Proceeds from sale of equity method investment           5,000  
Net cash (used in) provided by investing activities     11,934       (40,205 )
Cash Flows used in Financing  Activities                
Borrowings of debt     45,000       30,000  
Repayment of principal on long-term debt     (46,709 )     (15,423 )
Repayment of revolving credit facility     (30,000 )      
Payment of debt issuance costs           (817 )
Contingent purchase price payment     (2,470 )      
Issuance of common stock, net     1,574       9,058  
Net cash (used in) provided by financing activities     (32,605 )     22,818  
Effects of exchange rates     (5,193 )     3,248  
Net changes in cash and cash equivalents, and restricted cash     (51,964 )     (7,472 )
                 
Beginning of period:                
Cash and cash equivalents     53,186       77,136  
Restricted cash     24,362       7,884  
Total cash and cash equivalents, and restricted cash, beginning of period     77,548       85,020  
Cash and cash equivalents, and restricted cash, end of period     25,584       77,548  
Cash and cash equivalents     25,575       53,186  
Restricted cash     9       24,362  
Total cash and cash equivalents, and restricted cash, end of period   $ 25,584     $ 77,548  
                 
Supplemental Cash Flow Information                
Cash paid for interest   $ 121,916     $ 115,236  
Cash paid for income tax   $ 13,210     $ 14,722  
Capital expenditures included in accounts payable   $ 5,166     $ 2,473  

 

The accompanying notes are an integral part of these financial statements

 

F- 7  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Note 1:    Background and Nature of Operations

 

Camelot Holdings (Jersey) Limited and its subsidiaries (“Jersey,” “us,” “we,” “our,” or the “Company”) was formed on August 4, 2016 as a private limited liability company organized under the laws of the Island of Jersey. Its registered office is located at 4th Floor, St Paul’s Gate, 22-24 New Street, St Helier, Jersey JE1 4TR.

 

On July 10, 2016, Camelot UK Bidco Limited, a private limited liability company incorporated under the laws of England and Wales, and a direct wholly owned subsidiary of Camelot UK Holdco Limited, a direct wholly owned subsidiary (“UK Holdco”), collectively referred to as (“Bidco”), entered into a separation agreement to acquire (i) certain assets and liabilities related to the Intellectual Property & Science business (“IP&S”) business from Thomson Reuters Corporation (“Former Parent”) and (ii) all of the equity interests and substantially all of the assets and liabilities of certain entities engaged in the IP&S business together with their subsidiaries (“2016 Transaction”). The 2016 Transaction total consideration was $3,566,599, net of cash acquired. Jersey is owned by affiliates of Onex Corporation and private investment funds managed by Baring Private Equity Asia GP VI, L.P (“Baring”) and certain co-investors and is controlled by Onex Corporation.

 

The Company is a provider of proprietary and comprehensive content, analytics, professional services and workflow solutions that enables users across government and academic institutions, life science companies and research and development (“R&D”) intensive corporations to discover, protect and commercialize their innovations.

 

Our Science Group consists of our Web of Science and Life Science Product Lines. Both product lines provide curated, high-value, structured information that is delivered and embedded into the workflows of our customers, which include research intensive corporations, life science organizations and universities world-wide. Our Intellectual Property Group consists of our Derwent, CompuMark and MarkMonitor Product Lines. These Product lines help manage customer’s end-to-end portfolio of intellectual property from patents to trademarks to corporate website domains.

 

Prior Period Expense Reclassifications

 

In conjunction with the implementation of a new enterprise resource planning system during the quarter ended September 30, 2018, the Company performed an assessment of its Cost of revenues (COR) and Selling, general & administrative expenses (SG&A). As a result of this assessment, certain errors in classification between COR and SG&A were identified, impacting prior periods. Similarly, the Company reclassified certain costs between COR and SG&A. Accordingly, the Company has performed a reclassification of certain prior period amounts to conform to the present period presentation. The Company has concluded that the reclassifications were not material individually or in aggregate to previously issued financial statements.

 

The following table details the impact of the reclassifications on the Consolidated Statements of Operations for 2017.

 

    Year Ended December 31, 2017  
    As Previously           As  
    Reported     Adjustment     Reclassified*  
Consolidated Statements of Operations                        
Cost of revenues, excluding depreciation and amortization   $ (422,213 )   $ 27,949     $ (394,264 )
Selling, general and administrative costs, excluding depreciation and  amortization   $ (318,887 )   $ (27,949 )   $ (346,836 )

 

 
* The “As reclassified” balance is prior to newly adopted accounting standards discussed in Note 3 — Summary of Significant Accounting Policies.

 

F- 8  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

We have also reclassified prior period Accounts payable to Accrued expenses and other current liabilities in our Consolidated Balance Sheets to conform to the current period presentation. These items had no impact in our Consolidated Statement of Operations or Consolidated Statement of Cash Flows.

 

Note 2:   Basis of Presentation

 

The accompanying consolidated financial statements for the years ended December 31, 2018 and 2017, respectively, were prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements of the Company include the accounts of all of its subsidiaries. Subsidiaries are entities over which the Company has control, where control is defined as the power to govern financial and operating policies. Generally, the Company has a shareholding of more than 50% of the voting rights in its subsidiaries. The effect of potential voting rights that are currently exercisable are considered when assessing whether control exists. Subsidiaries are fully consolidated from the date control is transferred to the Company, and are de-consolidated from the date control ceases. The U.S. dollar is Jersey’s reporting currency. As such, the financial statements are reported on a U.S. dollar basis.

 

Note 3:   Summary of Significant Accounting Policies

 

Business combinations

 

The Company determines whether substantially all the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If this threshold is met, the set is not a business. If it is not met, the Company then evaluates whether the set meets the requirement that a business include, at a minimum, an input and as substantive process that together significantly contribute to the ability to create outputs.

 

Business combinations are accounted for using the acquisition method at the acquisition date, which is when control is obtained. The consideration transferred is generally measured at fair value, as are the identifiable assets acquired and liabilities assumed. During the one-year period following the acquisition date, if an adjustment is identified based on new information about facts and circumstances that existed as of the acquisition date, the Company will record measurement-period adjustments related to the acquisitions in the period in which the adjustment is identified.

 

Goodwill is measured at the acquisition date as the fair value of the consideration transferred (including, if applicable, the fair value of any previously held equity interest and any non-controlling interests) less the net recognized amount (which is generally the fair value) of the identifiable assets acquired and liabilities assumed.

 

Transaction costs, other than those associated with the issuance of debt or equity securities incurred in connection with a business combination, are expensed as incurred and included in Transaction expenses in the Consolidated Statements of Operations.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts and operations of the Company, and its subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation.

 

F- 9  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. The most important of these relate to share-based compensation expenses, revenues recognition, the allowance for doubtful accounts, internally developed computer software, valuation of goodwill and other identifiable intangible assets, determination of the projected benefit obligations of the defined benefit plans, income taxes, fair value of stock options, derivatives and financial instruments, contingent earn-out, and the tax related valuation allowances. On an ongoing basis, management evaluates these estimates, assumptions and judgments, in reference to historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

 

Cash and Cash Equivalents

 

Cash and cash equivalents is comprised of cash on hand and short-term deposits with an original maturity at the date of purchase of three months or less.

 

Restricted Cash

 

As of December 31, 2017, the Company’s restricted cash primarily related to funds the Company has received from customers in advance of paying patent renewals on behalf of those customers. This activity was specific to the IPM Product Line, which was sold on October 1, 2018 (See Note 5: Divested Operations, for further details), and was $0 at December 31, 2018.

 

Accounts Receivable

 

Accounts receivable are presented net of the allowance for doubtful accounts and any discounts. Accounts receivable are recorded at the invoiced amount and do not bear interest. Collections of accounts receivable are included in cash provided by operating activities in the Consolidated Statements of Cash Flows. The Company maintains an allowance for doubtful accounts for estimated losses and assesses its adequacy each reporting period by evaluating factors such as the length of time receivables are past due, historical collection experience, and the economic and competitive environment. The expense related to doubtful accounts is included within Selling, general and administrative costs, excluding depreciation and amortization in the Consolidated Statements of Operations. Account balances are written off against the allowance when the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers.

 

Concentration of Credit Risk

 

Accounts receivable are the primary financial instrument that potentially subjects the Company to significant concentrations of credit risk. Account receivable represents arrangements in which services were transferred to a customer before the customer pays consideration or before payment is due. Contracts with payment in arrears are recognized as receivables after the Company considers whether a significant financing component exists. The Company does not require collateral or other securities to support customer receivables. Management performs ongoing credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed appropriate. Credit losses have been immaterial and reasonable within management’s expectations. No single customer accounted for more than 1% of revenues and our ten largest customers represented only 6% of revenues for the year ended December 31, 2018.

 

The Company maintains its cash and cash equivalent balances with high-quality financial institutions and consequently, the Company believes that such funds are subject to minimal credit risk.

 

Prepaid Assets

 

Prepaid assets represent amounts that the Company has paid in advance of receiving benefits or services. Prepaid assets include amounts for system and service contracts, sales commissions, deposits, prepaid royalties and insurance and are recognized as an expense over the general contractual period that the Company expects to benefit from the underlying asset or service.

 

F- 10  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Computer Hardware and Other Property

 

Generally, computer hardware and other property are recorded at cost and are depreciated over the respective estimated useful lives. Upon the 2016 Transaction, computer hardware and other property were revalued and recorded at net book value, which approximated fair value at the 2016 Transaction.

 

Depreciation is computed using the straight-line method. Repair and maintenance costs are expensed as incurred. The cost and related accumulated depreciation of sold or retired assets are removed from the accounts and any gain or loss is included within loss from operations in the Consolidated Statements of Operations.

 

The estimated useful lives are as follows:

 

Computer hardware 3 years
Furniture, fixtures and equipment 5 – 7 years
Leasehold improvements Lesser of lease term or estimated useful life

 

Computer Software

 

Development costs related to internally generated software are capitalized once a project has progressed beyond a conceptual, preliminary stage to that of the application development stage. Costs of significant improvements on existing software for internal use, both internally developed and purchased, are also capitalized. Costs related to the preliminary project stage, data conversion and post implementation/ operation stage of an internal use software development project are expensed as incurred.

 

Capitalized costs are amortized over five years, which is the estimated useful life of the related software. Purchased software is amortized over three years, which is the estimated useful life of the related software. The capitalized amounts, net of accumulated amortization, are included in Identifiable intangible assets, net in the Consolidated Balance Sheets. The cost and related accumulated amortization of sold or retired assets are removed from the accounts and any gain or loss is included in operating expense.

 

Computer software is evaluated for impairment whenever circumstances indicate the carrying amount may not be recoverable. The test for impairment compares the carrying amounts with the sum of undiscounted cash flows related to the asset. If the carrying value is greater than the undiscounted cash flows of the asset, the asset is written down to its estimated fair value.

 

Identif iable Intangible Assets, net

 

Upon acquisition, identifiable intangible assets are recorded at fair value and are carried at cost less accumulated amortization or accumulated impairment for indefinite-lived intangible assets. Useful lives are reviewed at the end of each reporting period and adjusted if appropriate. Fully amortized assets are retained in cost and accumulated amortization accounts until such assets are derecognized.

 

Customer Relationships — Customer relationships primarily consist of customer contracts and customer relationships arising from such contracts.

 

Databases and Content — Databases and content primarily consists of repositories of the Company’s specific financial and customer information, and intellectual content.

 

Trade Names — Trade names consist of purchased brand names that the Company continues to use.

 

F- 11  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Where applicable, intangible assets are amortized on a straight-line basis over their estimated useful lives as follows:

 

Customer  relationships 2 – 14 years
Databases and content 13 – 20 years
Trade names Indefinite

 

Impairment of Long-lived Assets

 

Residual values and useful lives are reviewed at the end of each reporting period and adjusted if appropriate. The Company evaluates its long-lived assets, including computer hardware and other property, computer software, and finite-lived intangible assets for impairment whenever circumstances indicate that their carrying amounts may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate over its remaining life. An asset is assessed for impairment at the lowest level that the asset generates cash inflows that are largely independent of cash inflows from other assets. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. Management determined that no impairment existed for any of the periods presented.

 

Goodwill and Indef inite-Lived Intangible Assets

 

The Company evaluates its goodwill for impairment at the reporting unit level, defined as an operating segment or one level below an operating segment, annually as of October 1 or more frequently if impairment indicators arise in accordance with ASC Topic 350. The Company identified one reporting unit for the year ended December 31, 2017 and five reporting units due to a change in the Company’s reporting structure for the year ended December 31, 2018.

 

The Company evaluates the recoverability of goodwill using a two-step impairment test approach at the reporting unit level. In the first step, the Company assesses various qualitative factors to determine whether the fair value of a reporting unit may be less than its carrying amount. If a determination is made that, based on the qualitative factors, an impairment does not exist, the Company is not required to perform further testing. If the aforementioned qualitative assessment results in the Company concluding that it is more likely than not that the fair value of a reporting unit may be less than its carrying amount, the fair value of the reporting unit will be determined and compared to its carrying value including goodwill.

 

In determining the fair value of a reporting unit, the Company estimates the fair value of a reporting unit using the fair value derived from the income approach, which is a change from the previous year which used a market approach. The market approach estimates fair value based on market multiples of revenues and earnings derived from comparable publicly-traded companies with similar operating and investment characteristics as the reporting unit; whereas, the income approach uses a discounted cash flow (“DCF”) model. The DCF model determines the fair value of our reporting units based on projected future discounted cash flows, which in turn were based on our views of uncertain variables such as growth rates, anticipated future economic conditions, and the appropriate discount rates relative to risk and estimates of residual values.

 

If the fair value of the reporting unit exceeds the carrying value of the net assets assigned to that unit, goodwill is not impaired and the Company is not required to perform further testing. If the fair value of the reporting unit is less than the carrying value, the Company will recognize the difference as an impairment charge. Management concluded that no goodwill impairment existed for any of the periods presented.

 

The Company also has indefinite-lived intangible assets related to trade names. Indefinite-lived intangible assets are subject to impairment testing annually or whenever events or changes in circumstances indicate that their carrying value may not be recoverable. For purposes of impairment testing, the fair value of trade names is determined using an income approach, specifically the relief from royalties method. Management concluded that no indefinite-lived intangible impairment existed for any of the periods presented.

 

F- 12  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Other Current and Non-Current Assets and Liabilities

 

The Company defines current assets and liabilities as those from which it will benefit from or which it has an obligation for within one year that do not otherwise classify as assets or liabilities separately reported on the Consolidated Balance Sheets. Other non-current assets and liabilities are expected to benefit the Company or cause its obligation beyond one year. The Company classifies the current portion of long-term assets and liabilities as current assets or liabilities.

 

Leases

 

Leases are classified as either operating or capital, based on the substance of the transaction at inception of the lease. Classification is re-assessed if the terms of the lease are changed.

 

Leases in which a significant portion of the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments under an operating lease (net of any incentives received from the lessor) are recognized in the Consolidated Statements of Operations on a straight-line basis over the period of the lease. The Company does not currently have any capital leases.

 

Accounts Payable and Accruals

 

Accounts payable and accruals are obligations to pay for goods or services that have been acquired in the ordinary course of business. Accounts payable and accruals are recognized initially at their settlement value, and are classified as current liabilities if payment is due within one year or less.

 

Debt

 

Debt is recognized initially at par value, net of any applicable discounts or financing costs. Debt is subsequently stated at amortized cost with any difference between the proceeds (net of transactions costs) and the redemption value recognized in the Consolidated Statements of Operations over the term of the debt using the effective interest method. Interest on indebtedness is expensed as incurred.

 

Debt is classified as a current liability when due within 12 months after the end of the reporting period.

 

Derivative Financial Instruments

 

Foreign Exchange Derivative Contracts

 

Prior to the sale of IPM, the Company used derivative financial instruments to manage foreign currency exchange rate risk in IPM. The Company’s derivative financial instruments consist of foreign currency forward contracts (“forward contracts”). Derivative financial instruments were neither held nor issued by the Company for trading purposes.

 

Interest Rate Swaps

 

The Company has interest rate swaps with counterparties to reduce its exposure to variability in cash flows relating to interest payments on a portion of its outstanding first lien senior secured term loan facility in an aggregate principal amount of $1,550,000 (“Term Loan Facility”). The Company applies hedge accounting and has designated these instruments as cash flow hedges of the risk associated with floating interest rates on designated future quarterly interest payments. Management assumes the hedge is highly effective and therefore changes in the value of the hedging instrument are recorded in Accumulated other comprehensive income in the Consolidated Balance Sheets. Any ineffectiveness is recorded in earnings. Amounts in Accumulated other comprehensive income (loss) are reclassified into earnings in the same period during which the hedged transactions affect earnings, or upon termination of the hedging relationship.

 

F- 13  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Fair Value of Financial Instruments

 

In determining fair value, the use of various valuation methodologies, including market, income and cost approaches is permissible. The Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability. The accounting guidance for fair value measurements establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value based on the reliability of inputs. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company’s interest rate swap derivative instruments are classified as Level 2. Earn-out liabilities and defined benefit plan assets are classified as Level 3.

 

Contingent Considerations

 

The Company records liabilities for the estimated cost of such contingencies when expenditures are probable and reasonably estimable. A significant amount of judgment is required to estimate and quantify the potential liability in these matters. We engage outside experts as deemed necessary or appropriate to assist in the calculation of the liability, however management is responsible for evaluating the estimate. As information becomes available regarding changes in circumstances for ongoing contingent considerations, our potential liability is reassessed and adjusted as necessary. See Note 19 — Commitments and Contingencies for further information on contingencies.

 

Pension and Other Post-Retirement Benefits

 

The Company may be required to sponsor pension benefit plans, for certain international markets, which are unfunded and are not significant for the Company. The net periodic pension expense is actuarially determined on an annual basis by independent actuaries using the projected unit credit method. The determination of benefit expense requires assumptions such as the discount rate, which is used to measure service cost, benefit plan obligations and the interest expense on the plan obligations. Other significant assumptions include expected mortality, the expected rate of increase with respect to future compensation and pension. Because the determination of the cost and obligations associated with employee future benefits requires the use of various assumptions, there is measurement uncertainty inherent in the actuarial valuation process. Actual results will differ from results which are estimated based on assumptions.

 

The liability recognized in the Consolidated Balance Sheet is the present value of the defined benefit obligation at the end of the reporting period. The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of high-quality corporate bonds that are denominated in the currency in which the benefits will be paid and that have terms to maturity approximating the terms of the related pension liability. The defined benefit obligation is included in Other non-current liabilities in the Consolidated Balance Sheets. All actuarial gains and losses that arise in calculating the present value of the defined benefit obligation are recognized immediately in accumulated deficit and included in the consolidated statement of comprehensive income (loss). See Note 11 — Pension and Other Post Retirement Benefits for balances and further details including an estimate of the impact on the consolidated financial statements from changes in the most critical assumptions.

 

F- 14  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Employer contributions to defined contribution plans are expensed as incurred, which is as the related employee service is rendered.

 

Certain prior year amounts have been reclassified to conform to current year presentation.

 

Taxation

 

The Company recognizes income taxes under the asset and liability method. Our income tax expense, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect our best assessment of estimated current and future taxes to be paid. Significant judgments and estimates are required in determining the consolidated income tax expense for financial statement purposes. Deferred income taxes arise from temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements, which will result in taxable or deductible amounts in the future. In assessing the realizability of deferred tax assets, we consider future taxable income by tax jurisdiction and tax planning strategies. The Company records a valuation allowance to reduce our deferred tax assets to equal an amount that is more likely than not to be realized.

 

Changes in tax laws and tax rates could also affect recorded deferred tax assets and liabilities in the future. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. Accounting Standards Codification (ASC) Topic 740, Income Taxes, states that a benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of the technical merits. The Company first records unrecognized tax benefits as liabilities in accordance with ASC 740 and then adjusts these liabilities when our judgment changes as a result of the evaluation of new information not previously available at the time of establishing the liability. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the unrecognized tax benefit liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is available.

 

Interest accrued related to unrecognized tax benefits and income tax related penalties are included in the provision for income taxes.

 

Deferred tax is provided on taxable temporary differences arising on investments in foreign subsidiaries, except where we intend, and are able, to reinvest such amounts on a permanent basis.

 

Revenue Recognition

 

The Company derives revenue by selling information on a subscription and single transaction basis as well as from performing professional services. The Company recognizes revenues when control of these services are transferred to the customer for an amount, referred to as the transaction price, that reflects the consideration to which the Company is expected to be entitled in exchange for those goods or services. The Company determines revenue recognition utilizing the following five steps: (1) identification of the contract with a customer, (2) identification of the performance obligations in the contract (promised goods or services that are distinct), (3) determination of the transaction price, (4) allocation of the transaction price to the performance obligations, and (5) recognition of revenues when, or as, the Company transfers control of the product or service for each performance obligation. Revenues are recognized net of discounts and rebates, as well as value added and other sales taxes. Cash received or receivable in advance of the delivery of the services or publications is included in deferred revenues. The Company disaggregates revenue based on revenue recognition pattern. Subscription based revenues are recognized over time whereas our transactional revenues are recognized at a point in time. The Company believes subscription and transaction is reflective of how the Company manages the business. The revenues recognition policies for the Company’s revenue streams are discussed below.

 

F- 15  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Subscription Revenues

 

Subscription-based revenues are recurring revenues that are earned under annual, evergreen or multi-year contracts pursuant to which we license the right to use our products to our customers. Revenues from the sale of subscription data and analytics solutions are typically invoiced annually in advance and recognized ratably over the year as revenues are earned. Subscription revenues are typically generated either on (i) an enterprise basis, meaning that the organization has a license for the particular product or service offering and then anyone within the organization can use it at no additional cost, (ii) a seat basis, meaning each individual that uses the particular product or service offering has to have his or her own license, or (iii) a unit basis, meaning that incremental revenues are generated on an existing subscription each time the product is used (e.g., a trademark or brand is searched or assessed).

 

Transactional Revenues

 

Transactional revenues are revenues that are earned under contracts for specific deliverables that are typically quoted on a product, data set or project basis and often derived from repeat customers, including customers that also generate subscription based revenues. Revenues from the sale of transactional products and services are invoiced according to the terms of the contract, typically in arrears. Transactional content sales are usually delivered to the customer instantly or in a short period of time, at which time revenues are recognized. In the case of professional services, these contracts vary in length from several months to years for multi-year projects and customers and typically invoices based on the achievement of milestones. Transactional revenues are typically generated on a unit basis, although for certain product and service offerings transactional revenues are generated on a seat basis. Transactional revenues may involve sales to the same customer on multiple occasions but with different products or services comprising the order.

 

Performance Obligations

 

Content Subscription: Content subscription performance obligations are most prevalent in the Web of Science, Derwent, and Cortellis product lines. Content subscriptions are subscriptions that can only be accessed through the Company’s on-line platform for a specified period of time through downloads or access codes. In addition to the primary content subscription, these types of performance obligations can often include other performance obligations, such as training subscriptions, access to historical content, maintenance and other optional content. While revenues for these performance obligations are primarily recognized over the length of the contract (subscription revenues) there are instances where revenues could be recognized upon delivery (transactional revenue). Historical content and some optional content can be purchased via a perpetual license, which would be recognized upon delivery. Fees are typically paid annually at the beginning of each term.

 

Domain Registration Services: This performance obligation relates to the MarkMonitor Product Line. This is a service to register domain names with the applicable registries, with the Company being responsible for monitoring the domain name expiration and paying the registry before expiration. In addition, the Company has an ongoing responsibility to ensure the domain name is maintained at the registry. Customers typically sign a 1 – 2 year contract, identifying specific domain names to be registered and tracked. Revenue is recognized over the term of the contract and fees are typically invoiced annually at the beginning of each contract term.

 

Search Services: This performance obligation relates to the CompuMark Product Line. It is a comprehensive search report across multiple databases for a proposed trademark. The report is compiled by Clarivate’s analysts and sent to customers. Revenues are recognized upon delivery of the report. Fees are typically paid upon delivery.

 

Trademark Watch: This performance obligation relates to the CompuMark Product Line. Trademark watch service is an annual subscription that allows customers to protect their trademarks from infringement by providing timely notification of newly filed or published trademarks. Revenues are recognized over the term of the contract, with fees paid annually at the beginning of each contract term.

 

F- 16  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Patent Management: This performance obligation related to the IPM Product Line. The Company paid patent registration fees for customers in multiple countries to ensure their patents do not expire. Transaction fee Revenues were recognized at the time payment is made on the client’s behalf to the applicable patent office. Fees were paid annually at the beginning of each term.

 

Variable Consideration

 

In some cases, contracts provide for variable consideration that is contingent upon the occurrence of uncertain future events, such as retroactive discounts provided to the customers, indexed or volume based discounts, and revenues between contract expiration and renewal. Variable consideration is estimated at the expected value or at the most likely amount depending on the type of consideration. Estimated amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenues recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimate of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of its anticipated performance and all information (historical, current, and forecasted) that is reasonably available to the Company.

 

Significant Judgments

 

Significant judgments and estimates are necessary for the allocation of the proceeds received from an arrangement to the multiple performance obligations and the appropriate timing of revenues recognition. Our contracts with customers often include promises to transfer multiple products and services to a customer. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Determining a standalone selling price that may not be directly observable amongst all the products and performance obligations requires judgment. Specifically, many Web of Science Product Line contracts include multiple product offerings, which may have both subscription and transactional revenues. Judgment is also required to determine whether the software license is considered distinct and accounted for separately, or not distinct and accounted for together with the subscription service and recognized over time for other products. The Company allocates value to primary content subscriptions or licenses and accompanying performance obligations, such as training subscriptions, access to historical content, maintenance and other optional content. When multiple performance obligations exist in a single contract, the transaction price is allocated to each performance obligation based on the standalone selling price of each performance obligation. The Company utilizes its standard price lists to determine the standalone selling price based on the product and country.

 

The Company allocates the transaction price to each performance obligation based on the best estimate of the standalone selling price of each distinct good or service in the contract. The transaction price in the contract is allocated at contract inception to the distinct good or service underlying each performance obligation in proportion to the standalone selling price. The standalone selling prices are based on the Company’s normal pricing practices when sold separately with consideration of market conditions and other factors, including customer demographics and geographic location. Discounts applied to the contract will be allocated based on the same proportion of standalone selling prices.

 

Cost to Obtain a Contract

 

Commission costs represent costs to obtain a contract and are considered contract assets. The Company pays commissions to the sales managers and support teams for earning new customers and renewing contracts with existing customers. These commission costs are capitalized within Prepaid expenses and other non-current assets on the Consolidated Balance Sheet. The costs are amortized to Selling, general and administrative expenses within the Consolidated Statements of Operations. The amortization period is between one and five years based on the estimated length of the customer relationship.

 

F- 17  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Deferred Revenues

 

The timing of revenue recognition may differ from the timing of invoicing to customers. We record deferred revenues when revenues are recognized subsequent to invoicing. For multi-year agreements, we generally invoice customers annually at the beginning of each annual coverage period and recognize revenues over the term of the coverage period.

 

Cost of Revenues, Excluding Depreciation and Amortization

 

Cost of revenues consists of costs related to the production and servicing of the Company’s offerings. These costs primarily relate to information technology, production and maintenance of content and personnel costs relating to professional services and customer service.

 

Selling, General and Administrative, Excluding Depreciation and Amortization

 

Selling, general and administrative includes compensation for support and administrative functions in addition to rent, office expenses, professional fees and other miscellaneous expenses. In addition, it includes selling and marketing costs associated with acquiring new customers or selling new products or product renewals to existing customers. Such costs primarily relate to wages and commissions for sales and marketing personnel.

 

Depreciation

 

Depreciation expense relates to the Company’s fixed assets including furniture & fixtures, hardware, and leasehold improvements. These assets are depreciated over their expected useful lives, and in the case of leasehold improvements over the shorter of their useful life or the life of the related lease.

 

Amortization

 

Amortization expense relates to the Company’s finite-lived intangible assets including databases and content, customer relationships, and computer software. These assets are being amortized over periods of 2 to 20 years.

 

Share-Based Compensation

 

Share-based compensation expense includes cost associated with stock options granted to certain members of key management. The fair value of stock options is estimated at the date of grant using the Black-Scholes option pricing model, which requires management to make certain assumptions of future expectations based on historical and current data. The assumptions include the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate. The expected term represents the amount of time that options granted are expected to be outstanding, based on forecasted exercise behavior. The risk-free rate is based on the rate at grant date of zero-coupon U.S. treasury notes with a term comparable to the expected term of the option. Expected volatility is estimated based on the historical volatility of comparable public entities’ stock price from the same industry. The Company’s dividend yield is based on forecasted expected payments, which are expected to be zero for current plan. The Company recognizes compensation expense over the vesting period of the award on a straight-line basis. The Company elects to recognize forfeitures as they occur.

 

Transaction Expenses

 

Transaction expenses are incurred by the Company to complete business transactions, including acquisitions and disposals, and typically include advisory, legal and other professional and consulting costs.

 

F- 18  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Transition, Integration and Other

 

Transition, integration and other related expenses provide for the costs of transitioning certain activities performed by the Former Parent to the Company to enable operation on a stand-alone basis. Transition full time employee expense represents labor costs of full time employees who are currently working on migration projects and being expensed. Their traditional role is application development, which was capitalized.

 

Other operating income (expense), net

 

Other operating income (expense), net includes a tax indemnification write down related to the 2016 Transaction for the year ended December 31, 2018. See Note 19: Commitments and Contingencies ( Tax Indemnity ) for further details. The gain on sale of the divested IPM Product Line and related assets is also included in the year ended December 31, 2018. See Note 5: Divested Operations for further details.

 

Interest Expense

 

Interest expense consists of interest expense related to our borrowings under the Term Loan Facility and the Notes as well as the amortization of debt issuance costs and interest related to certain derivative instruments.

 

Foreign Currency Translation

 

The operations of each of the Company’s entities are measured using the currency of the primary economic environment in which the subsidiary operates (“functional currency”). Nonfunctional currency monetary balances are re-measured into the functional currency of the operation with any related gain or loss recorded in Selling, general and administrative costs, excluding depreciation and amortization in the accompanying Consolidated Statements of Operations. Assets and liabilities of operations outside the U.S., for which the functional currency is the local currency, are translated into U.S. dollars using period-end exchange rates. Revenues and expenses are translated at the average exchange rate in effect during each fiscal month during the year. The effects of foreign currency translation adjustments are included as a component of Accumulated other comprehensive income (loss) in the accompanying Consolidated Balance Sheets.

 

Comprehensive Income (Loss)

 

Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from net income, transactions and other events or circumstances from non-owner sources.

 

Advertising and Promotion Costs

 

Advertising and promotion costs are expensed as of the first date that the advertisements take place. Advertising expense was approximately $12,150 and $14,416 for the years ended December 31, 2018 and 2017.

 

Legal Costs

 

Legal costs are expensed as incurred.

 

Debt Issuance Costs

 

Fees incurred to issue debt are generally deferred and amortized as a component of interest expense over the estimated term of the related debt using the effective interest rate method.

 

F- 19  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Earnings Per Share

 

The calculation of earnings per share is based on the weighted average number of common shares or common stock equivalents outstanding during the applicable period. The dilutive effect of common stock equivalents is excluded from basic earnings per share and is included in the calculation of diluted earnings per share. Potentially dilutive securities include outstanding stock options. Employee equity share options and similar equity instruments granted by the Company are treated as potential common shares outstanding in computing diluted earnings per share. Diluted shares outstanding are calculated based on the average share price for each fiscal period using the treasury stock method. Under the treasury stock method, the amount the employee must pay for exercising stock options, the amount of compensation cost for future service that the Company has not yet recognized, and the amount of benefits that would be recorded in additional paid-in capital when the award becomes deductible for tax purposes are assumed to be used to repurchase shares.

 

Newly Adopted Accounting Standards

 

In May 2014, the FASB issued new guidance related to revenues from contracts with customers which supersedes previous revenue recognition requirements. This new guidance affects any entity that enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards. Areas of revenue recognition that are affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. We elected to adopt the standard using the full retrospective method effective January 1, 2018, which required us to revise each prior reporting period presented.

 

The Company implemented new policies, processes, and systems to enable both the preparation of financial information and internal controls over financial reporting in connection with its adoption of ASC 606. The most significant impact of the standard relates to our accounting for prepaid commissions as part of our cost of subscription contracts. Specifically, commissions paid for new customer sales are now being deferred over a five year life to match the new customer’s expected life and use of the Company’s own capitalized costs for related software technology. This five-year life is considered to cross products and capture the average value a customer benefits from purchasing the Company’s data and products. Additional impacts of the standard related to changes in the method of identifying performance obligations within our EndNote product of the Web of Science Product Line.

 

Adoption of the standard using the full retrospective method required us to restate certain previously reported results. Adoption of the standard related to revenue recognition impacted our previously reported results as follows:

 

      Year Ended December 31, 2017  
    As Previously     New Revenue
Standard
       
      Reported*     Adjustment     As Adjusted  
Statement of Operation                        
Revenues, net   $ 919,749       (2,115 )   $ 917,634  
Cost of revenues, excluding depreciation and amortization     (394,264 )     49       (394,215 )
Selling, general and administrative costs, excluding depreciation and amortization     (346,836 )     3,693       (343,143 )
Total operating expenses     (1,068,403 )     3,742       (1,064,661 )
Loss from operations     (148,654 )     1,627       (147,027 )
Loss before income tax     (286,850 )     1,627       (285,223 )
Net Loss   $ (265,557 )   $ 1,627     $ (263,930 )

 

F- 20  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

    December 31, 2017  
    As Previously     New Revenues
Standard
       
    Reported     Adjustment     As Adjusted  
Balance Sheet                        
Prepaid expenses   $ 29,465     $ (1,070 )   $ 28,395  
Total current assets     444,978       (1,070 )     443,908  
Other non-current assets     54,569       5,460       60,029  
Total assets     4,000,721       4,390       4,005,111  
Current portion of deferred revenues     356,002       5,258       361,260  
Total current liabilities     655,815       5,258       661,073  
Total liabilities     2,713,747       5,258       2,719,005  
Accumulated deficit     (389,231 )     (868 )     (390,099 )
Total Shareholders’ Equity     1,286,974       (868 )     1,286,106  
Total Liabilities and Shareholders’ Equity   $ 4,000,721     $ 4,390     $ 4,005,111  

 

* Reflects additional reclassifications of certain expenses to align the presentation with how the Company currently manages these expenses. Refer to Note 1 — Background and Nature of Operations for further details.

 

In August 2016, the FASB issued new guidance, ASU 2016-15, related to the statement of cash flows which addresses eight specific cash flow classification issues to reduce diversity in practice. This guidance is effective for the Company for annual reporting periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2017. The guidance should be applied on a retrospective basis. The Company adopted the standard beginning on January 1, 2018. The adoption has no material impact on the consolidated financial statements.

 

In October 2016, the FASB issued new guidance, ASU 2016-16, for intra-entity transfers of assets other than inventory. This standard requires that an entity should recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. Consequently, the amendments in this standard eliminate the exception for an intra-entity transfer of an asset other than inventory. This guidance is effective for annual reporting periods beginning after December 15, 2017, and interim reporting periods within annual reporting periods beginning after December 15, 2017. The Company adopted the standard effective January 1, 2018. The adoption has no material impact on the consolidated financial statements.

 

In January 2017, the FASB issued new guidance, ASU 2017-01, which clarifies the requirements needed for assets and activities to meet the definition of a business which affects multiple areas of accounting including acquisitions, disposals, goodwill and consolidations. This guidance is effective for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2017. The Company adopted the standard beginning on January 1, 2018. The adoption has no material impact on the consolidated financial statements.

 

In February 2017, the FASB issued new guidance, ASU 2017-05, which clarifies the accounting for derecognition (e.g. sales) of nonfinancial assets in contracts with non-customers and defines what is considered an in substance nonfinancial asset. The new standard is effective at the same time of adoption of ASU 2014-09. The Company adopted the standard effective January 1, 2018. The standard did not have a material impact on the consolidated financial statements.

 

F- 21  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

In March 2017, the FASB issued new guidance, ASU 2017-07, which changes how the net periodic benefit cost of defined benefit and other post retirement benefit plans is presented in the statements of operations. Under the new guidance, the service cost would be presented as a component of operating expenses in the same line item or items as employee compensation costs, and the other components of net periodic benefit cost would be presented outside of operating income. Further, the only component that would be eligible for capitalization into assets such as inventory would be service cost. The guidance is effective for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2017. The guidance is required to be applied on a retrospective basis, with the exception that the guidance regarding capitalization of service cost is to be applied on a prospective basis. The Company elected to adopt the standard effective January 1, 2018. The standard did not have a material impact on the consolidated financial statements.

 

In August 2017, the FASB issued guidance, ASU 2017-12, which provides targeted improvements to the accounting for hedging activities to better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. The guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. The Company early adopted effective January 1, 2018 with a modified retrospective transition method. The standard did not have a material impact on the consolidated financial statements.

 

In February 2018, the FASB issued guidance, ASU 2018-02, which allows companies to reclassify the tax effects stranded in Accumulated Other Comprehensive Income resulting from The Tax Cuts and Jobs Act to retained earnings. The guidance is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. Early adoption is permitted, including adoption in any interim period. The Company elected to adopt the standard effective December 31, 2018. The standard did not have a material impact on the consolidated financial statements.

 

Recently Issued Accounting Standards

 

In February 2016, the FASB issued new guidance, ASU 2016-02, related to leases in which lessees will be required to recognize assets and liabilities on the balance sheet for leases having a term of more than 12 months. Recognition of these lease assets and lease liabilities represents a change from previous GAAP, which did not require lease assets and lease liabilities to be recognized for operating leases. Qualitative disclosures along with specific quantitative disclosures will be required to provide enough information to supplement the amounts recorded in the financial statements so that users can understand more about the nature of an entity’s leasing activities. The Company has elected to adopt the standard effective January 1, 2019.

 

The provisions of ASU 2016-02 are effective for the Company’s fiscal year beginning January 1, 2019, including interim periods within that fiscal year. The Company plans to elect the package of practical expedients included in this guidance, which allows it to not reassess whether any expired or existing contracts contain leases, the lease classification for any expired or existing leases, and the initial direct costs for existing leases. The Company does not plan to recognize short-term leases on its Consolidated Balance Sheet, and will recognize those lease payments in the Consolidated Statements of Operations on a straight-line basis over the lease term.

 

In July 2018, the FASB issued ASU 2018-11, Leases — Targeted Improvements, as an update to the previously-issued guidance. This update added a transition option which allows for the recognition of a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption without recasting the financial statements in periods prior to adoption. The Company plans to elect this transition option.

 

F- 22  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

At adoption, the Company expects to recognize a material increase in total assets and total liabilities resulting from the recognition of right-of-use assets and the related lease liabilities initially measured at the present value of its future operating lease payments. The Company continues to evaluate the impacts of adopting this guidance on its 2019 Consolidated Balance Sheet, Statement of Operations, Statement of Cash Flows, and is updating processes and internal controls to meet the new reporting and disclosure requirements in ASU 2016-02. The Company believes the most significant impact relates to its accounting for real estate leases. We do not anticipate significant impact from leases embedded in service contracts, significant changes to cash flows, or changes to our lease portfolio prior to adoption. The adoption of this standard will have no impact on the Company’s covenant compliance under its current debt agreements.

 

In June 2016, the FASB issued new guidance, ASU 2016-13, related to measurement of credit losses on financial instruments which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. This new guidance replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. The guidance is effective for annual reporting periods beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2019. The Company is currently in the process of evaluating the impact of the adoption of this standard on its consolidated financial statements.

 

In January 2017, the FASB issued new guidance, ASU 2017-04, which simplifies testing goodwill for impairment by eliminating Step 2 from the goodwill impairment test as described in previously issued guidance. The guidance is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company is currently in the process of evaluating the impact of the adoption of this standard on its consolidated financial statements.

 

In June 2018, the FASB issued guidance, ASU 2018-07, which simplifies the accounting for nonemployee share-based payment transactions. The guidance is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently in the process of evaluating the impact of the adoption of this standard on its consolidated financial statements.

 

In July 2018, the FASB issued guidance, ASU 2018-09, Codification Improvements, which clarifies guidance that may have been incorrectly or inconsistently applied by certain entities. The guidance is effective for all entities for fiscal years beginning after December 15, 2018. The Company is currently in the process of evaluating the impact of the adoption of this standard on its consolidated financial statements.

 

In August 2018, the FASB issued guidance, ASU 2018-13, which modifies the disclosure requirements on fair value measurements. The guidance is effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. The Company is currently in the process of evaluating the impact of the adoption of this standard on its consolidated financial statements.

 

In August 2018, the FASB issued guidance, ASU 2018-14, which modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The guidance is effective for all entities for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of the adoption of this standard on its consolidated financial statements.

 

In August 2018, the FASB issued guidance, ASU 2018-15, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internaluse software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by the amendments in this Update. The guidance is effective for all entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently in the process of evaluating the impact of the adoption of this standard on its consolidated financial statements.

 

There were no other new accounting standards that we expect to have a material impact to our financial position or results of operations upon adoption.

 

F- 23  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Note 4:    Business Combinations

 

On October 25, 2018, Clarivate closed on the acquisition of TrademarkVision USA, LLC (“TrademarkVision”), an artificial intelligence technology start-up organization headquartered in Brisbane, Australia. The total purchase price for the acquisition consisted of $20,042 in closing date net cash consideration, subject to subsequent working capital adjustments, plus potential earn-out cash payments dependent upon achievement of certain milestones and financial performance metrics. The fair market value of the liability associated with the earn-out was $4,115 on the date of acquisition. Subsequent changes in the fair value will be included within the Consolidated Statement of Operations. Additionally, the excess value of the total purchase price over the estimated fair value of our identifiable assets and liabilities upon the closing of the acquisition of $19,205 was allocated to goodwill. The consolidated financial statements include the results of the acquisition subsequent to the closing date. TrademarkVision and its revolutionary image recognition software search tool for trademarks will join the trademark clearance and protection partner CompuMark.

 

In March 15, 2018, the Company acquired all of the outstanding stock of Kopernio (“Kopernio”), an artificial-intelligence technology startup, for $3,497. The Kopernio acquisition was accounted for using the acquisition method of accounting. As a result of the Kopernio acquisition and the application of purchase accounting, Kopernio’s identifiable assets and liabilities were adjusted to their estimated fair market values as of the closing date, which included a finite life intangible of $1,258 relating to computer software. Additionally, the excess value of the total purchase price over the estimated fair value of our identifiable assets and liabilities upon the closing of the acquisition of $2,322 was allocated to goodwill. The consolidated financial statements include the results of the acquisition subsequent to the closing date.

 

On June 1, 2017, the Company acquired all assets, liabilities and equity interests of Publons Limited and its wholly -owned subsidiary (“Publons”). Total net cash consideration for the acquisition was $7,401, plus potential future cash payments of up to $9,500 contingent upon Publons achieving certain milestones or financial and non-financial performance targets through 2020, including platform users and reviews. The fair market value of the liability associated with the earn-out was $5,900 on the date of acquisition. Subsequent changes in the fair value will be included within the Consolidated Statement of Operations. Publons is a researcher-facing peer-review data and recognition platform. The acquisition of Publons, its platform and data, is believed to increase the value of multiple existing Company products, while supporting researchers in the process. The consolidated financial statements include the results of the acquisitions subsequent to the closing date.

 

F- 24  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

The fair value of identifiable assets acquired and liabilities assumed for all acquisitions at closing during 2018 and 2017, respectively, which were adjusted for qualifying measurement period adjustments, net of cash acquired, and contingent consideration liabilities incurred in relation to the acquisitions are summarized below:

 

    2018     2017  
Other current assets   $ 706     $ 51  
Finite-lived intangible assets     7,928       3,600  
Indefinite-lived intangible assets           70  
Goodwill     21,527       9,767  
Other non-current assets     38       14  
Total assets     30,199       13,502  
Current liabilities     491       182  
Non-current liabilities     2,054       19  
Total liabilities     2,545       201  
Net assets acquired   $ 27,654     $ 13,301  

 

None of the goodwill associated with any of the business combinations above will be deductible for income tax purposes. Pro forma information is not presented for these acquisitions as the aggregate operations of the acquisitions were not significant to the overall operations of the Company.

 

Note 5:    Divested Operations

 

Effective October 1, 2018, all assets, liabilities and equity interest of the IP Management (IPM) Product Line and related assets were sold to CPA Global for a total purchase price of $100,130. Proceeds received were inclusive of amounts subject to working capital adjustments of $6,135, which are recorded in Accrued expenses and other current liabilities on the Consolidated Balance Sheet. Net proceeds received excluded Cash and cash equivalents and Restricted cash of $25,382. The results of the IPM Product Line and related assets are included in the Consolidated Statement of Operations through September 30, 2018. As a result of the sale, the Company recorded a net gain on sale of $36,072, inclusive of incurred transaction costs of $3,032 in connection with the divestiture. The gain on sale is included in Other operating income (expense), net within the Consolidated Statement of Operations. As a result of the sale, the Company wrote off Goodwill in the amount of $49,349.

 

The Company used $31,378 of the proceeds to pay down the Term Loan Facility on October 31, 2018. See Note 12: Debt, for further details.

 

The divestiture of the IPM Product Line and related assets does not represent a strategic shift that is expected to have a major effect on the Company’s operations or financial results, as defined by ASC 205-20, Discontinued Operations ; as a result, the divestiture does not meet the criteria to be classified as discontinued operations.

 

F- 25  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Note 6:    Computer Hardware and Other Property, Net

 

Computer hardware  and other property  consisted of the following:

 

    December 31,  
  2018     2017  
Computer hardware   $ 18,130     $ 11,238  
Leasehold improvements     13,298       13,885  
Furniture, fixtures and equipment     6,816       6,768  
Total computer hardware and other property     38,244       31,891  
Accumulated depreciation     (17,603 )     (8,881 )
Total computer hardware and other property, net   $ 20,641     $ 23,010  

 

Depreciation amounted to $9,422 for the year ended December 31, 2018. Depreciation amounted to $6,997 for the year ended December 31, 2017.

 

Note 7:    Identifiable Intangible Assets, net

 

The Company’s identifiable intangible assets consist of the following:

 

    December 31, 2018     December 31, 2017  
    Gross    

Accumulated

Amortization

    Net     Gross    

Accumulated

Amortization

    Net  
Finite-lived intangible assets                                                
Customer  relationships   $ 291,503     $ (164,611 )   $ 126,892     $ 299,886     $ (95,606 )   $ 204,280  
Databases and content     1,725,878       (233,733 )     1,492,145       1,733,304       (130,271 )     1,603,033  
Computer software     268,704       (97,570 )     171,134       235,420       (52,696 )     182,724  
Finite-lived intangible assets     2,286,085       (495,914 )     1,790,171       2,268,610       (278,573 )     1,990,037  
                                                 
Indefinite-lived intangible assets                                                
Trade names     168,349             168,349       170,050             170,050  
Total intangible assets   $ 2,454,434     $ (495,914 )   $ 1,958,520     $ 2,438,660     $ (278,573 )   $ 2,160,087  

 

The Company performed the indefinite-lived impairment test as of October 1, 2018. As part of this analysis, the Company determined that its trade name, with a carrying value of $168,349, and $170,050 as of December 31, 2018 and 2017, respectively, was not impaired and will continue to be reported as indefinite-lived intangible assets.

 

The weighted-average amortization period for each class of finite-lived intangible assets and for total finite-lived intangible assets, which range between two and 20 years, is as follows:

  

    Remaining
Weighted-Average
Amortization Period
(in years)
 
Customer relationships     10.6  
Databases and content     14.9  
Computer software     4.9  
Total     13.9  

 

F- 26  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Amortization amounted to $227,803 for the year ended December 31, 2018. Amortization amounted to $221,466 for the year ended December 31, 2017.

 

Estimated amortization for each of the five succeeding years as of December 31, 2018 is as follows:

 

2019   $ 176,545  
2020     158,807  
2021     149,326  
2022     117,865  
2023     113,545  
Thereafter     1,036,411  
Subtotal finite-lived intangible assets     1,752,499  
Internally developed software projects in process     37,672  
Total finite-lived intangible assets     1,790,171  
Intangibles with indefinite lives     168,349  
Total intangible assets   $ 1,958,520  

 

Note 8:    Goodwill

 

The change in the carrying amount of goodwill is shown below:

 

Balance as of December 31, 2016   $ 1,305,571  
Acquisition     9,767  
Measurement period adjustments     (4,175 )
Impact of foreign currency fluctuations and other     90  
Balance as of December 31, 2017   $ 1,311,253  
Acquisition     21,527  
Disposals     (49,349 )
Impact of foreign currency fluctuations and other     (512 )
Balance as of December 31, 2018   $ 1,282,919  

 

The Company performed the goodwill impairment test as of October 1, 2018 and 2017. Additionally, the Company reviewed goodwill for indicators of impairment at December 31, 2018 and 2017.

 

Goodwill represents the purchase price in excess of the fair value of the net assets acquired in a business combination. If the carrying value of a reporting unit exceeds the implied fair value of that reporting unit, an impairment charge to goodwill is recognized for the excess. The Company’s reporting units are one level below the operating segment, as determined in accordance with ASC 350. For the years ended December 31, 2017 and 2018, the Company had one reporting unit and five reporting units, respectively. The number of reporting units increased during 2018 due to a change in the Company’s reporting structure resulting in five reporting units.

 

The Company estimates the fair value of its reporting units using the income approach, which is a change from the previous year, which used a market approach. Under the income approach, the fair value of a reporting unit is calculated based on the present value of estimated cash flows. No indicators of impairment existed as a result of the Company’s assessments. However, based on the results of the 2018 annual impairment analysis performed, the Company has determined that the Derwent Product Line, previously known as the Intellectual Property & Standard (“IP&S”), reporting unit is at risk of a future goodwill impairment. The total goodwill associated with this reporting unit was approximately $130,381 as of December 31, 2018. Based on the latest annual impairment test, the estimated fair value of the Derwent Product Line reporting unit is approximately 2% above its carrying value.

 

F- 27  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

In connection with the 2016 Transaction, during the third quarter of 2017, the Company recorded measurement period adjustments due to additional analysis of facts and circumstances that existed after closing, which increased computer hardware and other property by $3,925, decreased accounts receivable by $614, decreased other current liabilities by $360, and decreased other non-current liabilities by $504. These adjustments resulted in an decrease to goodwill of $4,175. None of these measurement period adjustments had a material impact on the Company’s results of operations. Effective October 1, 2018, the Company divested the IPM Product Line, which included $49,349 of goodwill. See Note 5: Divested Operations for further details.

 

Note 9:    Derivative Instruments

 

Prior to the sale of the IPM Product Line and related assets, the Company entered into forward contracts in order to mitigate exposure from changes in foreign currency exchange rates related to certain foreign denominated payables. We utilized derivative instruments to help us manage these risks. The maximum term of the forward contracts was six months with the majority of forward contracts having a term of one month. The Company recorded these forward contracts in either Accounts receivable or Accrued expenses and other current liabilities at fair value in the Consolidated Balance Sheets and recognized changes in the fair value of these forward contracts through earnings, as these instruments had not been designated as hedges.

 

The IPM Product Line and related assets, which was divested on October 1, 2018, had forward contracts with notional values of $36,639 at December 31, 2017. Losses/(gains) on the forward contracts amounted to $240 and $(1,479) for the years ended December 31, 2018 and 2017, respectively, and were recorded in Revenues, net in the Consolidated Statements of Operations. The cash flows from forward contracts were reported as operating activities in the Consolidated Statements of Cash Flows. The fair value of the forward contracts was $83 at December 31, 2017. The fair value of the forward contracts was recorded in Other current assets in the Consolidated Balance Sheets.

 

Effective March 31, 2017, the Company entered into interest rate swap arrangements with counterparties to reduce its exposure to variability in cash flows relating to interest payments on $300,000 of its outstanding Term Loan arrangements. Additionally, effective February 28, 2018, the Company entered into another interest rate swap relating to interest payments on $50,000 of its outstanding Term Loan arrangements. These hedging instruments mature on March 31, 2021. The Company applies hedge accounting by designating the interest rate swaps as a hedge on applicable future quarterly interest payments. This interest rate swap was effective as of December 31, 2018 and 2017. The fair value of the interest rate swaps is recorded in Other long-term assets according to the duration of related cash flows. The total fair value of interest rate swap asset was $3,644 and $1,107 at December 31, 2018 and 2017, respectively.

 

Note 10:    Fair Value Measurements

 

The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

 

Level 1 — Quoted prices in active markets for identical assets or liabilities.

 

F- 28  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Level 2 — Observable inputs other than quoted prices include in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

 

Level 3 — Unobservable inputs that are support by little or no market activity. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

 

Below is a summary of the valuation techniques used in determining fair value:

 

Derivatives — Derivatives consist of foreign exchange contracts and interest rate swaps. The fair value of foreign exchange contracts is based on observable market inputs of spot and forward rates or using other observable inputs. The fair value of the interest rate swaps is the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. See Note 9 — Derivative Instruments for additional information.

 

Contingent consideration — The Company values contingent consideration related to business combinations using a weighted probability calculation of potential payment scenarios discounted at rates reflective of the risks associated with the expected future cash flows. Key assumptions used to estimate the fair value of contingent consideration include revenues, net new business and operating forecasts and the probability of achieving the specific targets. See Note 4 — Business Combinations for additional information.

 

The following inputs and assumptions were used to value the foreign exchange contract derivative liabilities outstanding during the years ended December 31, 2018 and 2017:

  

    December 31,  
    2018     2017  
Discount Rate     N/A       1.26 – 1.5%  

 

The carrying value of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments. Additionally, the Company has a long-term indemnification asset from the Former Parent, the amount of which is equal to certain tax liabilities incurred prior to the 2016 Transaction. The carrying amount approximates fair value because settlement is expected to be based on the underlying tax amount. The carrying value of the Company’s variable interest rate debt, excluding unamortized debt issuance costs and original issue discount, approximates fair value due to the short-term nature of the interest rate bench mark rates. The fair value of the fixed rate debt is estimated based on market observable data for debt with similar prepayment features. The fair value of the Company’s debt was $1,950,318 and $2,093,827 at December 31, 2018 and 2017, respectively. The fair value is considered Level 2 under the fair value hierarchy.

 

Assets and Liabilities Recorded at Fair Value on a Recurring Basis

 

The Company has determined that its forward contracts, included in Other current assets, along with the interest rate swaps, included in Accrued expenses and other current liabilities and Other non-current liabilities according to the duration of related cash flows, reside within Level 2 of the fair value hierarchy.

 

The earn-out liability is recorded in Accrued expenses and other current liabilities and Other non-current liabilities and is classified as Level 3 in the fair value hierarchy. Additionally, the earn-out relates to the TrademarkVision and the Publons acquisitions that occurred in 2018 and 2017, respectively. The amount payable is contingent upon the achievement of certain company specific milestones and performance metrics over a 1-year and 3-year period, respectively, including number of cumulative users, cumulative reviews and annual revenues. In accordance with ASC 805, we estimated the fair value of the earn-out using a Monte Carlo simulation. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in ASC 820. Significant changes in the key assumptions and inputs could result in a significant change in the fair value measurement of the earn-out. As of December 31, 2018, there were no significant changes in the range of outcomes for the earn out.

 

F- 29  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

There were no transfers of assets or liabilities between levels during the years ended December 31, 2018 and 2017.

 

The following inputs and assumptions were used to value the earn-out liability as of December 31, 2018:

 

TrademarkVision      
Risk free rate     2.77 %
Discount  rate     8.09 %
Expected life (in years)     1.54  
         
Publons        
Risk free rate        2.34 – 2.63 %
Discount  rate         9.23 – 9.72 %
Expected life (in years)          1.04 – 3.04  

 

The following inputs and assumptions were used to value the earn-out liability as of December 31, 2017:

 

Publons        
Risk free rate     1.17 – 1.62 %
Discount  rate     11.44 – 11.90 %
Expected life (in years)       1.12 – 4.12  

 

The following table presents the changes in the earn-out, the only Level 3 item, for the years ended December 31, 2018 and 2017.

 

Balance as of December 31, 2016   $  
Earn-out liability   5,900  
Balance at December 31, 2017     5,900  
Business combinations     4,115  
Payment of Earn-out liability(1)     (2,470 )
Revaluations included in earnings     (470 )
Balance as of December 31, 2018   $ 7,075  

 

 

 

(1) See Note 19: Commitments and Contingencies for further details.

 

F- 30  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

The following table provides a summary of the Company’s assets and liabilities that were recognized at fair value on a recurring basis as at December 31, 2018 and 2017:

 

    December 31, 2018  
    Level 1     Level 2     Level 3    

Total Fair

Value

 
                         
Assets                                
Interest rate swap asset   $     $ 3,644     $     $ 3,644  
            3,644             3,644  
Liabilities                                
Earn-out                 7,075       7,075  
Total   $     $     $ 7,075     $ 7,075  

 

    December 31, 2017  
    Level 1     Level 2     Level 3     Total Fair
Value
 
                         
Assets                                
Forward contracts  asset   $     $ 83     $     $ 83  
Interest rate swap asset           1,107             1,107  
            1,190             1,190  
Liabilities                                
Earn-out Liability                 5,900       5,900  
Total   $     $     $ 5,900     $ 5,900  

 

Non-Financial Assets Valued on a Non-Recurring Basis

 

The Company’s long-lived assets, including goodwill and finite-lived intangible assets subject to amortization, are measured at fair value on a non-recurring basis. These assets are measured at cost but are written-down to fair value, if necessary, as a result of impairment. There have been no impairments of the Company’s long-lived assets during any of the periods presented.

 

Finite-lived Intangible Assets — If a triggering event occurs, the Company determines the estimated fair value of finite-lived intangible assets by determining the present value of the expected cash flows.

 

Indefinite-lived Intangible Asset — If a qualitative analysis indicates that it is more likely than not that the estimated fair value is less than the carrying value of an indefinite-lived intangible asset, the Company determines the estimated fair value of the indefinite-lived intangible asset (trade name) by determining the present value of the estimated royalty payments on an after-tax basis that it would be required to pay the owner for the right to use such trade name. If the carrying amount exceeds the estimated fair value, an impairment loss is recognized in an amount equal to the excess.

 

Note 11:    Pension and Other Post-Retirement Benefits

 

Retirement Benef its

 

Defined contribution plans

 

Employees participate in various defined contribution savings plans that provide for Company-matching contributions. Costs for future employee benefits are accrued over the periods in which employees earn the benefits. Total expense related to defined contribution plans was $13,170 for the year ended December 31, 2018 and $12,488 for the year ended December 31, 2017, which approximates the cash outlays related to the plans.

 

F- 31  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Defined benefit plans

 

A limited number of employees participate in noncontributory defined benefit pension plans that are maintained in certain international markets. The plans are managed and funded to provide pension benefits to covered employees in accordance with local regulations and practices. The Company’s obligations related to the defined benefit pension plans is in Accrued expenses and other current liabilities and Other non-current liabilities.

 

The following table presents the changes in projected benefit obligations, the plan assets, and the funded status of the defined benefit pension plans:

 

    December 31,  
    2018     2017  
Obligation and funded status:                
Change in benefit obligation                
Projected benefit obligation at beginning of year   $ 14,258     $ 13,621  
Service costs     888       442  
Interest cost     283       168  
Plan participant contributions     109        
Actuarial (gain)/losses     29       (640 )
Divestiture     (138 )      
Benefit payments     (274 )     (123 )
Expenses paid from assets     (35 )      
Effect of foreign currency translation     (634 )     790  
Projected benefit obligation at end of year   $ 14,486     $ 14,258  
                 
Change in plan assets                
Fair value of plan assets at beginning of year   $ 5,062     $ 5,062  
Actual return on plan assets     95        
Plan participant contributions     109        
Employer contributions     460       123  
Benefit payments     (274 )     (123 )
Expenses paid from assets     (35 )      
Effect of foreign currency translation     (233 )      
Fair value of plan assets at end of year     5,184       5,062  
Unfunded status   $ (9,302 )   $ (9,196 )

  

The following table summarizes the amounts recognized in the consolidated balance sheets related to the defined benefit pension plans:

 

    December 31,  
    2018     2017  
Current liabilities   $ (443 )   $ (342 )
Non current liabilities   $ (8,859 )   $ (8,854 )
AOCI   $ (1,054 )   $ (1,252 )

 

F- 32  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

The following table provides information for those pension plans with an accumulated benefit obligation in excess of plan assets and projected benefit obligations in excess of plan assets:

 

    December 31,  
    2018     2017  
Plans with accumulated benefit obligation  in excess of plan assets:            
Accumulated benefit obligation   $ 13,605     $ 13,499  
Fair value of plan assets   $ 5,184     $ 5,062  
Plans with projected benefit obligation  in excess of plan assets:                
Projected benefit obligation   $ 14,486     $ 14,258  
Fair value of plan assets   $ 5,184     $ 5,062  

 

The components of net periodic benefit cost changes in plan assets and benefit obligations recognized in other comprehensive loss were as follows:

 

    December 31,  
    2018     2017  
Service cost   $ 888     $ 442  
Interest cost     283       168  
Expected return on plan assets     (150 )      
Amortization of actuarial gains     (78 )     (4 )
Net period benefit cost   $ 943     $ 606  

 

The following table presents the weighted-average assumptions used to determine the net periodic benefit cost as of:

 

    December 31,  
    2018     2017  
Discount rate     2.31 %     2.38 %
Expected return on plan assets     3.00 %     %
Rate of compensation increase     3.76 %     4.56 %
Social Security increase rate     2.50 %     2.50 %
Pension increase rate     1.80 %     2.00 %

 

The following table presents the weighted-average assumptions used to determine the benefit obligations as of:

 

    December 31,  
    2018     2017  
Discount rate     2.26 %     2.31 %
Rate of compensation increase     3.68 %     3.76 %
Social Security increase rate     2.50 %     2.50 %
Pension increase rate     1.80 %     1.80 %

 

The Company determines the assumptions used to measure plan liabilities as of the December 31 measurement date.

F- 33  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

  

The discount rate represents the interest rate used to determine the present value of the future cash flows currently expected to be required to settle the Company’s defined benefit pension plan obligations. The discount rates are derived using weighted average yield curves on corporate bonds. The cash flows from the Company’s expected benefit obligation payments are then matched to the yield curve to derive the discount rates. At December 31, 2018, the discount rates ranged from 0.40% to 7.10% for the Company’s pension plan and postretirement benefit plan. At December 31, 2017, the discount rates ranged from 0.45% to 7.10% for the Company’s pension plan and postretirement benefit plan.

 

Plan Assets

 

The general investment objective for our plan assets is to obtain a rate of investment return consistent with the level of risk being taken and to earn performance rates of return as required by local regulations for our defined benefit plans. For such plans, the strategy is to invest primarily 100% in insurance contracts. Plan assets held in insurance contracts do not have target asset allocation ranges. The expected long-term return on plan assets is estimated based off of historical and expected returns. As of December 31, 2018, the expected weighted-average long-term rate of return on plan assets was 3%.

 

The fair value of our plan assets and the respective level in the far value hierarchy by asset category is as follows:

 

    December 31, 2018     December 31, 2017  
    Level 1     Level 2     Level 3     Total
Assets
    Level 1     Level 2     Level 3     Total
Assets
 
Fair value measurement  of pension plan assets:                                                                                     
Insurance contract   $             5,184     $ 5,184     $             5,062     $ 5,062  

 

The fair value of the insurance contracts is an estimate of the amount that would be received in an orderly sale to a market participant at the measurement date. The amount the plan would receive from the contract holder if the contracts were terminated is the primary input and is unobservable. The insurance contracts are therefore classified as Level 3 investments.

 

The following table provides the estimated pension benefit payments that are payable from the plans to participants as of December 31, 2018 for the following years:

 

2019   $ 488  
2020     610  
2021     489  
2022     643  
2023     781  
2024 to 2027     4,923  
Total   $ 7,934  

 

Based on the current status of our defined benefit obligations, we expect to make payments in the amount of $274 to fund these plans in 2019. However, this estimate may change based on future regulatory changes.

 

F- 34  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Note 12:    Debt

 

The following is a summary of the Company’s debt:

 

        December 31, 2018     December 31, 2017  
Type   Maturity   Effective
Interest
Rate
   

Carrying
Value 

   

Effective
Interest
Rate  

   

Carrying
Value

 
Senior Unsecured Notes   2024     7.875 %   $ 500,000       7.875 %   $ 500,000  
Term Loan Facility   2023     5.729 %     1,483,993       4.700 %     1,530,700  
The Revolving Credit Facility   2021     5.754 %     5,000       %      
The Revolving Credit Facility   2021     5.729 %     40,000       4.751 %     30,000  
Total debt outstanding                 2,028,993               2,060,700  
Debt issuance costs                 (34,838 )             (43,086 )
Term Loan Facility, discount                 (3,633 )             (4,534 )
Short-term debt, including current portion  of long-term debt                 (60,345 )             (45,345 )
Long-term  debt, net of current portion  and debt issuance costs               $ 1,930,177             $ 1,967,735  

 

The loans were priced at market terms and collectively have a weighted average interest rate and term of 6.259% and 5.473% for the year ended December 31, 2018 and 2017, respectively.

 

Senior Unsecured Notes

 

On October 3, 2016, in connection with the 2016 Transaction, Camelot Finance S.A., a wholly-owned subsidiary of the Company, issued senior unsecured notes (“Notes”) in an aggregate principal amount of $500,000. The Notes bear interest at a rate of 7.875% per annum, payable semi-annually to holders of record in April and October and mature in October 2024. The first interest payment was made April 2017. The Notes include customary covenants, including covenants that restrict, subject to certain exceptions, Bidco’s, and certain of its subsidiaries’, ability to incur indebtedness, issue certain types of stock, incur liens, make certain investments, dispose of assets, make certain types of restricted payments, consolidate or merge with certain entities or enter into certain related party transactions.

 

The Notes are subject to redemption as a result of certain changes in tax laws or treaties of (or their interpretation by) a relevant taxing jurisdiction at 100% of the principal amount, plus accrued and unpaid interest to the date of redemption, and upon certain changes in control at 101% of the principal amount, plus accrued and unpaid interest to the date of purchase. Additionally, at the Company’s election the Notes may be redeemed (i) prior to October 15, 2019 at a redemption price equal to 100% of the aggregate principal amount of Notes being redeemed plus a “make-whole” premium, plus accrued and unpaid interest to the date of redemption or (ii) on October 15 of each of the years referenced below based on the call premiums listed below, plus accrued and unpaid interest to the date of redemption.

 

Period   Redemption Price
(as a percentage of principal)
 
2019     103.938 %
2020     101.969 %
2021 and thereafter     100.000 %

 

F- 35  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

  

Senior Secured Credit Facility

 

The Company’s credit agreement, dated as of October 3, 2016 (“Credit Agreement”), initially consisted of a $1,550,000 Term Loan Facility and a $175,000 first lien senior secured revolving credit facility in an aggregate principal amount of $175,000, with a letter of credit sub limit of $25,000 (“Revolving Credit Facility”). The Revolving Credit Facility carries an interest rate at LIBOR plus 3.25% per annum or Prime plus a margin of 2.25% per annum, as applicable depending on the borrowing, and matures on October 3, 2021. The Revolving Credit Facility interest rate margins will decrease upon the achievement of certain first lien net leverage ratios (as the term is used in the Credit Agreement). The Term Loan Facility consisted of a $651,000 borrowing by Camelot Finance LP, a subsidiary of Onex Corporation, and an $899,000 borrowing by Camelot Cayman LP, a subsidiary of Onex Corporation (collectively “Tower Borrowers”). The proceeds of the loans to Tower Borrowers were, in turn, loaned to the Company in loans with identical principal amounts and substantially similar repayment terms. In addition to the interest rates above the Company pays 0.1% interest to the Tower Borrowers. Camelot Finance LP was dissolved on December 31, 2017, at which time Credit Suisse AG, Cayman Islands Branch, acting as the administrative agent for the respective portion of the Term Loan Facility, became the direct lender to the Company. The Term Loan Facility matures on October 3, 2023. Principal repayments under the Term Loan Facility are due quarterly in an amount equal to 0.25% of the aggregate outstanding principal amount borrowed under the Term Loan Facility on October 3, 2016 and on the maturity date, in an amount equal to the aggregate outstanding principal amount on such date, together in each case, with accrued and unpaid interest. In connection with the Term Loan Facility, the Company incurred $64,888 of debt issuance costs.

 

On April 6, 2017, and November 16, 2017, the Borrowers and the other loan parties entered into Amendments (the “Amendments”) to the Credit Agreement in order to (i) reduce the margins under the existing senior secured U.S. dollar-denominated Term Loan Facility to LIBOR plus 3.50%, and 3.25%, respectively, per annum (with a 1.00% LIBOR floor) or Prime plus 2.25% per annum, as applicable, and (ii) reset the prepayment premium of 101% on certain prepayments and amendments of the Term Loan Facility in connection with re-pricing events (“Amended Term Loan Facility”). In addition, the Company pays 0.1% interest to the Tower Borrowers. Effective December 31, 2017, the Company no longer pays interest to Camelot Finance LP. The Amended Term Loan Facility was $1,534,539. As a result of the Amendments, debt issuance costs and debt discounts of $13,892, which had been capitalized in connection with the original Term Loan Facility issued on October 3, 2016, were written off to Interest expense, net in the Consolidated Statements of Operations as extinguishment charges for the year ended December 31, 2017. The Amendments also provided for a 0.25% step-down in margin once UK Holdco achieves a B2 corporate family rating from Moody’s. Except as noted above, all other terms of the Amended Term Loan Facility are substantially similar to terms of the Company’s existing Term Loan Facility.

 

Upon sale of the IPM Product Line and related assets, the Company made an excess cash payment of $31,378 toward the Company’s Term Loan Facility in accordance with the Credit Facility.

 

The Revolving Credit Facility provides for revolving loans, same-day borrowings and letters of credit pursuant to commitments in an aggregate principal amount of $175,000 with a letter of credit sublimit of $25,000. Proceeds of loans made under the Revolving Credit Facility may be borrowed, repaid and reborrowed prior to the maturity of the Revolving Credit Facility. Our ability to draw under the Revolving Credit Facility or issue letters of credit thereunder will be conditioned upon, among other things, delivery of required notices, accuracy of the representations and warranties contained in the Credit Agreement and the absence of any default or event of default under the Credit Agreement.

 

With respect to the Amendments, the Company may be subject to certain negative covenants, including either a fixed charge coverage ratio, total first lien net leverage ratio, or total net leverage ratio if certain conditions are met. These conditions were not met and the Company was not required to perform these covenants as of December 31, 2018.

F- 36  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

The obligations of the borrowers under the Credit Agreement are guaranteed by UK Holdco and certain of its restricted subsidiaries and are collateralized by substantially all of UK Holdco’s and certain of its restricted subsidiaries’ assets (with customary exceptions described in the Credit Agreement). UK Holdco and its restricted subsidiaries are subject to certain covenants including restrictions on UK Holdco’s ability to pay dividends, incur indebtedness, grant a lien over its assets, merge or consolidate, make investments, or make payments to affiliates.

 

As of December 31, 2018, letters of credit totaling $2,002 were collateralized by the Revolving Credit Facility. Notwithstanding the Revolving Credit Facility, as of December 31, 2018 the Company had an unsecured corporate guarantee outstanding for $9,639 and cash collateralized letters of credit totaling $38, all of which were not collateralized by the Revolving Credit Facility. The Company borrowed $45,000 and $30,000 against the Revolving Credit Facility as of December 31, 2018 and 2017, respectively, to support current operations. The Company’s cash from operations is expected to meet repayment needs for the next twelve months.

 

Amounts due under all of the outstanding borrowings as of December 31, 2018 for the next five years are as follows:

 

2019   $ 60,345  
2020     15,345  
2021     15,345  
2022     15,345  
2023     1,422,613  
Thereafter     500,000  
Total maturities     2,028,993  
Less: capitalized debt issuance costs and original issue discount     (38,471 )
Total debt outstanding as of December 31, 2018   $ 1,990,522  

 

Note 13:    Revenue

 

Disaggregated Revenues

 

The tables below show the Company’s disaggregated revenues for the periods presented:

 

    Years Ended December 31,  
    2018     2017  
Subscription revenues   $ 794,097     $ 785,717  
Transaction revenues     177,523       181,590  
Total revenues, gross     971,620       967,307  
Deferred revenues adjustment(1)     (3,152 )     (49,673 )
Total Revenues, net   $ 968,468     $ 917,634  

 

 

 

(1) This accounting adjustment relates to the 2016 Transaction, which included a revaluation of deferred revenues to account for the difference in value between the customer advances retained by the Company upon the consummation of the 2016 Transaction and our outstanding performance obligations related to those advances.

 

F- 37  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Cost to Obtain a Contract

 

The Company has prepaid sales commissions included in both Prepaid expenses and Other non-current assets on the balance sheets. The amount of prepaid sales commissions included in Prepaid expenses was $10,407 and $8,285 as of December 31, 2018 and 2017, respectively. The amount of prepaid sales commissions included in Other non-current assets was $9,493 and $5,457 as of December 31, 2018 and 2017, respectively. Amortization expense of the commission balances amounted to $9,995 and $4,335 for the years ended December 31, 2018 and 2017, respectively. The Company has not recorded any impairments against these prepaid sales commissions.

 

Contract Balances

 

    Accounts
receivables
    Current portion
of deferred
revenues
    Non-current
portion of
deferred revenues
 
Opening (1/1/2018)   $ 317,808     $ 361,260     $ 15,796  
Closing (12/31/2018)     331,295       391,102       17,112  
Increase/(decrease)   $ (13,487 )   $ (29,842 )   $ (1,316 )
                         
Opening (1/1/2017)   $ 361,586     $ 333,944     $ 18,602  
Closing (12/31/2017)     317,808       361,260       15,796  
Increase/(decrease)   $ 43,778     $ (27,316 )   $ 2,806  

 

The amount of revenues recognized in the period that were included in the opening deferred revenues current and long-term balances were $361,260. This revenue consists primarily of subscription revenue.

 

Transaction Price Allocated to the Remaining Performance Obligation

 

As of December 31, 2018, approximately $68,394 of revenue is expected to be recognized in the future from remaining performance obligations, excluding contracts with durations of one year or less. The Company expects to recognize revenue on approximately 63% of these performance obligations over the next 12 months. Of the remaining 37%, 21% is expected to be recognized within the following year, with the final 16% expected to be recognized within years 3 to 9.

 

Note 14:    Shareholders’ Equity

 

Shareholders’ Equity

 

In March 2017, the Company formed the Management Incentive Plan under which certain employees of the Company may be eligible to purchase shares of the Company. In exchange for each share purchase subscription, the purchaser is entitled to a fully vested right to an ordinary share. Additionally, along with a subscription, employees receive a corresponding number of options to acquire additional ordinary shares subject to five year vesting. See “Note 15 — Employment and Compensation Arrangements” for additional detail related to the options. The Company has received net subscriptions for 1,503 and 9,220 shares during the years ended December 31, 2018 and 2017, respectively. Additionally, the Company granted 500 ordinary shares in exchange for services provided during the year ended December 31, 2017. At December 31, 2018, the number of shares issued and outstanding under the Management Incentive Plan was 11,223.

 

F- 38  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Note 15:    Employment and Compensation Arrangements

 

Employee Incentive Plans

 

The Company’s 2016 Equity Incentive Plan provides for certain employees of the Company to be eligible to participate in equity ownership in the Company. Equity awards may be issued in the form of options to purchase shares of the Company which are exercisable upon the occurrence of conditions specified within individual award agreements. Equity awards may also be issued in the form of restricted shares with dividend rights subject to vesting terms and conditions specified in individual award agreements. Additionally, the Company may make available share purchase rights under the terms of the 2016 Equity Incentive Plan. Total share-based compensation expense included in the Consolidated Statements of Operations amounted to $13,715 and $17,663 for the years ended December 31, 2018 and 2017, respectively. The total associated tax benefits recognized amounted to $2,740 and $3,192 for the years ended December 31, 2018 and 2017, respectively.

 

The Company’s Management Incentive Plan provides for certain employees of the Company to be eligible to purchase shares of the Company. See Note 14 — Shareholders’ Equity for additional information. Along with each subscription, employees may receive a corresponding number of options to acquire additional ordinary shares subject to five year vesting.

 

The Company issues shares for stock options from authorized shares. At December 31, 2018, the Company was authorized to grant up to 250,000 stock options under its existing stock incentive plans. As of December 31, 2018 and 2017, 64,399 and 79,307, respectively, stock options have not been granted.

 

As of December 31, 2018 and 2017, there was $19,637 and $29,633, respectively, of total unrecognized compensation cost, related to outstanding stock options, which is expected to be recognized through 2023 with a remaining weighted-average service period of 5.0 years.

 

The Company’s stock option activity is summarized below:

 

    Number
of
Options
    Weighted Average
Exercise Price per
Share
    Weighted Average
Remaining
Contractual Life
    Aggregate
Intrinsic
Value
 
Outstanding as of December 31, 2017     170,693     $ 1,572       9.3     $ 2,262  
Granted     31,178       1,678       9.7        
Forfeited  and expired     (16,270 )     1,601              
Outstanding as of December 31, 2018     185,601     $ 1,587       8.5     $ 13,293  
Vested and exercisable at December 31, 2018     50,364     $ 1,568       8.3     $ 3,880  

 

The aggregate intrinsic value in the table above represents the difference between the Company’s most recent valuation and the exercise price of each in-the-money option on the last day of the period presented.

 

No stock options were exercised in the years ended December 31, 2018 or 2017. The weighted-average fair value of options granted per share was $244 and $253 as of December 31, 2018 and 2017, respectively.

 

F- 39  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

  

The Company accounts for awards issued under the Equity Incentive Plan as additional contributions to equity. Share-based compensation includes expense associated with stock option grants which is estimated based on the grant date fair value of the award issued. Share-based compensation expense related to stock options is recognized over the vesting period of the award, which is generally five years, on a graded-scale basis. The Company uses the Black-Scholes option pricing model to estimate the fair value of options granted. The Black-Scholes model takes into account the fair value of an ordinary share and the contractual and expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate. The fair value of our ordinary shares is determined utilizing an external third party pricing specialist. The contractual term of the option ranges from the 1 year to 10 years. While the Company does not have any history for expected terms, employees do not have any specific benefit to exercise the options before the terms are met as the shares are not freely tradable, and as such an expected term near the high end of the contractual range is deemed most appropriate. Expected volatility is the average volatility over the expected terms of comparable public entities from the same industry historical data. The risk-free interest rate is based on a treasury rate with a remaining term similar to the contractual term of the option. The Company is recently formed and at this time does not expect to distribute any dividends. The Company recognizes forfeitures as they occur and does not expect to have material forfeitures. The assumptions used to value the Company’s options granted during the period presented and their expected lives were as follows:

 

    December 31,  
    2018     2017  
Weighted-average expected dividend yield            
Expected volatility     21.00 – 23.05 %     24.84 – 27.90 %
Weighted-average expected volatility     21.86 %     27.50 %
Weighted-average risk-free interest rate     3.02 %     2.53 %
Expected life (in years)     8.5       9.0  

 

Note 16:    Income Taxes

 

Income tax (benefit)/expense on income/(loss) analyzed by jurisdiction is as follows:

 

    Years Ended December 31,  
    2018     2017  
Current            
U.K.   $ 1,014     $ (142 )
U.S. Federal     6,395       5,202  
U.S. State     2,146       833  
Other     11,061       8,552  
Total current     20,616       14,445  
                 
Deferred                
U.K.     85       (427 )
U.S. Federal     (5,465 )     (10,648 )
U.S. State     (227 )     (142 )
Other     (9,360 )     (24,521 )
Total deferred(1)     (14,967 )     (35,738 )
Total provision (benefit) for income taxes   $ 5,649     $ (21,293 )

 

 

 

(1) Due to rate reductions in the U.S. and Belgium enacted in the 4th quarter of 2017.

  

The components of pre-tax loss are as follows:

 

    Years Ended December 31,  
    2018     2017  
U.K   $ (222,043 )   $ (211,944 )
U.S     (11,880 )     (58,054 )
Other loss     (2,590 )     (15,225 )
Pre-tax loss   $ (236,513 )   $ (285,223 )

 

F- 40  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

A reconciliation of the statutory U.K. income tax rate to the Company’s effective tax rate is as follows:

 

    Years Ended December 31,  
    2018     2017  
Loss before tax:   $ (236,513 )   $ (285,223 )
Income tax, at the statutory rate     (44,937 )     (54,905 )
Statutory rate(1)     19.0 %     19.3 %
Effect of different tax rates     (1.2 )%     3.3 %
Tax rate modifications(2)     %     5.7 %
Valuation Allowances     (18.0 )%     (20.8 )%
Permanent differences     (0.7 )%     0.3 %
Withholding tax     (0.2 )%     (0.3 )%
Tax indemnity     (2.7 )%     %
Sale of Subsidiary     2.2 %     %
Other     (0.8 )%     %
Effective rate     (2.4 )%     7.5 %

  

 

 

(1) The Company performs a reconciliation of the income tax provisions based on its domicile and statutory rate. Reconciliations are based on the U.K. statutory corporate tax rate.

 

(2) Due to rate reductions in the U.S. and Belgium enacted in the 4th quarter of 2017.

 

The tax effects of the significant components of temporary differences giving rise to the Company’s deferred income tax assets and liabilities are as follows:

 

    December 31,  
    2018     2017  
Accounts receivable   $ 916     $ 1,310  
Goodwill           1,217  
Fixed assets, net           1,670  
Accrued expenses     3,735       3,417  
Deferred revenues     3,570       915  
Other assets     9,655       4,700  
Unrealized gain/loss     74       528  
Debt issuance costs     1,199        
Operating losses and tax attributes     135,219       94,571  
Total deferred tax assets     154,368       108,328  
Valuation allowances     (133,856 )     (92,812 )
Net deferred tax assets     20,512       15,516  
Other identifiable intangible assets, net     (43,247 )     (57,082 )
Other liabilities     (7,785 )     (3,286 )
Goodwill     (42 )      
Fixed Assets, net     (238 )      
Debt issuance costs           (116 )
Total deferred tax liabilities     (51,312 )     (60,484 )
Net deferred tax liabilities   $ (30,800 )   $ (44,968 )

 

F- 41  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

In the Consolidated Balance Sheets, deferred tax assets and liabilities are shown net if they are in the same jurisdiction. The components of the net deferred tax liabilities as reported on the Consolidated Balance Sheets are as follows:

  

    December 31,  
    2018     2017  
Deferred tax asset   $ 12,426     $ 6,824  
Deferred tax liability     (43,226 )     (51,792 )
Net deferred tax liability   $ (30,800 )   $ (44,968 )

 

The Tax Cuts and Jobs Act (the Act) was enacted in the US on December 22, 2017. Of most relevance to the Company, the Act reduced the US federal corporate income tax rate to 21% from 35%, established a Base Erosion Anti-Abuse Tax (“BEAT”) regime and changed the provisions limiting current interest deductions and use of NOL carryforwards. Certain new provisions are effective for the Company beginning December 1, 2018 and did not have a material impact to the 2018 financial statements.

 

SAB 118 measurement period

 

We applied the guidance in SAB 118 when accounting for the enactment-date effects of the Act in 2017 and throughout 2018. At December 31, 2017, we had not completed our accounting for all of the enactment-date income tax effects of the Act under ASC 740, Income Taxes, for the remeasurement of deferred tax assets and liabilities and recorded a provisional tax benefit amount of $2,237 under SAB 118. At December 31, 2018, we have now completed our accounting for all of the enactment-date income tax effects of the Act. As further discussed above, during 2018, we did not recognize any adjustments to the provisional amounts recorded at December 31, 2017.

 

Deferred tax assets and liabilities

 

As of December 31, 2017, we remeasured certain deferred tax assets and liabilities based on the rates at which they were expected to reverse in the future (which was generally 21% for the US and 25% for Belgium), by recording a tax benefit amount of $2,237 (provisional) related to the US and $14,290 related to Belgium. Upon further analysis and refinement of our calculations during the 12 months ended December 31, 2018, it was determined that no adjustment to these amounts was necessary.

 

The Company is required to assess the realization of its deferred tax assets and the need for a valuation allowance. The assessment requires judgment on the part of management with respect to benefits that could be realized from future taxable income. The valuation allowance is $133,856 and $92,812 at December 31, 2018 and 2017, respectively against certain deferred tax assets, as it more likely than not that such amounts will not be fully realized. During the years ended December 31, 2018 and 2017, the valuation allowance increased by $41,044 and $44,633, respectively, primarily due to operating losses in certain jurisdictions and an increase in deferred tax assets with a full valuation allowance. The increases were partially offset by the release of valuation allowances in jurisdictions with current year operating income.

 

At December 31, 2018, the Company had U.K. tax loss carryforwards of $352,632, Japan tax loss carryforwards of $58,901, U.S. federal tax loss carryforwards of $104,122, tax loss carryforwards in other foreign jurisdictions of $18,495, and U.S. state tax loss carryforwards of $67,823. The majority of the unrecognized deductible tax losses relate to UK, US, and Japan. The carryforward period for the Japan tax losses is nine years, and the expiration period begins 2025. The carryforward period for the UK tax losses is indefinite. The carryforward period for US federal tax losses is twenty years for losses generated in tax years ended prior to December 31, 2017. The expiration period for these losses begins in 2036. For US losses generated in tax years beginning after January 1, 2018, the carryforward period is indefinite. The carryforward period for US state losses varies, and the expiration period is between 2018 and 2036.

 

F- 42  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

The Company has not provided income taxes and withholding taxes on the undistributed earnings of foreign subsidiaries as of December 31, 2018 because the Company intends to permanently reinvest such earnings. As of December 31, 2018, the cumulative amount of earnings upon which income taxes and withholding taxes have not been provided is approximately $7,748. Determination of the amount of unrecognized deferred tax liability related to these earnings is not practicable.

 

Uncertain Tax Positions

 

Unrecognized tax benefits represent the difference between the tax benefits that we are able to recognize for financial reporting purposes and the tax benefits that we have recognized or expect to recognize in filed tax returns. The total amount of net unrecognized tax benefits that, if recognized, would impact the Company’s effective tax rate were $1,450 and $91 as of December 31, 2018 and 2017, respectively.

 

The Company recognizes accrued interest and penalties associated with uncertain tax positions as part of the tax provision. As of December 31, 2018, the interest and penalties are $449 and as of December 31, 2017, the interest and penalties are $5. It is reasonably possible that the amount of unrecognized tax benefits will change during the next 12 months by a range of $0 to $252.

 

The Company files income tax returns in the United States and various non-U.S. jurisdictions. As of December 31, 2018, the Company’s open tax years subject to examination were 2014 through 2018.

 

The following table summarizes the Company’s unrecognized tax benefits, excluding interest and penalties:

 

    December 31,  
    2018     2017  
Balance at the Beginning of the year     $ 91     $ 211  
Increases for tax positions taken in prior years     1,339        
Increases for tax positions taken in the current year     72        
Decreases due to statute expirations     (52 )     (120 )
Balance at the End of the year   $ 1,450     $ 91  

 

Note 17:    Earnings per Share

 

Potential common shares of 185,601 and 170,693 related to options under the employee incentive plan were excluded from diluted EPS for the years ended December 31, 2018 and 2017, respectively, as the Company had a net loss for the years ended December 31, 2018 and 2017. See “Note 15 — Employment and Compensation Arrangements.”

 

The basic and diluted EPS computations for our common stock are calculated as follows (in thousands, except per share amounts):

 

    Years Ended December 31,  
    2018     2017  
Basic/Diluted EPS                
Net loss   $ (242,162 )   $ (263,930 )
Preferred stock dividends            
Income available to common stockholders   $ (242,162 )   $ (263,930 )
Weighted-average number of common shares outstanding     1,645,818       1,641,095  
Basic EPS   $ (147.14 )   $ (160.83 )
Diluted EPS   $ (147.14 )   $ (160.83 )

 

F- 43  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Note 18:    Product and Geographic Sales Information

 

The Company’s chief operating decision maker (“CODM”) assesses Company-wide performance and allocates resources based on consolidated financial information. As such, the company has one operating and reportable segment. The CODM evaluates performance based on profitability.

 

No single customer accounted for more than 1% of revenues and our ten largest customers represented only 6% and 7% of revenues for the years ended December 31, 2018 and 2017, respectively.

 

Revenues by geography

 

The following table summarizes revenues from external customers by geography, which is based on the location of the customer:

 

    Years Ended December 31,  
  2018     2017  
Revenues:            
North America   $ 450,356     $ 455,791  
Europe     242,415       243,245  
APAC     209,118       201,234  
Emerging Markets     69,731       67,037  
Deferred revenues adjustment     (3,152 )     (49,673 )
Total   $ 968,468     $ 917,634  

 

Assets by geography

 

Assets are allocated based on operations and physical location. The following table summarizes non-current assets other than financial instruments and deferred tax assets by geography:

 

    December 31,  
  2018     2017  
Assets:            
North America   $ 1,036,192     $ 1,163,704  
Europe     2,145,073       2,294,998  
APAC     79,487       68,034  
Emerging Markets     24,241       26,533  
Total   $ 3,284,993     $ 3,553,269  

 

Revenue by product group

 

The following table summarizes revenue by product group (in thousands):

 

    Years Ended December 31,  
    2018     2017  
Web of Science Product Line   $ 361,957     $ 352,995  
Cortellis Product Line     169,225       169,299  
Science Group     531,182       522,294  
Derwent Product Line     176,016       172,897  
MarkMonitor Product Line     122,947       120,408  

 

F- 44  

 

  

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

    Years Ended December 31,  
    2018     2017  
CompuMark Product Line     121,025       119,854  
Intellectual Property Group     419,988       413,159  
IP Management Product Line     20,450       31,854  
Deferred revenues adjustment     (3,152 )     (49,673 )
Total   $ 968,468     $ 917,634  

 

Note 19:    Commitments and Contingencies

 

The Company does not have any recorded or unrecorded guarantees of the indebtedness of others.

 

Contingencies

 

Lawsuits and Legal Claims

 

The Company is engaged in various legal proceedings, claims, audits and investigations that have arisen in the ordinary course of business. These matters include, but are not limited to, antitrust/competition claims, intellectual property infringement claims, employment matters and commercial matters. The outcome of all of the matters against the Company is subject to future resolution, including the uncertainties of litigation. Based on information currently known to the Company and after consultation with outside legal counsel, management believes that the ultimate resolution of any such matters, individually or in the aggregate, will not have a material impact on the Company’s financial condition taken as a whole.

 

Contingent Liabilities

 

In conjunction with the acquisition of Publons, the Company agreed to pay former shareholders up to an additional $9,500 through 2020. Amounts payable are contingent upon Publons’ achievement of certain milestones and performance metrics. The Company paid $2,470 of the contingent purchase price in the year ended December 31, 2018, as a result of Publons achieving the first tier of milestones and performance metrics. The Company had an outstanding liability for $2,960 and $5,900 related to the estimated fair value of this contingent consideration as of December 31, 2018 and 2017, respectively. The outstanding balance consisted of $1,600 and $2,250 included in Accrued expenses and other current liabilities, and $1,360 and $3,650 included in Other non-current liabilities in the Consolidated Balance Sheets as of December 31, 2018 and 2017 respectively.

 

In conjunction with the acquisition of Kopernio, the Company agreed to pay former shareholders up to an additional $3,500 through 2021. Amounts payable are contingent upon Kopernio’s achievement of certain milestones and performance metrics and will be recognized over the concurrent service period.

 

In conjunction with the acquisition of TrademarkVision, the Company agreed to pay former shareholders a potential earn-out dependent upon achievement of certain milestones and financial performance metrics through 2020. Amounts payable are contingent upon TrademarkVision’s achievement of certain milestones and performance metrics. As of December 31, 2018, the Company had an outstanding liability for $4,115 related to the estimated fair value of this contingent consideration, of which $4,115 was included in Other non-current liabilities in the Consolidated Balance Sheets.

 

Tax Indemnity

 

In connection with the 2016 Transaction, the Company recorded certain tax indemnification assets pursuant to the terms of the separation and indemnified liabilities identified therein. As a result of counterparty dispute related to certain of the indemnification claims, the Company wrote off $33,819 accumulated foreign currency impacts. Management continues to interpret the contractual obligation due from Former Parent and its controlled entities (“Thomson Reuters”) as due in full. The asset write down was recorded within Other operating income (expense), net within the Consolidated Statement of Operations. Although the claim has uncertainty of collectability, the Company will continue to vigorously defend its claim for the full value of the indemnity, including the filing of formal legal claims as necessary.

 

F- 45  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Commitments

 

Leases

 

The Company enters into operating leases in the ordinary course of business, primarily for real property and equipment. Payments for these leases are contractual obligations as scheduled per each agreement. Total rental expense under operating leases amounted to $25,527 for the year ended December 31, 2018. The total rental expense under operating leases amounted to $17,255 for the year ended December 31, 2017.

 

The future aggregate minimum lease payments as of December 31, 2018 under all non-cancelable operating leases for the years noted are as follows:

 

 

Year ended December 31,      
2019   $ 22,140  
2020     19,531  
2021     17,240  
2022     15,333  
2023     14,944  
Thereafter     40,367  
Total operating  lease commitments   $ 129,555  

 

In connection with certain leases, the Company guarantees the restoration of the leased property to a specified condition after completion of the lease period. As of December 31, 2018 and 2017, the liability of $4,100 and $4,200, respectively, associated with these restorations is recorded within other liabilities.

 

There were no material future minimum sublease payments to be received under non-cancelable subleases at December 31, 2018. There was no material sublease income as of December 31, 2018 and 2017, respectively.

 

Unconditional purchase obligations

 

Purchase obligations are defined as agreements to purchase goods or services that are enforceable and legally binding and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum or variable pricing provisions and the approximate timing of the transactions. The Company has various purchase obligations for materials, supplies, outsourcing and other services contracted in the ordinary course of business. These items are not recognized as liabilities in our consolidated financial statements but are required to be disclosed. The contractual terms of these purchase obligations extend through 2021. The Company paid $71,859 towards these purchase obligations during the year ended December 31, 2018.

 

F- 46  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

The future unconditional purchase obligations as of December 31, 2018 are as follows:

 

Year ended December 31,      
2019   $ 34,321  
2020     24,370  
2021     8,151  
2022     13  
Total   $ 66,855  

 

Note 20:    Related Party and Former Parent Transactions

 

Onex Partners Advisor LP (“Onex”), an affiliate of the Company, is considered a related party. Concurrent with the 2016 Transaction, the Company entered into a Consulting Services Agreement with Onex, pursuant to which the Company is provided certain ongoing strategic and financing consulting services in exchange for a quarterly management fee. In connection with this agreement, the Company recognized $920 and $1,230 in operating expenses related to this agreement for the years ended December 31, 2018 and 2017, respectively. As noted in Note 12 — Debt, the Company pays 0.1% interest per annum to Onex for the Credit Agreement. For the years ended December 31, 2018 and 2017, the Company recognized interest expense, for Onex related interest, of $905 and $1,557, respectively. The Company had an outstanding liability of $450 and $162 to Onex as of December 31, 2018 and 2017, respectively.

 

Baring, an affiliate of the Company, is considered a related party. Concurrently with the 2016 Transaction, the Company entered into a Management Services Agreement with Baring, pursuant to which the Company is provided certain ongoing strategic and financing consulting services. In connection with this agreement, the Company recognized $669 and $854 in operating expenses related to this agreement for the years ended December 31, 2018 and 2017, respectively. The Company had an outstanding liability of $334 and $641 to Baring as of December 31, 2018 and 2017, respectively.

 

The fees to Onex and Baring were negotiated at a rate that management believes is appropriate and reasonable for the value of the services being provided, and is commensurate with the fee that would be charged by independent third parties for similar services.

 

In connection with the 2016 Transaction, Bidco and a subsidiary of the Former Parent entered into the Transition Service Agreement, which became effective on October 3, 2016, pursuant to which such subsidiary of the Former Parent will, or will cause its affiliates and/or third-party service providers to, provide Bidco, its affiliates and/or third-party service providers with certain technology, facilities management, human resources, sourcing, financial, accounting, data management, marketing and other services to support the operation of the IP&S business as an independent company. Such services are provided by such subsidiary of the Former Parent or its affiliates and/or third-party service providers for various time periods and at various costs based upon the terms set forth in the Transition Service Agreement.

 

In connection with the acquisition of Publons, the Company paid a $716 consulting fee for the year ended December 31, 2017, which is included in Transaction expenses, to a former member of its Board of Directors.

 

A controlled affiliate of Baring is a vendor of ours. Total payments to this vendor were $531 and $388 for the years ended December 31, 2018 and 2017, respectively. The Company had an outstanding liability of $120 and $199 as of December 31, 2018 and 2017, respectively.

 

One member of our key management is the Co-founder of a vendor of ours. Total payments to this vendor were $865 for the year ended December 31, 2018 and the Company had an outstanding liability of $332 as of December 31, 2018. This vendor was not a related party in 2017.

F- 47  

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Amounts in Thousands, Except Per Share Data, Option Price Amounts, Ratios or As Noted)

 

Note 21:    Subsequent Events

 

On January 14, 2019, the Company entered into a definitive agreement to merge with Churchill Capital Corporation (“Churchill”), a public investment vehicle listed on the New York Stock Exchange (Ticker: CCC). An amendment to this agreement was executed effective February 26, 2019. The Company’s existing shareholders will retain 100% of their equity, which converts to 73.8% ownership of the outstanding shares of the combined company at closing, assuming no redemptions by Churchill’s public stockholders. The remaining outstanding shares of the combined company will be held by the current stockholders and founders of Churchill. The transaction is expected to be completed during the second quarter of 2019, subject to approval by Churchill stockholders and other customary closing conditions. The combined company will be called Clarivate Analytics.

 

Prior to the consummation of the merger, Clarivate will enter into a tax receivable agreement with its current equity holders, which will provide for the sharing of tax benefits relating to certain pre-business combination tax attributes as those tax benefits are realized by Clarivate. Under the Tax Receivable Agreement, the aggregate reduction in income taxes payable will be computed by comparing the actual tax liability of Camelot Holdings (Jersey) Limited and its subsidiaries with the estimated tax liability of applicable entities had such entities not been able to utilize the Covered Tax Assets, taking into account several assumptions including, for example, that the relevant entities will pay U.S. state and local taxes at a rate of 7%, the tax assets existing at the time of the Company’s entry into the Tax Receivable Agreement are deemed to be utilized and give rise to a tax savings before certain other tax benefits, and certain asset or equity transfers by certain of the Company’s subsidiaries will be treated under the Tax Receivable Agreement as giving rise to tax benefits associated with the Covered Tax Assets implicated by such asset or equity transfers. Payments under the Tax Receivable Agreement will generally be made annually in cash, and the amounts payable will be subject to interest from the due date (without extensions) of the applicable tax filing that reflects a covered savings until the payment under the Tax Receivable Agreement is made. Tax Receivable Agreement payments are expected to commence in 2021 (with respect to taxable periods ending in 2019) and will be subject to deferral, at the Company’s election, for payment amounts in excess of $30 million for payments to be made in 2021 and 2022, but will not be subject to deferral thereafter. Amounts deferred under the preceding sentence will accrue interest until paid in accordance with the terms of the Tax Receivable Agreement. The Tax Receivable Agreement is subject to certain events of default that may give rise to an acceleration of the Company’s obligations under the Tax Receivable Agreement. The amount and timing of Tax Receivable Agreement payments, however, may vary based on a number of factors, including the amount, character and timing of our subsidiaries’ taxable income in the future, and any successful challenges to our tax positions. Consequently, we are unable to reliably estimate the timing or amount of payments expected to be made under the Tax Receivable Agreement.

 

Through January 31, 2019, management paid down $15,000 of the $45,000 outstanding Revolving Credit Facility balance as of December 31, 2018.

 

Management has evaluated the impact of events that have occurred subsequent to December 31, 2018 through February 26, 2019, which is the date the financial statements were available for issuance. Based on this evaluation, other than as recorded or disclosed within these consolidated financial statements and related notes, the Company has determined no other events were required to be recognized or disclosed.

 

F- 48

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Interim Condensed Consolidated Balance Sheets (Unaudited)

(In thousands, except share data)

 

    March 31,
2019
    December 31,
2018
 
Assets                
Current assets:                
Cash and cash equivalents   $ 28,045     $ 25,575  
Restricted cash     9       9  
Accounts receivable, less allowance for doubtful accounts of $14,971 and $14,076 at March 31, 2019 and December 31, 2018, respectively     343,113       331,295  
Prepaid expenses     41,487       31,021  
Other current assets     19,745       20,712  
                 
Total current assets     432,399       408,612  
Computer hardware and other property, net     19,328       20,641  
Other intangible assets, net     1,911,160       1,958,520  
Goodwill     1,283,275       1,282,919  
Other non-current assets     22,826       26,556  
Deferred income taxes     12,767       12,426  
Operating lease right-of-use assets     95,551        
Total Assets   $ 3,777,306     $ 3,709,674  
                 
Liabilities and Shareholders’ Equity                
Current liabilities:                
Accounts payable   $ 43,729     $ 38,418  
Accrued expenses and other current liabilities     149,250       153,849  
Current portion of deferred revenues     461,928       391,102  
Current portion of operating lease liabilities     26,077        
Current portion of long-term debt     30,345       60,345  
                 
Total current liabilities     711,329       643,714  
Long-term debt     1,928,440       1,930,177  
Non-current portion of deferred revenues     17,987       17,112  
Other non-current liabilities     18,102       24,838  
Deferred income taxes     38,937       43,226  
Operating lease liabilities     71,758        
Total liabilities     2,786,553       2,659,067  
Commitments and Contingencies (Note 14)                
Shareholders’ equity:                
Share capital, $0.01 par value; 2,000,000 shares authorized at March 31, 2019 and December 31, 2018; 1,646,223 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively     16       16  
Additional paid-in capital     1,680,670       1,677,494  
Accumulated other comprehensive income     1,588       5,358  
Accumulated deficit     (691,521 )     (632,261 )
Total shareholders’ equity     990,753       1,050,607  
Total Liabilities and Shareholders’ Equity   $ 3,777,306     $ 3,709,674  

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

F- 49

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Interim Condensed Consolidated Statements of Operations (Unaudited)

(In thousands)

 

    Three Months Ended March 31,  
    2019     2018  
Revenues, net   $ 234,025     $ 237,027  
                 
Operating costs and expenses:                
Cost of revenues, excluding depreciation and amortization     (89,267 )     (105,170 )
Selling, general and administrative costs, excluding depreciation and amortization     (92,296 )     (95,327 )
Share-based compensation expense     (3,176 )     (4,180 )
Depreciation     (2,051 )     (1,401 )
Amortization     (56,106 )     (57,131 )
Transaction expenses     (10,270 )     (593 )
Transition, integration and other related expenses     (1,161 )     (19,479 )
Other operating income (expense), net     (5,617 )     362  
Total operating expenses     (259,944 )     (282,919 )
Loss from operations     (25,919 )     (45,892 )
Interest expense     (33,101 )     (30,799 )
Loss before income tax     (59,020 )     (76,691 )
Provision for income taxes     (240 )     (346 )
Net loss   $ (59,260 )   $ (77,037 )
                 
Per Share:                
Basic   $ (36.00 )   $ (46.84 )
Diluted   $ (36.00 )   $ (46.84 )
                 
Weighted-average shares outstanding                
Basic     1,646,223       1,644,827  
Diluted     1,646,223       1,644,827  

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

F- 50

 

  

CAMELOT HOLDINGS (JERSEY) LIMITED

Interim Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)

(In thousands)

 

    Three Months Ended March 31,  
    2019     2018  
Net loss   $ (59,260 )   $ (77,037 )
Other comprehensive loss, net of tax:                
Interest rate swaps     (1,946 )     3,498  
Foreign currency translation adjustments     (1,824 )     3,038  
Total other comprehensive income (loss), net of tax     (3,770 )     6,536  
Comprehensive loss   $ (63,030 )   $ (70,501 )

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

F- 51

 

  

CAMELOT HOLDINGS (JERSEY) LIMITED

Interim Condensed Consolidated Statement of Changes in Equity (Unaudited)

(In thousands, except share data)

 

    Share Capital    

Additional

Paid-In

   

Accumulated

Other

Comprehensive

    Accumulated    

Total

Shareholders’

 
    Shares     Amount     Capital     Income (Loss)     Deficit     Equity  
Balance at December 31, 2017     1,644,720     $ 16     $ 1,662,205     $ 13,984     $ (390,099 )   $ 1,286,106  
Issuance of common stock, net     971             1,014                   1,014  
Share-based compensation                 4,180                   4,180  
Comprehensive income (loss)                       6,536       (77,037 )     (70,501 )
Balance at March 31, 2018     1,645,691     $ 16     $ 1,667,399     $ 20,520     $ (467,136 )   $ 1,220,799  
                                                 
Balance at December 31, 2018     1,646,223     $ 16     $ 1,677,494     $ 5,358     $ (632,261 )   $ 1,050,607  
Share-based compensation                 3,176                   3,176  
Comprehensive loss                       (3,770 )     (59,260 )     (63,030 )
Balance at March 31, 2019     1,646,223     $ 16     $ 1,680,670     $ 1,588     $ (691,521 )   $ 990,753  

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

F- 52

 

  

CAMELOT HOLDINGS (JERSEY) LIMITED

Interim Condensed Consolidated Statements of Cash Flows (Unaudited)

(In thousands)

 

    Three Months Ended March 31,  
    2019     2018  
CASH FLOWS FROM OPERATING ACTIVITIES                
Net loss   $ (59,260 )   $ (77,037 )
Adjustments to reconcile net loss to net cash provided by operating activities:                
Depreciation and amortization     58,157       58,532  
Bad debt expense     689       671  
Deferred income tax benefit     (3,946 )     (3,295 )
Share-based compensation     3,176       4,180  
Deferred finance charges     2,099       2,155  
Other operating activities     5,440       (1,173 )
Changes in operating assets and liabilities:                
Accounts receivable     (13,362 )     5,226  
Prepaid expenses     (9,813 )     (6,574 )
Other assets     (1,507 )     (5,286 )
Accounts payable     4,942       2,344  
Accrued expenses and other current liabilities     (9,049 )     (10,947 )
Deferred revenue     68,929       70,986  
Operating lease right of use assets     5,696        
Operating lease liabilities     (5,750 )      
Other liabilities     (3,988 )     (1,604 )
                 
Net cash provided by operating activities     42,453       38,178  
                 
CASH FLOWS FROM INVESTING ACTIVITIES                
Capital expenditures     (5,957 )     (13,059 )
Acquisition, net of cash acquired           (3,497 )
                 
Net cash used in investing activities     (5,957 )     (16,556 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES                
Repayment of principal on long-term debt     (3,836 )     (3,834 )
Repayment of Revolving Credit Facility     (30,000 )     (30,000 )
Issuance of common stock, net
          1,014  
                 
Net cash used in financing activities     (33,836 )     (32,820 )
Effects of exchange rates     (190 )     2,016  
                 
Net increase (decrease) in cash and cash equivalents, and restricted cash     2,470       (9,182 )
Beginning of period:                
Cash and cash equivalents     25,575       53,186  
Restricted cash     9       24,362  
Total cash and cash equivalents, and restricted cash, beginning of period     25,584       77,548  
Cash and cash equivalents, and restricted cash, end of period     28,054       68,366  
                 
Cash and cash equivalents     28,045       50,430  
Restricted cash     9       17,936  
Total cash and cash equivalents, and restricted cash, end of period   $ 28,054     $ 68,366  

 

F- 53

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Interim Condensed Consolidated Statements of Cash Flows (Unaudited)

(In thousands)

 

    Three Months Ended March 31,  
    2019     2018  
SUPPLEMENTAL CASH FLOW INFORMATION                
Cash paid for interest   $ 21,023     $ 19,248  
Cash paid for income tax   $ 7,789     $ 5,408  
Capital expenditures included in accounts payable   $ 6,836     $ 2,473  

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

F- 54

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

Note 1: Background and Nature of Operations

 

Camelot Holdings (Jersey) Limited and its subsidiaries (“Jersey,” “us,” “we,” “our,” or the “Company”) was formed on August 4, 2016 as a private limited liability company organized under the laws of the Island of Jersey. Its registered office is located at 4th Floor, St Paul’s Gate, 22-24 New Street, St Helier, Jersey JE1 4TR.

 

On July 10, 2016, Camelot UK Bidco Limited, a private limited liability company incorporated under the laws of England and Wales, and a direct wholly owned subsidiary of Camelot UK Holdco Limited, a direct wholly owned subsidiary (“UK Holdco”), collectively referred to as (“Bidco”), entered into a separation agreement to acquire (i) certain assets and liabilities related to the Intellectual Property & Science business (“IP&S”) business from Thomson Reuters Corporation (“Former Parent”) and (ii) all of the equity interests and substantially all of the assets and liabilities of certain entities engaged in the IP&S business together with their subsidiaries (“2016 Transaction”). The 2016 Transaction total consideration was $3,566,599, net of cash acquired. Jersey is owned by affiliates of Onex Corporation and private investment funds managed by Baring Private Equity Asia GP VI, L.P (“Baring”) and certain co-investors and is controlled by Onex Corporation.

 

The Company is a provider of proprietary and comprehensive content, analytics, professional services and workflow solutions that enables users across government and academic institutions, life science companies and research and development (“R&D”) intensive corporations to discover, protect and commercialize their innovations.

 

Our Science Group consists of our Web of Science and Life Science Product Lines. Both product lines provide curated, high-value, structured information that is delivered and embedded into the workflows of our customers, which include research intensive corporations, life science organizations and universities world-wide. Our Intellectual Property Group consists of our Derwent, CompuMark and MarkMonitor Product Lines. These Product lines help manage customer’s end-to-end portfolio of intellectual property from patents to trademarks to corporate website domains.

 

Prior Period Expense Reclassifications

 

In conjunction with the implementation of a new enterprise resource planning system during the quarter ended September 30, 2018, the Company performed an assessment of its Cost of revenues ("COR") and Selling, general & administrative expenses ("SG&A"). As a result of this assessment, certain errors in classification between COR and SG&A were identified, impacting prior periods. In addition, the Company reclassified certain costs between COR and SG&A. Accordingly, the Company has performed a reclassification of certain prior period amounts to conform to the present period presentation. The Company has concluded that the reclassifications were not material individually or in aggregate to previously issued financial statements.

 

The following table details the impact of the reclassifications on the Interim Condensed Consolidated Statement of Operations for the three months March 31, 2018.

 

Consolidated Statement of Operation

Three Months Ended March 31, 2018   As Previously
Reported
    Adjustment     As Reclassified  
Cost of revenues, excluding depreciation and amortization   $ (122,902 )     17,732     $ (105,170 )
Selling, general and administrative costs, excluding depreciation and amortization   $ (77,595 )     (17,732 )   $ (95,327 )

 

We have also reclassified prior period Accounts payable to Accrued expenses and other current liabilities in our Consolidated Balance Sheets to conform to the current period presentation. These items had no impact in our condensed consolidated statement of operations or condensed consolidated statement of cash flows.

 

F- 55

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

Note 2: Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements for the three months ended March 31, 2019 and 2018 were prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP"). The condensed consolidated financial statements do not include all of the information or notes necessary for a complete presentation in accordance with GAAP. Accordingly, these condensed consolidated financial statements should be read in conjunction with the Company’s annual financial statements as of and for the year ended December 31, 2018. The results of operations for the three months ended March 31, 2019 and 2018 are not necessarily indicative of the operating results for the full year.

 

In the opinion of management, the interim financial data includes all adjustments, consisting only of normal recurring adjustments, necessary to a fair statement of the results for the interim periods. The condensed consolidated financial statements of the Company include the accounts of all of its subsidiaries. Subsidiaries are entities over which the Company has control, where control is defined as the power to govern financial and operating policies. Generally, the Company has a shareholding of more than 50% of the voting rights in its subsidiaries. The effect of potential voting rights that are currently exercisable are considered when assessing whether control exists. Subsidiaries are fully consolidated from the date control is transferred to the Company, and are de-consolidated from the date control ceases. The U.S. dollar is Jersey’s reporting currency. As such, the financial statements are reported on a U.S. dollar basis.

 

Note 3: Summary of Significant Accounting Policies

 

Our significant accounting policies are those that we believe are important to the portrayal of our financial condition and results of operations, as well as those that involve significant judgments or estimates about matters that are inherently uncertain. There have been no material changes to the significant accounting policies discussed in Note 3 of our Annual Report, except as noted below.

 

Lease Accounting

 

We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use ("ROU") assets, other current liabilities, and operating lease liabilities on our interim condensed consolidated balance sheets.

 

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

 

We have lease agreements with lease and non-lease components, which are accounted as a single lease component. Additionally, for certain equipment leases, we apply a portfolio approach to effectively account for the operating lease ROU assets and liabilities.

 

Newly Adopted Accounting Standards

 

In February 2016, the FASB issued new guidance, Accounting Standard Update (“ASU”) 2016-02, related to leases in which lessees are required to recognize assets and liabilities on the balance sheet for leases having a term of more than 12 months. Recognition of these lease assets and lease liabilities represents a change from previous GAAP, which did not require lease assets and lease liabilities to be recognized for operating leases. Qualitative disclosures along with specific quantitative disclosures will be required to provide enough information to supplement the amounts recorded in the financial statements so that users can understand more about the nature of an entity’s leasing activities. The Company adopted the standard on January 1, 2019.

 

The provisions of ASU 2016-02 are effective for the Company’s fiscal year beginning January 1, 2019, including interim periods within that fiscal year. The Company elected the package of practical expedients included in this guidance, which allows it to not reassess whether any expired or existing contracts contain leases, the lease classification for any expired or existing leases, and the initial direct costs for existing leases. The Company does not plan to recognize short-term leases on its Interim Condensed Consolidated Balance Sheet, and will recognize those lease payments in Selling, general and administrative costs, excluding depreciation and amortization on the Interim Condensed Consolidated Statements of Operations on a straight-line basis over the lease term.

 

In July 2018, the FASB issued ASU 2018-11, Leases - Targeted Improvements, as an update to the previously-issued guidance. This update added a transition option which allows for the recognition of a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption without recasting the financial statements in periods prior to adoption. The Company elected this transition option.

 

F- 56

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

The standard had a material impact on our interim condensed consolidated balance sheet, but did not have an impact on our interim condensed consolidated statement of operations. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases.

 

In June 2018, the FASB issued guidance, ASU 2018-07, which simplifies the accounting for nonemployee share-based payment transactions. The guidance is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. This standard did not have a material impact on the Company’s interim condensed consolidated financial statements.

 

In July 2018, the FASB issued guidance, ASU 2018-09, Codification Improvements, which clarifies guidance that may have been incorrectly or inconsistently applied by certain entities. The guidance is effective for all entities for fiscal years beginning after December 15, 2018. This standard did not have a material impact on the Company’s interim condensed consolidated financial statements.

 

In August 2018, the FASB issued guidance, ASU 2018-13, which modifies the disclosure requirements on fair value measurements. The guidance is effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. This standard did not have a material impact on the Company’s interim condensed consolidated financial statements.

 

Recently Issued Accounting Standards

 

Except as noted below, there have been no material changes from the recently issued accounting standards previously disclosed in the Annual Report. Please refer to Note 3 - "Summary of Significant Accounting Policies" section of the Annual Report for a discussion of the recently issued accounting standards that relate to the Company.

 

In March 2019, the FASB issued ASU 2019-01, Leases, as an update to the previously-issued guidance. This update added a transition option which excluded the interim disclosure requirements as defined in Accounting Standard Codification 250-10-50-3. The guidance is effective for all entities during the same period that ASU 2016-02 is adopted.

 

Note 4: Leases

 

As the lessee, we currently lease real estate space, automobiles, and certain equipment under non-cancelable operating lease agreements. Some of the leases include options to extend the leases for up to an additional 10 years. We do not include any of our renewal options in our lease terms for calculating our lease liability as the renewal options allow us to maintain operational flexibility, and we are not reasonably certain we will exercise these renewal options at this time.

 

We determine if an arrangement is a lease at inception. Operating leases are included in Operating lease right-of-use assets, Current portion of operating lease liabilities, and Operating lease liabilities on our interim condensed consolidated balance sheets.

 

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. As such, the Company used judgment to determine an appropriate incremental borrowing rate. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our variable lease payments consist of non-lease services related to the lease and lease payments that are based on annual changes to an index. Variable lease payments are excluded from the ROU assets and lease liabilities and are recognized in the period in which the obligation for those payments is incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

 

We have lease agreements with lease and non-lease components, which are accounted as a single lease component. Additionally, for certain equipment leases, we apply a portfolio approach to effectively account for the operating lease ROU assets and liabilities.

 

F- 57

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

As of March 31, 2019, we have additional operating leases, primarily for real estate, that have not yet commenced of $5,582. These operating leases will commence between fiscal year 2019 and fiscal year 2020 with lease terms of 1 year to 8 years.

 

    Three months
ended March 31,
 
    2019  
Lease cost        
Operating lease cost   $ 7,222  
Variable lease cost     657  
Total lease cost   $ 7,879  

 

    Three months
ended March 31,
 
    2019  
Other information        
Cash Paid for amounts included in measurement of lease liabilities        
Operating cash flows from operating leases   $ 7,234  
         
Weighted-average remaining lease term - operating leases     7  
Weighed-average discount rate - operating leases     5.7 %

 

The future aggregate minimum lease payments as of March 31, 2019 under all non-cancelable operating leases for the years noted are as follows:

 

Year ended December 31,      
2019 (excluding the three months ended March 31, 2019)   $ 20,460  
2020     21,034  
2021     17,336  
2022     14,927  
2023     13,648  
Thereafter     36,313  
Total operating lease payments     123,718  
Less imputed interest   (25,883 )
Total   $ 97,835  

 

In connection with certain leases, the Company guarantees the restoration of the leased property to a specified condition after completion of the lease period. As of March 31, 2019 and December 31, 2018, the liability of $4,097 and $4,100, respectively, associated with these restorations is recorded within other liabilities.

 

F- 58

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

Disclosures related to periods prior to adoption of Topic 842

 

As discussed above, the Company adopted Topic 842 effective January 1, 2019 using a modified retrospective approach. Under this transition method, the application date of the new standard shall begin in the reporting period in which we have adopted the standard. For comparability purposes, and as required, the following disclosure is provided for periods prior to adoption. The Company’s total future minimum annual rentals in effect at December 31, 2018 for noncancelable operating leases, which were accounted for under the previous leasing standard, Accounting Standards Codification 840, were as follows:

 

Year ended December 31,        
2019   $ 22,140  
2020     19,531  
2021     17,240  
2022     15,333  
2023     14,944  
Thereafter     40,367  
Total operating lease commitments   $ 129,555  

 

Note 5: Computer Hardware and Other Property, Net

 

Computer hardware and other property consisted of the following:

 

    March 31, 2019     December 31, 2018  
Computer hardware   $ 18,684     $ 18,130  
Leasehold improvements     13,254       13,298  
Furniture, fixtures and equipment     6,859       6,816  
Total computer hardware and other property     38,797       38,244  
Accumulated depreciation     (19,469 )     (17,603 )
Total computer hardware and other property, net   $ 19,328     $ 20,641  

 

Depreciation expense amounted to $2,051 and $1,401, for the three months ended March 31, 2019 and 2018, respectively.

 

Note 6: Other Intangible Assets and Goodwill

 

Other Intangible Assets

 

The following tables summarize the gross carrying amounts and accumulated amortization of the Company’s identifiable intangible assets by major class:

 

    March 31, 2019     December 31, 2018  
    Gross    

Accumulated

Amortization

    Net     Gross    

Accumulated

Amortization

    Net  
Finite-lived intangible assets                                                
Customer relationships   $ 291,401     $ (182,866 )   $ 108,535     $ 291,503     $ (164,611 )   $ 126,892  
Databases and content     1,722,953       (259,349 )     1,463,604       1,725,878       (233,733 )     1,492,145  
Computer software     280,006       (109,316 )     170,690       268,704       (97,570 )     171,134  
Finite-lived intangible assets     2,294,360       (551,531 )     1,742,829       2,286,085       (495,914 )     1,790,171  
Indefinite-lived intangible assets                                                
Trade names     168,331             168,331       168,349             168,349  
Total intangible assets   $ 2,462,691     $ (551,531 )   $ 1,911,160     $ 2,454,434     $ (495,914 )   $ 1,958,520  

 

F- 59

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

Amortization expense amounted to $56,106 and $57,131 for the three months ended March 31, 2019, and 2018, respectively.

 

Goodwill

 

The following table summarizes changes in the carrying amount of goodwill for the period ended March 31, 2019:

 

    Total  
Balance as of December 31, 2018   $ 1,282,919  
Changes due to foreign currency fluctuations     356  
Balance as of March 31, 2019   $ 1,283,275  

 

Note 7: Derivative Instruments

 

The IPM Product Line and related assets, which was divested on October 1, 2018, had forward contracts with notional values of $0 at March 31, 2019 and December 31, 2018, respectively. Gains or (losses) on the forward contracts amounted to $0 and $(59) for the three months ended March 31, 2019 and 2018, respectively. These amounts were recorded in Revenues, net in the interim condensed consolidated statements of operations. The cash flows from forward contracts are reported as operating activities in the Interim condensed consolidated statements of cash flows. The fair value of the forward contracts recorded in Accrued expenses and other current liabilities was $0 as at March 31, 2019 and December 31, 2018, respectively.

 

Effective March 31, 2017, the Company enters into interest rate swap arrangements with counterparties to reduce its exposure to variability in cash flows relating to interest payments on $300,000 of its outstanding Term Loan arrangements. Additionally, effective February 28, 2018, the Company entered into another interest rate swap relating to interest payments on $50,000 of its outstanding Term Loan arrangements. These hedging instruments mature on March 31, 2021. The Company applies hedge accounting by designating the interest rate swaps as a hedge on applicable future quarterly interest payments. Changes in the value are recorded in Accumulated other comprehensive income (loss). The fair value of the interest rate swaps is recorded in Other non-current assets according to the duration of related cash flows. The total fair value of interest rate swap asset was $1,698 and $3,644 at March 31, 2019 and December 31, 2018, respectively.

 

See Note 8 - "Fair Value Measurements" for additional information on derivative instruments.

 

Note 8: Fair Value Measurements

 

The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

 

Level 2 - Observable inputs other than quoted prices include in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

 

Level 3 - Unobservable inputs that are support by little or no market activity. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

 

Below is a summary of the valuation techniques used in determining fair value:

 

Derivatives - Derivatives consist of foreign exchange contracts and interest rate swaps. The fair value of foreign exchange contracts is based on observable market inputs of spot and forward rates or using other observable inputs. The fair value of the interest rate swaps is the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. See Note 7 - "Derivative Instruments" for additional information.

F- 60

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

Contingent consideration - The Company values contingent consideration related to business combinations using a weighted probability calculation of potential payment scenarios discounted at rates reflective of the risks associated with the expected future cash flows. Key assumptions used to estimate the fair value of contingent consideration include revenues, net new business and operating forecasts and the probability of achieving the specific targets.

 

The carrying value of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments. Additionally, the Company has a long-term indemnification asset from the Former Parent, the amount of which is equal to certain tax liabilities incurred prior to the Acquisition. The carrying amount approximates fair value because settlement is expected to be based on the underlying tax amount.

 

Assets and Liabilities Recorded at Fair Value on a Recurring Basis

 

The Company has determined that its forward contracts, included in Accrued expenses and other current liabilities, and interest rate swaps, included in Accumulated other comprehensive (loss) income and Other current assets and Other non-current assets according to the duration of related interest payments, reside within Level 2 of the fair value hierarchy.

 

The earn-out liability is recorded in Accrued expenses and other current liabilities and Other non-current liabilities and is classified as Level 3 in the fair value hierarchy. Additionally, the earn-out relates to the TrademarkVision and the Publons acquisitions that occurred in 2018 and 2017, respectively. The amount payable is contingent upon the achievement of certain company specific milestones and performance metrics over a 1-year and 3-year period, respectively, including number of cumulative users, cumulative reviews and annual revenues. In accordance with ASC 805, we estimated the fair value of the earn-out using a Monte Carlo simulation. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in ASC 820. Significant changes in the key assumptions and inputs could result in a significant change in the fair value measurement of the earn-out. As of March 31, 2019, there were no significant changes in the range of outcomes for the earn out. There were no transfers of assets or liabilities between levels during the periods ended March 31, 2019 and December 31, 2018.

  

F- 61

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

The following table provides a summary of the Company's assets and liabilities that were recognized at fair value on a recurring basis as at March 31, 2019 and December 31, 2018:

 

    Level 1     Level 2     Level 3     Total Fair
Value
 
March 31, 2019                                
Assets                                
Interest rate swap asset           1,698             1,698  
    $     $ 1,698     $     $ 1,698  
Liabilities                                
Earn-out liability                 7,075       7,075  
  Total   $     $     $ 7,075     $ 7,075  
                         
    Level 1     Level 2     Level 3     Total Fair
Value
 
December 31, 2018                                
Assets                                
Interest rate swap asset           3,644             3,644  
    $     $ 3,644     $     $ 3,644  
Liabilities                                
Earn-out liability                 7,075       7,075  
Total   $     $     $ 7,075     $ 7,075  

 

Non-Financial Assets Valued on a Non-Recurring Basis

 

The Company’s long-lived assets, including goodwill and finite-lived intangible assets subject to amortization, are measured at fair value on a non-recurring basis. These assets are measured at cost but are written-down to fair value, if necessary, as a result of impairment. There have been no impairments of the Company’s long-lived assets during any of the periods presented. Finite-lived Intangible Assets - If a triggering event occurs, the Company determines the estimated fair value of finite-lived intangible assets by determining the present value of the expected cash flows. Indefinite-lived Intangible Asset - If a qualitative analysis indicates that it is more likely than not that the estimated fair value is less than the carrying value of an indefinite-lived intangible asset, the Company determines the estimated fair value of the indefinite-lived intangible asset (trade name) by determining the present value of the estimated royalty payments on an after-tax basis that it would be required to pay the owner for the right to use such trade name. If the carrying amount exceeds the estimated fair value, an impairment loss is recognized in an amount equal to the excess.

F- 62

 

  

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

Note 9: Debt

 

The following is a summary of the Company’s debt:

 

        March 31, 2019     December 31, 2018  
                             
Type   Maturity  

Interest

Rate

   

Carrying

Value

   

Interest

Rate

   

Carrying

Value

 
Senior Unsecured Notes   2024     7.875 %   $ 500,000       7.875 %   $ 500,000  
Term Loan Facility   2023     5.746 %     1,480,154       5.729 %     1,483,993  
The Revolving Credit Facility   2021     %           5.754 %     5,000  
The Revolving Credit Facility   2021     5.743 %     15,000       5.729 %     40,000  
Total debt outstanding                 1,995,154               2,028,993  
Deferred financing charges                 (32,938 )             (34,838 )
Term Loan Facility, discount                 (3,431 )             (3,633 )
Current Portion of Long-Term Debt                 (30,345 )             (60,345 )
Long-term debt, net of current portion and deferred financing charges               $ 1,928,440             $ 1,930,177  

  

During the three months ended March 31, 2019, the Company paid down $30,000 drawn on the Revolving Credit Facility at December 31, 2018.

 

With respect to the Credit Agreement, the Company may be subject to certain negative covenants, including compliance with, total first lien net leverage ratio, if certain conditions are met.  These conditions were not met and the Company was not required to test compliance with these covenants as of March 31, 2019.

 

The obligations of the Borrowers under the Credit Agreement are guaranteed by UK Holdco and certain of its restricted subsidiaries and are secured by substantially all of UK Holdco's and certain of its restricted subsidiaries’ assets (with customary exceptions described in the Credit Agreement). UK Holdco and its restricted subsidiaries are subject to certain covenants including restrictions on UK Holdco’s ability to pay dividends, incur indebtedness, grant a lien over its assets, merge or consolidate, make investments, or make payments to affiliates.

 

As of March 31, 2019, letters of credit totaling $1,979 were collateralized by the Revolving Credit Facility. Notwithstanding the Revolving Credit Facility, as of March 31, 2019, the Company had an unsecured corporate guarantee outstanding for $9,639 and cash collateralized letters of credit totaling $38, all of which were not collateralized by the Revolving Credit Facility. The Company’s cash from operations is expected to meet repayment needs on outstanding borrowings as of March 31, 2019 for the next twelve months.

 

The carrying value of the Company’s variable interest rate debt, excluding unamortized debt issuance costs, approximates fair value due to the short-term nature of the interest rate bench mark rates. The fair value of the fixed rate debt is estimated based on market observable data for debt with similar prepayment features. The fair value of the Company’s debt was $2,017,259 and $1,950,318 at March 31, 2019 and December 31, 2018, respectively. The debt is considered a Level 2 liability under the fair value hierarchy.

 

Note 10: Shareholders’ Equity

 

In March 2017, the Company formed the Management Incentive Plan under which certain employees of the Company may be eligible to purchase shares of the Company. In exchange for each share purchase subscription, the purchaser is entitled to a fully vested right to an ordinary share. Additionally, along with a subscription, employees receive a corresponding number of options to acquire additional ordinary shares subject to five year vesting. See Note 15 – “Employee Incentive Plans” for additional detail related to the options. The Company did not receive any subscriptions during the three months ended March 31, 2019 and received net subscriptions for 971 shares during the three months ended March 31, 2018.

 

F- 63

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

Note 11: Pension and Other Post-Retirement Benefits

 

The components of net periodic benefit cost changes in plan assets and benefit obligations recognized in other comprehensive loss were as follows:

 

    Three months ended March 31  
    2019     2018  
Service cost   $ 221     $ 222  
Interest cost     78       70  
Expected return on plan assets     (40 )     (37 )
Amortization of actuarial gains     (18 )     (19 )
Net periodic benefit cost   $ 241     $ 236  

 

Interest cost and expected return on plan assets are recorded in Interest expense on the accompanying Interim condensed consolidated statements of operation.

 

Note 12: Revenue Recognition

 

The tables below show the Company's disaggregated revenues for the periods presented:

 

    Three months ended March 31,  
    2019     2018  
Subscription revenue     192,492       195,583  
Transaction revenue     41,697       42,911  
Total revenue, gross     234,189       238,494  
Deferred revenue adjustment (1)     (164 )     (1,467 )
Total Revenues, net     234,025       237,027  

 

(1) This accounting adjustment relates to the 2016 Transaction, which included a revaluation of deferred revenues to account for the difference in value between the customer advances retained by the Company upon the consummation of the 2016 Transaction and our outstanding performance obligations related to those advances.

 

Contract Balances

    Accounts
receivable
    Current portion
of deferred
revenues
    Non-current
portion of
deferred
revenues
 
Opening (1/1/2019)   $ 331,295     $ 391,102     $ 17,112  
Closing (3/31/2019)     343,113       461,928       17,987  
Increase   $ (11,818 )   $ (70,826 )   $ (875 )
                         
Opening (1/1/2018)   $ 317,808     $ 361,260     $ 15,796  
Closing (12/31/2018)     331,295       391,102       17,112  
Increase   $ (13,487 )   $ (29,842 )   $ (1,316 )

 

The amount of revenue recognized in the period that were included in the opening deferred revenues current and long-term balances were $92,910. This revenue consists primarily of subscription revenue.

 

Transaction Price Allocated to the Remaining Performance Obligation

 

As of March 31, 2019, approximately $63,343 of revenue is expected to be recognized in the future from remaining performance obligations, excluding contracts with durations of one year or less. The Company expects to recognize revenue on approximately 59% of these performance obligations over the next 12 months. Of the remaining 41%, 22% is expected to be recognized within the following year, with the final 19% expected to be recognized within years 3 to 10.

   

F- 64

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

Note 13: Income Taxes

 

During the three months ended March 31, 2019, the Company recognized an income tax provision of $240, on a loss before income tax of $59,020. During the three months ended March 31, 2018, the Company recognized an income tax provision of $346, on a loss before income tax of $76,691. The tax provision in each period ended March 31, 2019, and March 31, 2018, respectively, reflects the mix of taxing jurisdictions in which pre-tax profits and losses were recognized.

 

Note 14: Commitments and Contingencies

 

Lawsuits and Legal Claims

 

The Company is engaged in various legal proceedings, claims, audits and investigations that have arisen in the ordinary course of business. These matters include, but are not limited to, antitrust/competition claims, intellectual property infringement claims, employment matters and commercial matters. The outcome of all of the matters against the Company is subject to future resolution, including the uncertainties of litigation. Based on information currently known to the Company and after consultation with outside legal counsel, management believes that the ultimate resolution of any such matters, individually or in the aggregate, will not have a material impact on the Company’s financial condition taken as a whole.

 

Contingent Liabilities

 

In conjunction with the acquisition of Publons, the Company agreed to pay former shareholders up to an additional $9,500 through 2020. Amounts payable are contingent upon Publons' achievement of certain milestones and performance metrics. The Company had an outstanding liability for $2,960 related to the estimated fair value of this contingent consideration as of March 31, 2019 and December 31, 2018. The outstanding balance consisted of $1,600 included in Accrued expenses and other current liabilities, and $1,360 included in Other non-current liabilities in the Interim Condensed Consolidated Balance Sheets as of March 31, 2019 and December 31, 2018.

 

In conjunction with the acquisition of TrademarkVision that occurred on October 25, 2018, the Company agreed to pay former shareholders a potential earn-out dependent upon achievement of certain milestones and financial performance metrics through 2020. Amounts payable are contingent upon TrademarkVision’s achievement of certain milestones and performance metrics. As of March 31, 2019 and December 31, 2018, the Company had an outstanding liability for $4,115 related to the estimated fair value of this contingent consideration. The outstanding balance consisted of $4,115 included in Accrued expenses and other current liabilities as of March 31, 2019, and $4,115 included in Other non-current liabilities December 31, 2018 in the Interim condensed consolidated balance sheets.

 

Tax Indemnity

 

In connection with the 2016 Transaction, the Company recorded certain tax indemnification assets pursuant to the terms of the separation and indemnified liabilities identified therein. Management continues to interpret the contractual obligation due from Former Parent and its controlled entities (“Thomson Reuters”) as due in full. The asset write down was recorded within Other operating income (expense), net within the Interim condensed consolidated statement of operations. Although the claim has uncertainty of collectability, the Company will continue to vigorously defend its claim for the full value of the indemnity, including the filing of formal legal claims as necessary.

 

Note 15: Employee Incentive Plans

 

The Company’s 2016 Equity Incentive Plan provides for certain employees of the Company to be eligible to participate in equity ownership in the Company. Equity awards may be issued in the form of options to purchase shares of the Company which are exercisable upon the occurrence of conditions specified within individual award agreements. Equity awards may also be issued in the form of restricted shares with dividend rights subject to vesting terms and conditions specified in individual award agreements. Additionally, the Company may make available share purchase rights under the terms of the 2016 Equity Incentive Plan.

 

The Company’s Management Incentive Plan provides for certain employees of the Company to be eligible to purchase shares of the Company. See Note 10 – “Shareholders’ Equity” for additional information. Along with each subscription, employees are granted options to acquire additional ordinary shares subject to a five year vesting period.

 

F- 65

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

A summary of the Company’s share-based compensation is as follows:

 

    Three Months Ended March 31,  
    2019     2018  
Share-based compensation expense   $ 3,176     $ 4,180  
Tax benefit recognized   $ 78     $ 107  

 

The Company issues shares for stock options from authorized shares. At March 31, 2019, the Company was authorized to grant up to 250,000 stock options under its existing stock incentive plans. As of March 31, 2019, 65,924 stock options have not been granted. As of March 31, 2019, there was $17,423 of total unrecognized compensation cost, related to outstanding stock options, which is expected to be recognized through 2024 with a remaining weighted-average service period of 3.1 years.

 

The Company’s stock option activity is summarized below:

 

   

Number of

Options

   

Weighted

Average Exercise

Price per Share

   

Weighted-Average

Remaining

Contractual Life

(in years)

   

Aggregate

Intrinsic

Value

 
Outstanding as of December 31, 2018     185,601     $ 1,587       8.5     $ 13,293  
Granted     5,500       2,561       9.9        
Forfeited     (7,025 )     1,581              
Outstanding as of March 31, 2019     184,076     $ 1,616       8.3     $ 43,857  
Vested and exercisable at March 31, 2019     56,305     $ 1,568       8.0     $ 14,377  

 

The aggregate intrinsic value in the table above represents the difference between the Company’s most recent valuation and the exercise price of each in-the-money option on the last day of the period presented. There were no stock options exercised in the three months ended March 31, 2019. The weighted-average fair value of options granted per share was $273 as of March 31, 2019.

 

The Company accounts for awards issued under the Equity Incentive Plan as additional contributions to equity. Share-based compensation includes expense associated with stock option grants which is estimated based on the grant date fair value of the award issued. Share-based compensation expense related to stock options is recognized over the vesting period of the award which is generally five years, on a straight-line basis. The Company uses the Black-Scholes option pricing model to estimate the fair value of options granted. The Black-Scholes model takes into account the fair value of an ordinary share and the contractual and expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate. The Company relies on an external valuation performed to determine the fair value of its ordinary shares. The contractual term of the option ranges from the 1 year to 10 years. While the Company does not have any history for expected terms, employees do not have any specific benefit to exercise the options before the terms are met as the shares are not freely tradable, and as such an expected term near the high end of the contractual range is deemed most appropriate. Expected volatility is the average volatility over the expected terms of comparable public entities from the same industry. The risk-free interest rate is based on a treasury rate with a remaining term similar to the contractual term of the option. The Company is recently formed and at this time does not expect to distribute any dividends. The Company recognizes forfeitures as they occur.

 

The assumptions used to value the Company’s options granted during the period presented and their expected lives were as follows:

 

    March 31, 2019  
Weighted-average expected dividend yield      
Weighted-average expected volatility     20.26 %
Weighted-average risk-free interest rate     2.73 %
Expected life (in years)     9  

 

F- 66

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

Note 16: Earnings per Share

 

The following potential common shares were excluded from diluted EPS for the three months ended March 31, 2019 and 2018, respectively, as the Company had a net loss: 184,076 and 177,613 related to options under the employee incentive plan outstanding as of the three months ended March 31, 2019 and 2018, respectively. See “Note 15 - Employee Incentive Plans.”

 

The basic and diluted EPS computations for our common stock are calculated as follows (in thousands, except per share amounts):

 

    Three months ended March 31  
    2019     2018  
Basic/Diluted EPS                
Net Income (loss)   $ (59,260 )   $ (77,037 )
Preferred stock dividends            
Income available to common stockholders   $ (59,260 )   $ (77,037 )
                 
Weighted-average number of common shares outstanding     1,646,223       1,644,827  
                 
Basic EPS     (36.00 )     (46.84 )
Diluted EPS     (36.00 )     (46.84 )

 

Note 17: Related Party and Former Parent Transactions

 

Onex Partners Advisor LP (“Onex”), an affiliate of the Company, is considered a related party. Concurrent with the Acquisition, the Company entered into a Consulting Services Agreement with Onex, pursuant to which the Company is provided certain ongoing strategic and financing consulting services in exchange for a quarterly management fee. In connection with this agreement, the Company recognized $231 and $208 for the three months ended March 31, 2019, and 2018, respectively. The Company pays 0.1% interest per annum to Onex for the Credit Agreement. For the three months ended March 31, 2019 and 2018, respectively, the Company recognized interest expense, for Onex related interest, of $215 and $226, respectively. The Company had an outstanding liability of $208 and $450 to Onex as of March 31, 2019, and December 31, 2018, respectively.

 

BPEA, an affiliate of the Company, is considered a related party. Concurrent with the Acquisition, the Company entered into a Management Services Agreement with BPEA, pursuant to which the Company is provided certain ongoing strategic and financing consulting services. In connection with this agreement, the Company recognized $167 for the three months ended March 31, 2019, and 2018, respectively, in operating expenses related to this agreement. The Company had an outstanding liability of $501 and $334 to BPEA as of March 31, 2019, and December 31, 2018, respectively.

 

The fees to Onex and Baring were negotiated at a rate that management believes is appropriate and reasonable for the value of the services being provided, and is commensurate with the fee that would be charged by independent third parties for similar services.

 

In connection with the 2016 Transaction, Bidco and a subsidiary of the Former Parent entered into the Transition Services Agreement, which became effective on October 3, 2016, pursuant to which such subsidiary of the Former Parent will, or will cause its affiliates and/or third-party service providers to, provide Bidco, its affiliates and/or third-party service providers with certain technology, facilities management, human resources, sourcing, financial, accounting, data management, marketing and other services to support the operation of the IP&S business as an independent company. Such services are provided by such subsidiary of the Former Parent or its affiliates and/or third-party service providers for various time periods and at various costs based upon the terms set forth in the Transition Service Agreement.

 

A controlled affiliate of Baring is a vendor of ours. Total payments to this vendor were $240 and $0 for the three months ended March 31, 2019 and 2018 respectively. The Company had an outstanding liability of $240 and $120 as of March 31, 2019 and December 31, 2018, respectively.

 

One member of our key management is the Co-founder of a vendor of ours. Total payments to this vendor were $78 for the three months ended March 31, 2019, and the Company had no outstanding liability as of March 31, 2019. This vendor was not a related party during the three months ended March 31, 2018.

 

F- 67

 

 

CAMELOT HOLDINGS (JERSEY) LIMITED

Notes to Interim Condensed Consolidated Financial Statements (Unaudited)

 

(Amounts in thousands, except per share data, option price amounts, ratios, or as noted)

 

Note 18: Subsequent Events

 

On January 14, 2019, the Company entered into a definitive agreement to enter into a business combination transaction with Churchill Capital Corporation (“Churchill”), a public investment vehicle listed on the New York Stock Exchange (Ticker: CCC).Amendments to this agreement were executed effective February 26, 2019 and March 29, 2019. The transaction was completed on May 13, 2019. The combined company is called Clarivate Analytics Plc. The Company’s shareholders hold approximately 71% of the outstanding shares of Clarivate Analytics Plc following the closing. The remaining outstanding shares of Clarivate Analytics Plc are held by the former stockholders and founders of Churchill.

 

Prior to the completion of the Transaction the Company entered into a Tax Receivable Agreement ("TRA") on May 10, 2019 with its current equity holders, which provided for the sharing of tax benefits relating to certain pre-business combination tax attributes, with the Company generally being required to pay to such equity holders 85% of the amount of cash savings, if any, realized (or, in some cases, deemed to be realized) as a result of the utilization of Covered Tax Assets (as defined in the TRA). Under the TRA, the aggregate reduction in income taxes payable will be computed by comparing the actual tax liability of the Company and its subsidiaries with the estimated tax liability of applicable entities had such entities not been able to utilize the Covered Tax Assets, considering several assumptions including, for example, that the relevant entities will pay U.S. state and local taxes at a rate of 7%, the tax assets existing at the time of the Company’s entry into the TRA are deemed to be utilized and give rise to a tax savings before certain other tax benefits, and certain asset or equity transfers by certain of the Company’s subsidiaries will be treated under the TRA as giving rise to tax benefits associated with the Covered Tax Assets implicated by such asset or equity transfers. Payments under the TRA will generally be made annually in cash, and the amounts payable will be subject to interest from the due date (without extensions) of the applicable tax filing that reflects a covered savings until the payment under the TRA is made. TRA payments are expected to commence in 2021 (with respect to taxable periods ending in 2019) and will be subject to deferral, at the Company’s election, for payment amounts in excess of $30 million for payments to be made in 2021 and 2022, but will not be subject to deferral thereafter. Amounts deferred under the preceding sentence will accrue interest until paid in accordance with the terms of the TRA. The TRA is subject to certain events of default that may give rise to an acceleration of the Company’s obligations under the Tax Receivable Agreement. The amount and timing of TRA payments, however, may vary based on a number of factors, including the amount, character and timing of our subsidiaries’ taxable income in the future, and any successful challenges to our tax positions. Consequently, we are unable to reliably estimate the timing or amount of payments expected to be made under the TRA.

 

Prior to the consummation of the Transactions, on May 13, 2019, the FHC Tower Borrower assigned its obligations under the Credit Agreement to certain other borrowers. Upon assumption of the FHC Tower Borrower’s obligations by the other borrowers under the Credit Agreement, the FHC Tower Borrower was released from its obligations under our Credit Agreement.

 

In April 2019, the Company entered into additional interest rate swap arrangements with counterparties to reduce its exposure to variability in cash flows relating to interest payments on $50,000 of its outstanding Term Loan, effective April 30, 2019. These hedging instruments mature on September 29, 2023. The Company will apply hedge accounting by designating the interest rate swaps as a hedge in applicable future quarterly interest payments.

 

In April 2019, management drew an additional $5,000 on the Revolving Credit Facility.

 

Management has evaluated the impact of events that have occurred subsequent to March 31, 2019. Based on this evaluation, other than as recorded or disclosed within these interim condensed consolidated combined financial statements and related notes, the Company has determined no other events were required to be recognized or disclosed.

 

F- 68

 

  

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

 

Introduction

 

Clarivate Analytics Plc, a public limited company incorporated under the laws of Jersey, Channel Islands (“Clarivate”), is providing the following unaudited pro forma condensed combined financial information to aid you in your analysis of the financial aspects of the Transactions. The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X.

 

Churchill Capital Corp (“Churchill”) is a special purpose acquisition company incorporated in Delaware on June 20, 2018. On September 11, 2018, Churchill consummated its initial public offering (the “Churchill IPO”). Upon the closing of the Churchill IPO, overallotment option and the private placements, $690.0 million of the net proceeds therefrom were placed in a trust account and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by Churchill, until the earlier of: (i) the consummation of a business combination or (ii) the distribution of the trust account, except that interest earned on the trust account can be released to Churchill to pay its tax obligations. As of December 31, 2018, there was $694.6 million held in the trust account. As a special purpose acquisition company, Churchill’s purpose is to acquire, through a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, one or more businesses or entities.

 

On January 14, 2019, Churchill entered into the Agreement and Plan of Merger (as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated February 26, 2019, and Amendment No. 2 to the Agreement and Plan of Merger, dated March 29, 2019, the “Merger Agreement”), by and among Clarivate, a Delaware corporation and wholly owned subsidiary of Clarivate (“Delaware Merger Sub”), Camelot Merger Sub (Jersey) Limited, a private limited company organized under the laws of Jersey, Channel Islands and wholly owned subsidiary of Clarivate (“Jersey Merger Sub”), and Camelot Holdings (Jersey) Limited, a private limited company organized under the laws of Jersey, Channel Islands (“Company”). Pursuant to the Merger Agreement, a combination of Churchill and the Company was effected through the Delaware Merger and the Jersey Merger and the Company Owners were issued an aggregate of 217,500,000 ordinary shares of Clarivate (subject to certain adjustments). At the closing of the transactions contemplated by the Merger Agreement (the “Transactions”), the shareholders of the Company prior to the closing of the Transactions (the “Company Owners”) hold approximately 71% of the issued and outstanding ordinary shares of Clarivate and current stockholders of Churchill hold approximately 29% of the issued and outstanding ordinary shares of Clarivate after redemptions.

 

The following unaudited pro forma condensed combined balance sheet as of December 31, 2018 assumes that the Transactions, including the related issuance of 1,500,000 shares of Churchill common stock to certain founders have occurred on December 31, 2018. The unaudited pro forma condensed combined statement of operations for the year ended December 31, 2018 present pro forma effect to the Transactions, including the related issuance of 1,500,000 shares of Churchill common stock to certain founders, as if they had been completed on January 1, 2018.

 

The pro forma combined financial statements do not necessarily reflect what the combined company’s financial condition or results of operations would have been had the Transactions occurred on the dates indicated. The pro forma combined financial information also may not be useful in predicting the future financial condition and results of operations of the combined company. The actual financial position and results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors.

 

The historical financial information of Churchill was derived from the audited financial statements of Churchill as of December 31, 2018 and for the period from June 20, 2018 (inception) through December 31, 2018, filed separately with the Securities and Exchange Commission (“SEC”). The historical financial information of the Company was derived from the audited consolidated financial statements of the Company as of and for the year ended December 31, 2018, filed herewith. This information should be read together with Churchill’s and the Company’s audited financial statements and related notes.

 

The Transactions will be accounted for as a reverse recapitalization, with no goodwill or other intangible assets recorded, in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Under this method of accounting, Churchill will be treated as the acquired company for financial reporting purposes. Accordingly, for accounting purposes, the Transactions will be treated as the equivalent of Clarivate issuing ordinary shares for the net assets of Churchill, accompanied by a recapitalization. The net assets of Churchill will be recognized at fair value (which is expected to be consistent with carrying value), with no goodwill or other intangible assets recorded.

 

The Company has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances:

 

· The Company Owners have the majority ownership interest and voting interest in the combined entity with over 71% ownership voting interest;

 

· the combined company’s board of directors initially consists of 14 directors; nine of whom are appointed by the affiliates of Onex Partners Advisor LP and Baring Private Equity Asia Pte Ltd that from time to time held ordinary shares of the Company prior to the closing of the Transactions or hold ordinary shares of Clarivate following the closing of the Transactions (“Onex” and “Baring,” respectively) and four of whom are appointed by Churchill. Martin Broughton was also appointed as a director. Mr. Broughton is not expected to be re-nominated in 2020 when his term ends and the size of the Board will be reduced to 13; and

 

· the Company is the larger entity, in terms of both revenues and total assets.

 

Other factors were considered, including composition of management, purpose and intent of the Transactions and the location of the combined company’s headquarters, noting that the preponderance of evidence as described above is indicative that the Company is the accounting acquirer in the Transactions.

 

F- 69

 

 

Description of the Transactions

 

Pursuant to the Merger Agreement, the aggregate stock consideration issued by Clarivate in the Transactions was $3,052.5 million, consisting of 305,250,000 newly issued ordinary shares of Clarivate valued at $10.00 per share, subject to certain adjustments described below. Of the $3,052.5 million, the Company Owners received $2,175.0 million in the form of 217,500,000 newly issued ordinary shares of Clarivate. In addition, of the $3,052.5 million, Churchill public shareholders received $690.0 million in the form of 68,999,999 newly issued ordinary shares of Clarivate, and Churchill Sponsor LLC, a Delaware limited liability company and an affiliate of M. Klein and Company (the “sponsor”), including shares distributed to Jerre Stead, Michael S. Klein, Sheryl von Blucher, Martin Broughton, Karen G. Mills, Balakrishnan S. Iyer, M. Klein Associates, Inc., The Iyer Family Trust dated 1/25/2001, Mills Family I, LLC and K&BM LP (the “founders”) and Garden State Capital Partners LLC, a Delaware limited liability company, in which Michael Klein holds an equity interest and is the managing member (“Garden State”) received $187.5 million in the form of 17,250,000 ordinary shares of Clarivate issued to the sponsor and 1,500,000 additional ordinary shares of Clarivate issued to Michael Klein and an affiliate of Jerre Stead in respect of 1,500,000 shares of Churchill common stock purchased by them prior to the Delaware Merger (as further described in the Sponsor Agreement). The following represents the consideration at closing of the Transactions (the “Closing”):

 

(in millions)      
Ordinary share issuance to the Company Owners (1)   $ 2,175.0  
Ordinary share issuance to Churchill public shareholders (1)     690.0  
Ordinary share issuance to sponsor (1)     172.5  
Additional purchase of ordinary shares by certain founders (1) (2)     15.0  
Share Consideration - at Closing   $ 3,052.5  

 

(1) Value represents the price per the Merger Agreement. The closing share price on the date of the consummation of the Transactions was $13.25. As the business combination was accounted for as a reverse recapitalization, the value per share is disclosed for informational purposes only to indicate the fair value of shares transferred.

 

(2) Additional shares of Churchill common stock purchased by certain founders as set forth in Section 5(a) of the letter agreement, dated January 14, 2019, as amended, among Churchill, the Company, Clarivate, sponsor, the founders and Garden State, which amended and restated the letter agreement, dated September 6, 2018, from the sponsor to Churchill and the founders (the “Sponsor Agreement”) issued at a price of $10.00 per share.

 

The value of share consideration issuable at the Closing is assumed to be $10.00 per share. The Transactions are accounted for as a reverse recapitalization, therefore any change in Clarivate’s trading price will not impact the pro forma financial statements because Clarivate will account for the acquisition of Churchill based on the amount of net assets acquired upon consummation of the Transactions. The consideration issued at the Closing as presented above does not include any warrants or options that are described below in Note 3 to the Unaudited Pro Forma Condensed Combined Financial Information. “Earnings Per Share.”

 

In connection with the execution of the Merger Agreement, the sponsor, the founders and Garden State entered into the Sponsor Agreement. Pursuant to the Sponsor Agreement, founder Jerre Stead (personally or through his designee – JMJS Group-II, LP) and founder Michael Klein agreed to purchase an aggregate of 1,500,000 newly-issued shares of Churchill common stock immediately prior to the completion of the Transactions for an aggregate purchase price of $15,000,000. In addition, if a $20.00 Stock Price Level (as described below) is achieved on or before the sixth anniversary of the Closing, the Incentive Shares shall be allotted and issued to the persons designated by Jerre Stead and Michael Klein (or, in the event of death or incapacity of either, by his respective successor).

 

Prior to the Closing, the Company entered into a tax receivable agreement with the Company Owners (the “Tax Receivable Agreement”) (see Item 7 “Major Shareholders and Related Party Transactions — B. Related Party Transactions”). The Tax Receivable Agreement generally provides for the payment by the Company to the Company Owners of 85% of certain tax benefits realized or deemed realized by the Company and its subsidiaries, as defined in the Tax Receivable Agreement. The term of the Tax Receivable Agreement commenced upon the execution date of the Tax Receivable Agreement and will continue indefinitely until all tax benefits that are subject to the Tax Receivable Agreement have been utilized, deemed utilized, or expired unless the Company exercises its right to terminate the Tax Receivable Agreement early, or there is otherwise a deemed early termination. If there is an early termination or a deemed early termination, the Company’s obligations under the Tax Receivable Agreement would accelerate and it generally would be required to make an immediate payment equal to the present value of the deemed anticipated future payments to be made by it under the Tax Receivable Agreement, calculated in accordance with certain valuation assumptions set forth in the Tax Receivable Agreement. Any publicly traded parent entity of the Company may consummate a public offering of shares and use net proceeds of such offering to settle its obligations. In lieu thereof, the Company Owners may waive the payment in cash and instead receive stock consideration to the extent mutually agreeable to Company and the TRA Party Representative and to the extent practicable.

 

F- 70

 

 

The following summarizes the pro forma Clarivate ordinary shares outstanding taking into consideration actual redemptions:

 

    (Shares)     %  
Clarivate ordinary shares issued to the Company Owners (1)     217,500,000          
Total Company Owners ordinary shares     217,500,000       71 %
                 
Shares held by current Churchill public shareholders     69,000,000          
Less: public shares redeemed (2)     (1 )        
Total Churchill shares     68,999,999       23 %
                 
Sponsor shares     17,250,000          
Plus: Shares purchased by certain founders immediately prior to Closing     1,500,000          
Net sponsor and founder shares     18,750,000       6 %
                 
Pro Forma Shares Outstanding (3)     305,249,999       100 %

 

(1) Shares are not adjusted for shares issued in connection with excess transaction costs incurred by Churchill.

 

(2) On May 9, 2019, one share was redeemed by a Churchill public shareholder for $10.14.

 

(3) Pro Forma Shares Outstanding includes the 10.6 million ordinary shares of Clarivate subject to the vesting restrictions but does not give effect to the 52,800,000 warrants, the additional 7,000,000 ordinary shares of Clarivate issuable upon the achievement of a $20.00 Stock Price Level (the “Incentive Shares”), or 185,601 Company management options that (based on the number of options to purchase Company ordinary shares outstanding as of December 31, 2018) will be converted in the Mergers into 24,524,698 options to purchase ordinary shares of Clarivate.

 

The following unaudited pro forma condensed combined balance sheet as of December 31, 2018 and the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2018 are derived from the historical financial statements of Churchill and the Company. The unaudited pro forma adjustments are based on information currently available, assumptions, and estimates underlying the unaudited pro forma adjustments are described in the accompanying notes. Actual results may differ materially from the assumptions used to present the accompanying unaudited pro forma condensed combined financial information. Certain amounts that appear in this section may not sum due to rounding.

 

F- 71

 

 

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET

 

(In thousands)

 

    As of December 31, 2018                 As of
December 31,
2018
 
    Company
(Historical)
    Churchill
(Historical)
    Pro Forma
Adjustments
          Pro Forma
Combined
 
ASSETS                              
Current assets                                        
Cash and cash equivalents   $ 25,575     $ 3,528     $ 694,575       (A)     $ 23,796  
                      (20,150 )     (B)          
                      (16,750 )     (C)          
                      (27,580 )     (D)          
                      15,000       (E)          
                      (649,500 )     (F)          
                      (902 )     (G)          
                      -       (O)          
                                         
Restricted cash     9       -       -               9  
Accounts receivable, net of allowance for doubtful accounts     331,295       -       -               331,295  
Prepaid expenses     31,021       -       317       (H)       31,338  
Prepaid expenses and other current assets     -       335       (335 )     (H)       -  
Other current assets     20,712       -       18       (H)       20,730  
                                         
Total Current Assets     408,612       3,863       (5,307 )             407,168  
                                         
Marketable securities held in Trust Account     -       694,575       (694,575 )     (A)       -  
Computer hardware and other property, net     20,641       -       -               20,641  
Identifiable intangible assets, net     1,958,520       -       -               1,958,520  
Goodwill     1,282,919       -       -               1,282,919  
Other non-current assets     26,556       -       -               26,556  
Deferred income taxes     12,426       -       -               12,426  
                                         
Total Assets   $ 3,709,674     $ 698,438     $ (699,882 )           $ 3,708,230  
                                         
LIABILITIES AND SHAREHOLDERS’ EQUITY                                        
Current liabilities                                        
Accounts payable   $ 38,418     $ -     $ (364 )     (D)     $ 38,057  
                      3       (H)          
Accounts payable and accrued expenses     -       1,936       (1,798 )     (C)       -  
                      (107 )     (G)          
                      (31 )     (H)          
Accrued expenses and other current liabilities     153,849       -       28       (H)       153,890  
                      13       (H)          
Current portion of deferred revenues     391,102       -       -               391,102  
Short-term debt, including current portion of long-term debt     60,345       -       (20,000 )     (F)       40,345  
Deferred tax liability     -       13       (13 )     (H)       -  
Income taxes payable     -       795       (795 )     (G)       -  
                                         
Total Current Liabilities     643,714       2,744       (23,064 )             623,394  
                                         
Long-term debt     1,930,177       -       (629,500 )     (F)       1,311,438  
                      10,761       (F)          
Non-current portion of deferred revenues     17,112       -       -               17,112  
Deferred underwriting fee payable     -       24,150       (24,150 )     (B)       -  
Other non-current liabilities     24,838       -       5,000       (C)       29,838  
Tax receivable liability     -       -       259,787       (N)       259,787  
Deferred income taxes     43,226       -       -               43,226  
                                         
Total Liabilities     2,659,067       26,894       (401,166 )             2,284,795  

   

F- 72

 

   

    As of December 31, 2018                 As of December 31,
2018
 
    Company
(Historical)
    Churchill
(Historical)
    Pro Forma
Adjustments
          Pro Forma
Combined
 
Commitments and Contingencies                                        
Common stock subject to possible redemption     -       666,543       (666,543 )     (I)     -  
                                         
Shareholders’ Equity                                        
Ordinary shares in Clarivate     -       -       15,000       (E)       2,088,315  
                      666,543       (I)          
                      2       (J)          
                      16       (K)          
                      (259,787 )     (N)          
                      1,677,494       (L)          
                      7,757       (L)          
                      (18,710 )     (M)          
                      -       (O)          
                                         
Preferred stock     -       -       -               -  
Class A common stock- Churchill     -       0       (0 )     (J)       -  
Class B common stock - Churchill     -       2       (2 )     (J)       -  
Share capital     16       -       (16 )     (K)       -  
Additional paid-in capital     1,677,494       3,757       (1,677,494 )     (L)       -  
                      (7,757 )     (L)          
                      4,000       (B)          
                                         
Accumulated other comprehensive income/(loss)     5,358       -       -               5,358  
Accumulated deficit     (632,261 )     -       (27,216 )     (D)       (670,238 )
                      (10,761 )     (F)          
Retained earnings     -       1,242       (19,952 )     (C)       -  
                      18,710       (M)          
                                         
Total Shareholders’ Equity     1,050,607       5,000       367,827               1,423,435  
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   $ 3,709,674     $ 698,438     $ (699,882 )         $ 3,708,230  

 

See accompanying notes to unaudited pro forma condensed combined financial information.

 

F- 73

 

 

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

(In thousands, except per share amounts)

 

    Twelve
Months
Ended
December
31, 2018
    For the
Period from
June 20,
2018
(inception)
thru
December
31, 2018
              Twelve
Months
Ended
December 31,
2018
 
    Company
(Historical)
    Churchill
(Historical)
    Pro Forma
Adjustments
        Pro Forma
Combined
 
                             
Revenues, net   $ 968,468     $ -     $ -         $ 968,468  
                                     
Operating costs and expenses:                                    
Cost of revenues, excluding depreciation and amortization     396,499       -       -           396,499  
Operating costs     -       2,525       (2,525 )   (AA)     -  
Selling, general and administrative costs, excluding depreciation and amortization     369,377       -                   369,377  
Share-based compensation expense     13,715       -       -           13,715  
Depreciation     9,422       -       -           9,422  
Amortization     227,803       -       -           227,803  
Transaction expenses     2,457       -       (364 )   (BB)     2,093  
Transition, integration and other     61,282       -       -           61,282  
Other operating expense (income)     (6,379 )     -       -           (6,379 )
                                     
Total operating expenses     1,074,176       2,525       (2,889 )         1,073,812  
                                     
Loss from operations     (105,708 )     (2,525 )     2,889           (105,344 )
                                     
Other income:                                    
Interest income     -       4,513       (4,513 )   (AA)     -  
Interest expense, net     (130,805 )     -       36,927     (CC)     (93,878 )
Unrealized gain on marketable securities held in Trust Account     -       62       (62 )   (AA)     -  
                                     
Other income, net     (130,805 )     4,575       32,352           (93,878 )
                                     
Income/(loss) before income tax     (236,513 )     2,050       35,241           (199,222 )
                                     
Benefit (provision) for income tax (1)     (5,649 )     (808 )     808     (AA)     (5,649 )
                                     
Net income (loss)   $ (242,162 )   $ 1,242     $ 36,049         $ (204,871 )
                                     
Per share:                                    
Basic and diluted net loss per common share   $ (147.14 )   $ (0.13 )               $ (0.67 )
Weighted average shares outstanding, basic and diluted     1,645,818       17,706,822                   305,249,999  

 

(1) The pro forma income statement adjustments do not have an income tax effect due to the pro forma net loss position and existing valuation allowance.

 

See accompanying notes to unaudited pro forma condensed combined financial information.

 

F- 74

 

 

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

1. Basis of Presentation

 

The Transactions will be accounted for as a reverse recapitalization, with no goodwill or other intangible assets recorded, in accordance with GAAP. Under this method of accounting, Churchill will be treated as the “acquired” company for financial reporting purposes. This determination was primarily based on the Company Owners being the majority stockholder and holding majority voting power in the combined company, the Company’s senior management comprising the majority of the senior management of the combined company, and the ongoing operations of the Company comprising the ongoing operations of the combined company. Accordingly, for accounting purposes, the Transactions will be treated as the equivalent of Clarivate issuing ordinary shares for the net assets of Churchill, accompanied by a recapitalization. The net assets of Churchill will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the business combination will be those of the Company.

 

The unaudited pro forma condensed combined balance sheet as of December 31, 2018 assumes that the Transactions occurred on December 31, 2018. The unaudited pro forma condensed combined statements of operations for the year ended December 31, 2018 present the pro forma effect of the Transactions as if they had been completed on January 1, 2018. These periods are presented on the basis of the Company as the accounting acquirer.

 

The unaudited pro forma condensed combined balance sheet as of December 31, 2018 has been derived from and should be read in conjunction with the following:

· Churchill’s audited balance sheet as of December 31, 2018 and the related notes for the period ended December 31, 2018, filed separately with the SEC; and
· the Company’s audited consolidated balance sheet as of December 31, 2018 and the related notes for the year ended December 31, 2018, filed herewith.

 

The unaudited pro forma condensed combined statement of operations for the year ended December 31, 2018 has been derived from and should be read in conjunction with the following:

· Churchill’s audited statement of operations for the period from June 20, 2018 (inception) through December 31, 2018 and the related notes, filed separately with the SEC; and
· the Company’s audited consolidated statement of operations for the year ended December 31, 2018 and the related notes, filed herewith.

 

Management has made significant estimates and assumptions in its determination of the pro forma adjustments. As the unaudited pro forma condensed combined financial information has been prepared based on these preliminary estimates, the final amounts recorded may differ materially from the information presented.

 

The unaudited pro forma condensed combined financial information does not give effect to any anticipated synergies, operating efficiencies, tax savings, or cost savings that may be associated with the Transactions. Management is currently finalizing certain equity agreements for the combined company. As these agreements are preliminary and not yet executed, management has not included a pro forma adjustment to reflect these equity agreements because such amounts are not known and not deemed factually supportable.

 

As of December 31, 2018, the sponsor, the founders and Garden State held 17,250,000 founder shares. In connection with the execution of the Merger Agreement, the sponsor, the founders and Garden State entered into the Sponsor Agreement. Pursuant to the Sponsor Agreement, 10,619,425 of the founder shares converted into ordinary shares of Clarivate to the sponsor in connection with the Delaware Merger and available for distribution to Jerre Stead, Michael Klein and Sheryl von Blucher are subject to certain time and performance-based vesting provisions. The remaining 6,630,575 founder shares converted into ordinary shares of Clarivate are not subject to time or performance-based vesting provisions. Of the 10,619,425 ordinary shares of Clarivate subject to vesting considerations (the “Unvested Founders Shares”), 50% of the Unvested Founders Shares shall vest in three equal annual installments, with the first, second and third installments vesting on the first, second and third anniversaries of May 13, 2019 (the “Closing Date”), respectively. The other 50% of the Unvested Founders Shares will vest at the achievement of two Stock Price Levels, defined in the Sponsor Agreement as when the last reported sale price per Clarivate ordinary share on the New York Stock Exchange equals or exceeds the applicable threshold for any 40 trading days during a 60 consecutive trading day period, which 60 consecutive trading day period will not commence until the earlier of (i) the date on which Onex or Baring sell any of their respective ordinary shares of Clarivate to a third party that is not an affiliate of Onex, Baring, any founder, the sponsor or Garden State or (ii) the first anniversary of the Closing Date. 25% of the Unvested Founders Shares shall vest at such time as a $15.25 Stock Price Level is achieved on or before the date that is 42 months after the Closing Date; provided, however, that none of such Unvested Founders Shares shall vest prior to the first anniversary of the Closing Date, not more than 1/3 of such Unvested Founders Shares shall vest prior to the second anniversary of the Closing Date and not more than 2/3 of such Unvested Founders Shares shall vest prior to the third anniversary of the Closing Date. 25% of the Unvested Founders Shares shall vest at such time as a $17.50 Stock Price Level is achieved on or before the fifth anniversary of the Closing Date; provided, however, that none of such Unvested Founders Shares shall vest prior to the first anniversary of the Closing Date, not more than 1/3 of such Unvested Founders Shares shall vest prior to the second anniversary of the Closing Date and not more than 2/3 of such Unvested Founders Shares shall vest prior to the third anniversary of the Closing Date. If a $15.25 Stock Price Level is not achieved on or before the date that is 42 months after the Closing Date, then the Unvested Founders Shares subject to vesting at the $15.25 Stock Price Level shall be eligible to vest with the Unvested Founders Shares subject to the $17.50 Stock Price Level. In the event of certain sale transactions involving the ordinary shares of Clarivate or all or substantially all of the assets of Clarivate, the Unvested Founders Shares subject only to time-based vesting shall automatically become vested. The Unvested Founders Shares subject to performance-based vesting will vest if the per share price implied in such sale transaction is equal to or greater than the applicable Stock Price Level. The Unvested Founders Shares that are subject to performance-based vesting will be forfeited for no consideration to the Company Owners if they do not vest in accordance with the Sponsor Agreement.

 

F- 75

 

 

The pro forma adjustments reflecting the consummation of the Transactions are based on certain currently available information and certain assumptions and methodologies that the Company believes are reasonable under the circumstances. The unaudited condensed pro forma adjustments, which are described in the accompanying notes, may be revised as additional information becomes available and is evaluated. Therefore, it is likely that the actual adjustments will differ from the pro forma adjustments and it is possible the difference may be material. Churchill believes that its assumptions and methodologies provide a reasonable basis for presenting all of the significant effects of the Transactions contemplated based on information available to management at the time and that the pro forma adjustments give appropriate effect to those assumptions and are properly applied in the unaudited pro forma condensed combined financial information.

 

The unaudited pro forma condensed combined financial information is not necessarily indicative of what the actual results of operations and financial position would have been had the Transactions taken place on the dates indicated, nor are they indicative of the future consolidated results of operations or financial position of the combined company. They should be read in conjunction with the audited financial statements and notes thereto of the Company included elsewhere in this Form 20-F and the audited financial statements and related notes of Churchill filed separately with the SEC.

 

2. Adjustments to Unaudited Pro Forma Condensed Combined Financial Information

 

The unaudited pro forma condensed combined financial information has been prepared to illustrate the effect of the Transactions and has been prepared for informational purposes only.

 

The historical financial statements have been adjusted in the unaudited pro forma condensed combined financial information to give pro forma effect to events that are (1) directly attributable to the Transactions, (2) factually supportable, and (3) with respect to the statement of operations, expected to have a continuing impact on the results of the combined company. The Company and Churchill have not had any historical relationship prior to the Transactions. Accordingly, no pro forma adjustments were required to eliminate activities between the companies.

 

The pro forma combined provision for income taxes does not necessarily reflect the amounts that would have resulted had the combined company filed consolidated income tax returns during the periods presented.

 

The pro forma basic and diluted earnings per share amounts presented in the unaudited pro forma condensed combined statement of operations are based upon the number of the Company’s shares outstanding, assuming the Transactions occurred on January 1, 2018.

 

Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet

 

The adjustments included in the unaudited pro forma condensed combined balance sheet as of December 31, 2018 are as follows:

 

(A) Reflects the reclassification of cash and cash equivalents held in the Churchill trust account that becomes available in connection with the Transactions.

 

(B) Reflects the settlement of deferred underwriters’ fees incurred during the Churchill IPO due upon completion of the Transactions, adjusted for the amendment to the underwriting agreement between Churchill and its underwriter.

 

(C) Reflects adjustments related to the payment of the anticipated transaction costs by Churchill including, but not limited to, advisory fees, legal fees and registration fees. This adjustment includes a reduction to accrued liabilities for any previously incurred transaction costs that are expected to be paid in connection with the consummation of the Transactions. A portion of the fees are not payable until after 2020 and are accrued for as a non-current liability.

 

F- 76

 

   
(D) Reflects adjustments related to the payment of anticipated transaction costs by the Company including, but not limited to, advisory fees, legal fees and registration fees. This adjustment includes a reduction to accounts payable for any previously incurred transaction costs that are expected to be paid in connection with the consummation of the Transactions.

 

(E) Reflects 1.5 million additional shares of Churchill common stock purchased by certain founders for $15.0 million in connection with the Transactions.

 

(F) Reflects paydown of the Term Loan Facility and Revolving Credit Facility with the cash acquired from Churchill, less total estimated transaction expenses and cash moved to the balance sheet for working capital purposes. The principal paydown is in increments of $0.5 million. The paydown results in the following adjustments:

· $20 million reduction in short-term debt; the reduction in this short-term debt represents a full paydown of the Revolving Credit Facility at transaction close, and
· $629.5 million reduction in long-term debt, offset by a proportional write-down of $10.8 million of unamortized deferred issuance costs and debt discount.

 

(G) Reflects the payment of Churchill’s income and franchise tax obligations.

 

(H) Reflects the reclassification of Churchill’s financial statement captions to the Company’s respective financial statement captions.

 

(I) Reflects the reclassification of Churchill common stock subject to possible redemption to permanent equity.

 

(J) Represents the re-capitalization of shares of Churchill’s Class A and Class B common stock to ordinary shares of Clarivate.

 

(K) Represents the re-capitalization of ordinary shares of the Company to ordinary shares of Clarivate.

 

(L) Represents the reclassification of additional paid-in capital of the Company and Clarivate to ordinary shares of Clarivate, which has no par value.

 

(M) Elimination of Churchill’s retained earnings, which is inclusive of historical retained earnings.

 

(N) Reflects the liability estimate for the Tax Receivable Agreement among the Company and the other parties to the Tax Receivable Agreement such that the Company will pay 85% of all future realized (or deemed realized) tax benefits that are covered by the Tax Receivable Agreement to such other parties. This adjustment will represent the estimated liability based on our preliminary analysis under ASC 450. The Tax Receivable Agreement liability is based on the tax attributes immediately prior to the Company’s entrance into the Tax Receivable Agreement and is subject to estimates and assumptions that may change materially. The total long-term liability for the Company’s Tax Receivable Agreement is approximately $259.8 million, but may increase to $517.2 million if all Covered Tax Assets (as defined in the Tax Receivable Agreement) are utilized. The actual liability may change based on the facts and circumstances at the time of recording the liability in the books and records of the Company. See Item 7 “Major Shareholders and Related Party Transactions — B. Related Party Transactions” for further information.

 

(O) Reflects the withdrawal of funds from the Churchill trust account to fund the redemption of one share of ordinary shares at $10.14 per share.

 

Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations

 

The pro forma adjustments included in the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2018 are as follows:

 

(AA) Reflects the elimination of Churchill historical operating costs, interest income and unrealized gain on the trust account and related tax impacts that would not have been incurred had the Transactions been consummated on January 1, 2018.

 

(BB) Elimination of transaction expenses related to the Transactions incurred in the year ended December 31, 2018.

 

(CC) Reflects the reduction in interest expense, related to the paydown of the Term Loan Facility and Revolving Credit Facility.

 

F- 77

 

 

3. Earnings per Share

 

Represents the net earnings per share calculated using the historical weighted average ordinary shares of the Company and the issuance of additional ordinary shares in connection with the Transactions, assuming the ordinary shares were outstanding since January 1, 2018. As the Transactions, including related proposed equity purchases, are being reflected as if they had occurred at the beginning of the period presented, the calculation of weighted average ordinary shares outstanding for basic and diluted net income (loss) per ordinary share assumes that the ordinary shares issuable in connection with the Transactions have been outstanding for the entire period presented.

 

(Net loss presented in thousands of dollars)      
Pro Forma Basic and Diluted Loss Per Share   Twelve Months
Ended December
31, 2018
 
Pro Forma net loss attributable to shareholders   $ (204,871 )
         
Weighted average ordinary shares outstanding, basic and diluted     305,249,999  
Basic and diluted net loss per ordinary share   $ (0.67 )

  

Pro Forma Weighted Average Shares - Basic and Diluted      
Clarivateordinary shares issued to the Company Owners     217,500,000  
Total Clarivate ordinary shares issued to the sponsor and the founders     18,750,000  
Clarivate ordinary shares issued to current Churchill public shareholders     68,999,999  
Pro Forma Weighted Average Ordinary Shares – Basic and Diluted     305,249,999  

 

As a result of the pro forma net loss, the earnings per share amounts exclude the anti-dilutive impact from the following securities:

 

· The 34,500,000 warrants sold during the Churchill IPO converted in the Mergers into warrants to purchase up to a total of 34,500,000 Clarivate ordinary shares, which are exercisable at $11.50 per share;
· The 18,300,000 private placement warrants sold concurrently with the Churchill IPO converted in the Mergers into warrants to purchase up to a total of 18,300,000 Clarivate ordinary shares. Approximately 17,265,826 of these private placement warrants are held by the sponsor, and available for distribution to certain founders and Garden State, exercisable at $11.50 per share but subject to vesting only when a $17.50 Stock Price Level is achieved. The remainder of the private placement warrants are not subject to such vesting threshold and are exercisable at $11.50;
· The 7,000,000 Incentive Shares shall be allotted and issued to the persons designated by Jerre Stead and Michael Klein (or, in the event of death or incapacity of either, by his respective successor) if a $20.00 Stock Price Level is achieved on or before the sixth anniversary of the Closing Date; and

· The 185,601 management options of the Company (based on the number of options to purchase Company ordinary shares outstanding as of December 31, 2018) converted in the Mergers into 24,524,698 options to purchase ordinary shares of Clarivate pursuant to the Clarivate Analytics Plc 2019 Incentive Award Plan, of which 6,655,037 are vested and 17,869,661 will be unvested and have weighted average exercise prices of $10.85 and $11.08, respectively, after giving effect to the expected adjustment to exercise prices of the management options of the Company in connection with the Tax Receivable Agreement. The number of outstanding management options assumes that no Company options will be exercised prior to the Closing Date.

 

F- 78

 

 

EXHIBIT INDEX

 

Exhibit No.   Description   Included   Form   Filing Date
1.1     Amended and Restated Memorandum of Association and Articles of Association of Clarivate Analytics Plc   Herewith    
                 
2.1     Warrant Agreement between Continental Stock Transfer & Trust Company and Churchill Capital Corp   By Reference   Churchill
8-K
  September 12, 2018
2.2     Indenture dated as of October 3, 2016 among Camelot Finance S.A., as Issuer, the guarantors party thereto and Wilmington Trust, National Association, as trustee governing the 7.875% Notes due 2024   By Reference   Clarivate
F-4
  February 27, 2019
4.1     Form of Warrants Subscription Agreement   By Reference   Churchill
S-1
  August 20, 2018
4.2     Form of Director and Officer Indemnification Agreements   By Reference   Clarivate
F-4
  April 15, 2019
4.3     Sponsor Agreement   By Reference   Clarivate
F-4
  February 27, 2019
4.4     Amendment No. 1 to the Sponsor Agreement   By Reference   Clarivate
F-4
  March 29, 2019
4.5     Amended and Restated Shareholders Agreement   By Reference   Clarivate
F-4
  April 23, 2019
4.6     Amended and Restated Registration Rights Agreement   Herewith    
                 
4.7     Form of Tax Receivable Agreement   By Reference   Clarivate
F-4
  April 25, 2019
4.8     Credit Agreement dated as of October 3, 2016 among Camelot UK Holdco Limited, as Holdings, Camelot UK Bidco Limited, as UK Holdco, Camelot Finance LP, as the US Tower Borrower, Camelot Cayman LP, as the FHC Tower Borrower, the US Company Borrowers specified therein, Camelot Finance S.A., as the Lux Company Borrower, certain Restricted Subsidiaries designated thereunder as Revolver Co-Borrowers, the several Lenders from time to time party thereto and Credit Suisse AG, Cayman Islands Branch, as Administrative Agent   By Reference   Clarivate
F-4
  February 27, 2019
4.9     First Amendment to the Credit Agreement   By Reference   Clarivate
F-4
  March 29, 2019
4.10     Second Amendment to the Credit Agreement   By Reference   Clarivate
F-4
  March 29, 2019
4.11     Director Acknowledgement Letter (Stead)   By Reference   Clarivate
F-4
  February 27, 2019
4.12     Director Acknowledgement Letter (von Blucher)   By Reference   Clarivate
F-4
  February 27, 2019
4.13     Director Acknowledgement Letter (Klein)   By Reference   Clarivate
F-4
  February 27, 2019
4.14     Form of Director Nomination Agreement   By Reference   Clarivate
F-4
  April 25, 2019
4.15     Clarivate Analytics Plc 2019 Incentive Award Plan   By Reference   Clarivate
F-4
  April 15, 2019
8.1   Subsidiaries of the Registrant   By Reference   Clarivate
F-4
  April 15, 2019
15.1   Consent of PricewaterhouseCoopers LLP (with respect to Camelot Holdings (Jersey) Limited financial statements)   Herewith    

 

   

 

Exhibit 1.1

 

Dated 13 May 2019

 

Companies (Jersey) Law 1991

 

Company Limited by Shares

 

 
     
  AMENDED AND RESTATED Memorandum of Association  
  of  
  Clarivate Analytics PLC  
     
 

 

 

 

 

 

 

Companies (Jersey) Law 1991

 

Company Limited by Shares

 

Amended and Restated

 

Memorandum of Association

 

of

 

Clarivate Analytics PLC

 

1. The name of the Company is Clarivate Analytics PLC.

 

2. The Company is a public company limited by shares.

 

3. The Company is a no par value company.

 

4. The Company has unrestricted corporate capacity.

 

5. The liability of each member arising from his or her holding of a share is limited to the amount (if any) unpaid on it.

 

6. There is no limit on the number of shares of any class which the Company is authorised to issue.

 

 

 

 

We, the subscribers to this memorandum of association, wish to form a company in accordance with this memorandum; and we agree to take the number of shares in the capital of the Company shown below.

 

Dated the 13 th day of May, 2019

 

Signed for and on behalf of Onex Partners IV LP of 190 Elgin Avenue, George Town, KY1-9005, Cayman Islands
By:  Onex Partners IV GP LP, its general partner
By:  Onex Partners Manager LP, its agent
By:  Onex Partners Manager GP ULC, its general partner
 
 
/s/ Joshua Hausman   /s/ Matthew Ross
Signature of authorised signatory   Signature of authorised signatory
     
Joshua Hausman   Matthew Ross
Print name   Print name

 

Number of shares: 1

 

Signed for and on behalf of Onex Partners IV GP LP of 190 Elgin Avenue, George Town, KY1-9005, Cayman Islands
By:  Onex Partners Manager LP, its agent
By: Onex Partners Manager GP ULC, its general partner
 
/s/ Joshua Hausman   /s/ Matthew Ross
Signature of authorised signatory   Signature of authorised signatory
     
Joshua Hausman   Matthew Ross
Print name   Print name

 

Number of shares: 1

 

Witness to above signatures   /s/ Lisa Kim
     
[Address]   Signature
     
    Lisa Kim
     
    Print name

 

 

 

 

Dated 13 May 2019

 

Companies (Jersey) Law 1991

 

Company Limited by Shares

 

 
 

 

AMENDED AND RESTATED

Articles of Association
of
Clarivate Analytics PLC

 
 

 

 

 

 

 

 

CONTENTS

 

1 Definitions, interpretation and exclusion of Standard Table 1
Definitions 1
Interpretation 5
Exclusion of Standard Table 6
     
2 Shares 7
Power to issue Shares and options, with or without special rights 7
Power to issue fractions of a Share 7
Capital contributions without issue of further Shares 7
Limit on the number of Joint Holders 7
Treasury Shares 7
     
3 Ordinary Shares 7
     
4 Preferred Shares 8
     
5 Register of Members and share certificates 9
Issue of share certificates 9
Renewal of lost or damaged share certificates 10
     
6 Reserved 11
     
7 Transfer of shares 11
Form of transfer 11
Power to refuse registration 11
Notice of refusal to register 11
Fee, if any, payable for registration 12
Company may retain instrument of transfer 12
Transfer to branch register 12
   
8 Redemption, Purchase and Surrender of Shares, Treasury Shares 12
Power to pay for redemption or purchase in cash or in specie 13
Effect of redemption or purchase of a Share 13
   
9 Variation of Rights Attaching to Shares 14
     
10 Commission on Sale of Shares 14
     
11 Non-Recognition of Trusts 14
     
12 Transmission of Shares 15
Persons entitled on death of a Member 15
Registration of transfer of a Share following death or bankruptcy 15
Indemnity 15
Rights of person entitled to a Share following death or bankruptcy 15
     
13 Alteration of capital 16
Increasing, consolidating, converting, dividing and cancelling share capital 16
Reducing share capital 16
Sale of fractions of Shares 16
     
14 Closing Register of Members or Fixing Record Date 16

 

 

 

 

15 General Meetings 17
Power to call meetings 17
Annual general meetings 18
Content of notice 18
Period of notice 19
Persons entitled to receive notice 19
Publication of notice on a website 19
Time a website notice is deemed to be given 20
Required duration of publication on a website 20
Accidental omission to give notice or non-receipt of notice 20
Notice of other business 20
     
16 Proceedings at meetings of Members 25
Quorum 25
Use of technology 25
Lack of quorum 25
Adjournment 26
Chairman 26
Right of a director or auditor's representative to attend and speak 26
Method of voting 26
Taking of a poll 26
Chairman does not have casting vote 27
Written resolutions 27
     
17 Voting rights of members 28
Right to vote 28
Rights of Joint Holders 28
Member with mental disorder 28
Objections to admissibility of votes 29
Form of proxy 29
How and when proxy is to be delivered 29
Voting by proxy 30
   
18 Corporations Acting by Representatives at Meeting 30
     
19 Clearing Houses 31
     
20 Directors 31
     
21 Appointment, disqualification and removal of directors 32
First directors 32
No age limit 32
No corporate directors 32
Appointment of directors 32
Removal of directors 33
Filling of vacancies 33
Resignation of directors 33
Corporate governance policies 34
No shareholding qualification 34

 

 

 

 

22 Reserved 34
     
23 Directors’ Fees and Expenses 34
     
24 Powers and duties of directors 34
     
25 Delegation of powers 35
Power to delegate any of the directors' powers to a committee 35
Power to appoint an agent of the Company 35
Power to appoint an attorney or authorised signatory of the Company 36
Management 36
     
26 Disqualification of Directors 37
     
27 Meetings of directors 37
Regulation of directors' meetings 37
Calling meetings 38
Use of technology 38
Quorum 38
Voting 38
Validity 39
     
28 Permissible directors' interests and disclosure 39
     
29 Minutes 42
Written resolutions 42
     
30 [Reserved] 42
     
31 Record Dates 42
     
32 Dividends 43
Payment of dividends by directors 43
Apportionment of dividends 43
Right of set off 43
Power to pay other than in cash 44
How payments may be made 44
Dividends or other monies not to bear interest in absence of special rights 44
Unclaimed Dividends 45
   
33 Accounts and audits 45
Accounting and other records 45
No automatic right of inspection 45
Sending of accounts and reports 45
Time of receipt if documents are published on a website 46
Validity despite accidental error in publication on website 46
When accounts are to be audited 46
     
34 Audit 46
     
35 Seal 47
Company seal 47
Official seal 47
When and how seal is to be used 47
If no seal is adopted or used 47

 

 

 

 

Power to allow non-manual signatures and facsimile printing of seal 47
Validity of execution 48
   
36 Officers 48
     
37 Register of Directors and Officers 49
     
38 Capitalisation of profits 49
Capitalisation of profits or of any stated capital account or capital redemption reserve 49
     
39 Notices 49
Form of notices 49
Signatures 50
Evidence of transmission 50
Delivery of notices 50
Giving notice to a deceased or bankrupt Member 50
Saving provisions 51
   
40 Authentication of Electronic Records 51
Application of Articles 51
Authentication of documents sent by Members by Electronic means 51
Authentication of document sent by the Secretary or Officers by Electronic means 52
Manner of signing 52
Saving provision 52
   
41 Information 53
     
42 Indemnity 53
Indemnity 53
     
43 Financial Year 54
     
44 Winding up 54
Distribution of assets in specie 54

 

 

 

 

Companies (Jersey) Law 1991

 

Company Limited by Shares

 

Amended and Restated

 

Articles of Association

 

of

 

Clarivate Analytics PLC

 

1 Definitions, interpretation and exclusion of Standard Table

 

Definitions

 

1.1 In these Articles, unless otherwise defined, the defined terms shall have the meanings assigned to them as follows:

 

Affiliate means:

 

(a) in the case of a natural person, such person’s parents, parents-in-law, spouse, children or grandchildren, a trust for the benefit of any of the foregoing, a company, partnership or any natural person or entity wholly or jointly owned by such person or any of the foregoing, and

 

(b) in the case of a corporation, partnership or other entity or any natural person or entity which directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such entity.

 

The term control shall mean the ownership, directly or indirectly, of shares possessing more than fifty per cent (50%) of the voting power of the corporation, or the partnership or other entity (other than, in the case of a corporation, shares having such power only by reason of the happening of a contingency), or having the power to control the management or elect a majority of members to the board of directors or equivalent decision-making body of such corporation, partnership or other entity; provided that the Company and its subsidiaries shall not be considered Affiliates of the Onex Shareholders, the Baring Shareholders or the Designated Shareholder.

 

Articles means, as appropriate:

 

(a) these Articles of Association as amended from time to time; or

 

(b) two or more particular Articles of these Articles;

 

and Article refers to a particular Article of these Articles;

 

  1  

 

 

Baring Shareholder Designee means an individual elected to the board of Directors that has been nominated by the Baring Shareholders pursuant to the Shareholders Agreement;

 

Baring Shareholders means the Baring Shareholders, as such term is defined in the Shareholders Agreement;

 

Business Day means a day, excluding Saturdays or Sundays, on which banks in New York, New York, United States of America and the Island are open for general banking business throughout their normal business hours;

 

Commission means the Securities and Exchange Commission of the United States of America or any other federal agency for the time being administering the Securities Act;

 

Company means the above-named company;

 

Company’s Website means the website of the Company, the address or domain name of which has been notified to Members;

 

Controlled Company has the meaning given to it in the rules of the Designated Stock Exchange;

 

Default Rate means 3% (three per cent) per annum over the base rate of the Bank of England from time to time;

 

Designated Shareholder means the Designated Shareholder, as such term is defined in the Director Nomination Agreement;

 

Designated Shareholder Designee means an individual elected to the board of Directors that has been nominated by the Designated Shareholder pursuant to the relevant Director Nomination Agreement;

 

Designated Stock Exchange means the New York Stock Exchange or any other stock exchange or automated quotation system on which the Company’s securities are then traded;

 

Director Nomination Agreement means the director nomination agreement to be entered into by and between the Company and the Designated Shareholder, as amended from time to time;

 

Directors means the directors of the Company for the time being, or as the case may be, the Directors assembled as a board or as a committee thereof;

 

Dividend means any dividend (whether interim or final) resolved to be paid on Shares pursuant to these Articles;

 

Electronic has the meaning given to that term in the Electronic Communications (Jersey) Law 2000;

 

  2  

 

 

electronic communication means electronic transmission to any number, address or internet website or other electronic delivery methods as otherwise decided and approved by not less than a majority vote of the Directors;

 

Electronic Record has the meaning given to that term in the Electronic Communications (Jersey) Law 2000;

 

Electronic Signature has the meaning given to that term in the Electronic Communications (Jersey) Law 2000;

 

Exchange Act means the United States Securities Exchange Act of 1934, as amended, or any similar federal statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time;

 

Exemption Order means the Companies (Transfers of Shares – Exemptions) (Jersey) Order 2014;

 

Fully Paid and Paid Up means that the agreed issue price for a Share has been fully paid or credited as paid in money or money's worth;

 

Island means Jersey, Channel Islands;

 

Joint Holders means two or more persons registered as the holders of a Share or Shares or who are jointly entitled to a Share or Shares by reason of the death or bankruptcy of the registered holder.

 

Law means the Companies (Jersey) Law 1991;

 

Market Price means for any given day, the price quoted in respect of the Ordinary Shares on the Designated Stock Exchange of the close of trading on such day, or if such day is not a date on which the Designated Stock Exchange is open, then the close of trading on the previous trading day;

 

Member means any person or persons entered on the register of members from time to time as the holder of a Share;

 

Memorandum means the Memorandum of Association of the Company as amended from time to time;

 

month means a calendar month;

 

Nominating Member means (i) the Member providing the notice of the nomination proposed to be made at a general meeting, (ii) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the nomination proposed to be made at any general meeting is made, and (iii) any affiliate or associate of such stockholder or beneficial owner;

 

  3  

 

 

Officer means a person appointed to hold an office in the Company; and the expression includes a director or liquidator, but does not include the Secretary;

 

Onex Shareholder Designee means an individual elected to the board of Directors that has been nominated by the Onex Shareholders pursuant to the Shareholders Agreement;

 

Onex Shareholders means the Onex Shareholders, as such term is defined in the Shareholders Agreement;

 

Ordinary Resolution means a resolution of a duly constituted general meeting of the Company passed by a simple majority of the votes cast by, or on behalf of, the Members entitled to vote. The expression also includes a written resolution signed by or on behalf of a simple majority of the Members who, at the date when the resolution is deemed to be passed, would be entitled to vote on the resolution if it were proposed at a meeting;

 

Ordinary Shares means an Ordinary Share in the capital of the Company of no par value designated as Ordinary Shares, and having the rights provided for in these Articles;

 

PDF means Portable Document Format;

 

Preferred Shares means shares in the capital of the Company of no par value designated as Preferred Shares, and having the rights provided for in these Articles;

 

Register of Members means the register maintained by the Company in accordance with Article 41 of the Law or any modification or re-enactment thereof for the time being in force;

 

Registered Office means the registered office for the time being of the Company;

 

Regulations means the Companies (Uncertificated Securities) (Jersey) Order 1999 including any modification or re-enactment of them for the time being in force;

 

Seal means the common seal of the Company including any facsimile thereof;

 

Secretary means a person appointed to perform the duties of the secretary of the Company, including a joint, assistant or deputy secretary;

 

Securities Act means the Securities Act of 1933 of the United States of America, as amended, or any similar federal statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time;

 

Share means a share in the share capital of the Company, and the expression:

 

(a) includes stock (except where a distinction between shares and stock is expressed or implied); and

 

(c) where the context permits, also includes a fraction of a share;

 

  4  

 

 

Shareholder Group has the meaning given in the Director Nomination Agreement.

 

Shareholders Agreement means the Amended and Restated Shareholders Agreement to be entered into by and among the Company, the Onex Shareholders, the Baring Shareholders and the other parties thereto, as amended from time to time;

 

signed means a signature or representation of a signature affixed by mechanical means or an electronic symbol or process attached to or logically associated with an electronic communication and executed or adopted by a person with the intent to sign the electronic communication;

 

Special Resolution has the meaning given to that term in the Law. The expression also includes a written resolution signed by or on behalf of the requisite majority of Members required for the passing of a Special Resolution who, at the date when the resolution is deemed to be passed, would be entitled to vote on the resolution if it were proposed at a meeting;

 

subsidiary has the meaning given to that term in Article 2 of the Law;

 

Treasury Share means a share held in the name of the Company as a treasury share in accordance with the Law; and

 

year means a calendar year.

 

Interpretation

 

1.2 In these Articles, save where the context requires otherwise:

 

(a) words importing the singular number shall include the plural number and vice versa;

 

(b) words importing the masculine gender only ( i.e. , he and his ) shall include the feminine gender ( i.e. , her and hers ) and shall include references to entities without gender ( i.e. , it and its );

 

(c) a reference to a person includes, as appropriate, a company, trust, partnership, joint venture, association, body corporate or government agency;

 

(d) may shall be construed as permissive and “shall” shall be construed as imperative;

 

(e) a reference to a dollar or dollars (or $) is a reference to dollars of the United States of America;

 

(f) references to a statutory enactment shall include reference to any amendment or re-enactment thereof for the time being in force;

 

  5  

 

 

(g) any phrase introduced by the terms including , include , in particular or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms;

 

(h) written and in writing means all modes of representing or reproducing words in visible form, including in the form of an electronic record and any requirements as to delivery under these Articles include delivery in the form of an electronic record; where used in connection with a notice served by the Company on Members or other persons entitled to receive notices hereunder, such writing shall also include a record maintained in an electronic medium which is accessible in visible form so as to be useable for subsequent reference;

 

(i) the term “clear days” in relation to the period of a notice means that period excluding the day when the notice is received or deemed to be received and the day for which it is given or on which it is to take effect;

 

(j) the term “holder” in relation to a Share means a person whose name is entered in the Register of Members as the holder of such Share;

 

(k) headings are inserted for convenience only and do not affect the interpretation of these Articles, unless there is ambiguity;

 

(l) where a word or phrase is given a defined meaning, another part of speech or grammatical form in respect to that word or phrase has a corresponding meaning; and

 

(m) all references to time are to be calculated by reference to time in the place where the Company's registered office is located.

 

Exclusion of Standard Table

 

1.3 The regulations contained in the Standard Table adopted pursuant to the Companies (Standard Table) (Jersey) Order 1992 and any other regulations contained in any statute or subordinate legislation are expressly excluded and do not apply to the Company.

 

Shareholders Agreement and Director Nomination Agreement

 

1.4 Notwithstanding any provision of these Articles to the contrary, each of the Onex Shareholders, the Baring Shareholders and the Designated Shareholder shall have the respective rights set forth in the Shareholders Agreement or the Director Nomination Agreement, as applicable.

 

  6  

 

 

2 Shares

 

Power to issue Shares and options, with or without special rights

 

2.1 Subject to the provisions, if any, in the Memorandum (and to any direction that may be given by the Company in general meeting), the Directors may, in their absolute discretion and without approval of the holders of Ordinary Shares, allot, issue, grant options over or otherwise dispose of Shares (including fractions of a Share) with or without preferred, deferred or other rights or restrictions, whether in regard to Dividend or other distribution, voting, return of capital or otherwise, any or all of which may be greater than the powers and rights associated with the Ordinary Shares, to such persons, at such times and on such other terms as they think proper, which shall be conclusively evidenced by their approval of the terms thereof, and may also (subject to the Law and these Articles) vary such rights.

 

2.2 The Company shall not issue Shares in bearer form and shall only issue Shares as fully paid.

 

Power to issue fractions of a Share

 

2.3 Subject to the Law, the Company may issue fractions of a Share of any class. A fraction of a Share shall be subject to and carry the corresponding fraction of liabilities, limitations, preferences, privileges, qualifications, restrictions, rights and other attributes of a Share of that class of Shares.

 

Capital contributions without issue of further Shares

 

2.4 With the consent of a Member, the Directors may accept a voluntary contribution from that Member without issuing Shares in return. If the Directors agree to accept a voluntary contribution from a Member, the Directors shall resolve whether that contribution shall be treated as an addition to the stated capital account of the Company or to a general reserve of the Company (it being understood that the contribution is not provided by way of loan).

 

Limit on the number of Joint Holders

 

2.5 In respect of a Share, the Company shall not be required to enter the names of more than four Joint Holders in the register of members of the Company.

 

2.6 If two or more persons are registered as Joint Holders of a Share, then any one of those Joint Holders may give effectual receipts for moneys payable in respect of that Share.

 

Treasury Shares

 

2.7 From time to time, the Company may hold its own Shares as treasury shares and the Directors may sell, transfer or cancel any treasury shares in accordance with the Law. For the avoidance of doubt, the Company shall not be entitled to vote or receive any distributions in respect of any treasury shares held by it.

 

3 Ordinary Shares

 

3.1 The holders of the Ordinary Shares shall be:

 

(a) entitled to dividends in accordance with the relevant provisions of these Articles;

 

  7  

 

 

(b) entitled to and are subject to the provisions in relation to winding up of the Company provided for in these Articles; and

 

(c) entitled to attend general meetings of the Company and shall be entitled to one vote for each Ordinary Share registered in the name of such holder in the Register of Members, both in accordance with the relevant provisions of these Articles.

 

3.2 All Ordinary Shares shall rank pari passu with each other in all respects.

 

4 Preferred Shares

 

4.1 Preferred Shares may be issued from time to time in one or more series, each of such series to have such voting powers (full or limited or without voting powers), designations, preferences and relative, participating, optional or other special rights and qualifications, limitations or restrictions thereof as are stated and expressed, or in any resolution or resolutions providing for the issue of such series adopted by the Directors as hereinafter provided.

 

4.2 Authority is hereby granted to the Directors, subject to the provisions of the Memorandum, these Articles and applicable law, to create one or more series of Preferred Shares and, with respect to each such series, to fix by resolution or resolutions, without any further vote or action by the Members of the Company providing for the issue of such series:

 

(a) the number of Preferred Shares to constitute such series and the distinctive designation thereof;

 

(b) the dividend rate on the Preferred Shares of such series, the dividend payment dates, the periods in respect of which dividends are payable ( Dividend Periods ), whether such dividends shall be cumulative and, if cumulative, the date or dates from which dividends shall accumulate;

 

(c) whether the Preferred Shares of such series shall be convertible into, or exchangeable for, Shares of any other class or classes or any other series of the same or any other class or classes of Shares and the conversion price or prices or rate or rates, or the rate or rates at which such exchange may be made, with such adjustments, if any, as shall be stated and expressed or provided in such resolution or resolutions;

 

(d) the preferences, if any, and the amounts thereof, which the Preferred Shares of such series shall be entitled to receive upon the winding up of the Company;

 

(e) the voting power, if any, of the Preferred Shares of such series;

 

(f) transfer restrictions and rights of first refusal with respect to the Preferred Shares of such series; and

 

  8  

 

 

(g) such other terms, conditions, special rights and provisions as may seem advisable to the Directors.

 

4.3 Notwithstanding the fixing of the number of Preferred Shares constituting a particular series upon the issuance thereof, the Directors at any time thereafter may authorise the issuance of additional Preferred Shares of the same series subject always to the Law and the Memorandum.

 

4.4 No dividend shall be declared and set apart for payment on any series of Preferred Shares in respect of any Dividend Period unless there shall likewise be or have been paid, or declared and set apart for payment, on all Preferred Shares of each other series entitled to cumulative dividends at the time outstanding which rank senior or equally as to dividends with the series in question, dividends rateably in accordance with the sums which would be payable on the said Preferred Shares through the end of the last preceding Dividend Period if all dividends were declared and paid in full.

 

4.5 If, upon the winding up of the Company, the assets of the Company distributable among the holders of any one or more series of Preferred Shares which (a) are entitled to a preference over the holders of the Ordinary Shares upon such winding up and (b) rank equally in connection with any such distribution shall be insufficient to pay in full the preferential amount to which the holders of such Preferred Shares shall be entitled, then such assets, or the proceeds thereof, shall be distributed among the holders of each such series of the Preferred Shares rateably in accordance with the sums which would be payable on such distribution if all sums payable were discharged in full.

 

5 Register of Members and share certificates

 

Issue of share certificates

 

5.1 The Company shall maintain or cause to be maintained the Register of Members in accordance with the Law.

 

5.2 Subject to and to the extent permitted by the Law, the Company, or the Directors on behalf of the Company, may cause to be kept and maintained in any country, territory or place, a branch register of Members resident in such country, territory or place, and the Company may, or the Directors on behalf of the Company may, make and vary such regulations as it or they may think fit regarding the keeping of any such branch register.

 

5.3 Upon being entered in the register of members as the holder of a Share, a Member shall, subject to Article 5.8, be entitled:

 

(a) without payment, to one certificate for all the Shares of each class held by that Member (and, upon transferring a part of the Member's holding of Shares of any class, to a certificate for the balance of that holding); and

 

  9  

 

 

(b) upon payment of such reasonable sum as the Directors may determine for every certificate after the first, to several certificates each for one or more of that Member's Shares.

 

5.4 Every certificate shall specify the number, class and distinguishing numbers (if any) of the Shares to which it relates and whether they are Fully Paid or partly paid up. A certificate may be executed under seal or executed in such other manner as the Directors determine.

 

5.5 The Company shall not be bound to issue more than one certificate for Shares held jointly by several persons and delivery of a certificate for a Share to one Joint Holder shall be a sufficient delivery to all of them.

 

5.6 All certificates for Shares shall be delivered personally or sent through the post addressed to the member entitled thereto at the Member’s registered address as appearing in the Register of Members. Every share certificate sent in accordance with these Articles will be sent at the risk of the Member or other person entitled to the certificate. The Company will not be responsible for any share certificate lost or delayed in the course of delivery.

 

Renewal of lost or damaged share certificates

 

5.7 If a share certificate is defaced, worn-out, lost or destroyed, it may be renewed on such terms (if any) as to:

 

(a) evidence;

 

(b) indemnity;

 

(c) payment of the expenses reasonably incurred by the Company in investigating the evidence; and

 

(d) payment of a reasonable fee, if any, for issuing a replacement share certificate;

 

as the Directors may determine, and (in the case of defacement or wearing-out) on delivery to the Company of the old certificate.

 

Uncertificated shares

 

5.8 Subject to Article 5.9, at any time the Shares are listed on the Designated Stock Exchange (provided that the Designated Stock Exchange remains an "approved stock exchange" (as defined in the Exemption Order)), the Company shall not be required to (although may, in its absolute discretion choose to), provide a share certificate in accordance with Article 5.3.

 

5.9 Following a written request at any time from a Member to the Company requesting a share certificate in respect of Shares held by that Member, the Company shall, within 2 months of receipt by the Company of that written request, complete and have ready for delivery the certificate of such Shares in respect of which the request was made unless the conditions of allotment of the Shares otherwise provide.

 

  10  

 

 

6 Reserved

 

7 Transfer of shares

 

Form of transfer

 

7.1 Subject to these Articles (including Article 7.8), any agreement between a Member and the Company, and the rules or regulations of the Designated Stock Exchange or any relevant securities laws (including, but not limited to the Exchange Act), any Member may transfer all or any of his Shares by an instrument of transfer in the usual or common form or in a form prescribed by the Designated Stock Exchange or in any other form approved by the Directors acting reasonably and may be under hand or, if the transferor or transferee is a clearing house or its nominee(s), by hand or by machine imprinted signature or by such other manner of execution as the Directors may approve from time to time.

 

7.2 The instrument of transfer shall be executed by or on behalf of the transferor. Without prejudice to the last preceding Article, the Directors may also resolve, either generally or in any particular case, upon request by the transferor or transferee to accept mechanically executed transfers. The transferor shall be deemed to remain the holder of the Share until the name of the transferee in entered into the Register of Members in respect thereof.

 

Power to refuse registration

 

7.3 The Directors may decline to recognise any instrument of transfer unless:

 

(a) the instrument of transfer is in respect of only one class of Share;

 

(b) the instrument of transfer is lodged at the Registered Office or such other place as the Register of Members is kept in accordance with the Law accompanied by the relevant share certificate(s) (if any) or such other evidence as the Directors may reasonably require to show the right of the transferor to make the transfer (and, if the instrument of transfer is executed by some other person on his behalf, the authority of that person so to do); and

 

(c) the instrument of transfer is duly and properly signed and endorsed or accompanied by the share certificates in respect of the relevant Shares or an indemnity.

 

Notice of refusal to register

 

7.4 If the Directors refuse to register a transfer of a Share, they must send notice of their refusal to the existing Member within two months after the date on which the transfer was lodged with the Company.

 

  11  

 

 

Fee, if any, payable for registration

 

7.5 If the Directors so decide, the Company may charge a reasonable fee for the registration of any instrument of transfer or other document relating to the title to a Share.

 

Company may retain instrument of transfer

 

7.6 The Company shall be entitled to retain any instrument of transfer which is registered; but an instrument of transfer which the Directors refuse to register shall be returned to the person lodging it when notice of the refusal is given.

 

Transfer to branch register

 

7.7 The Directors in so far as permitted by any applicable law and rules of the Designated Stock Exchange may, in their absolute discretion, at any time and from time to time transfer any Share upon the Register of Members to any branch register or any Share on any branch register to the Register of Members or any other branch register. In the event of any such transfer, the Member requesting such transfer shall bear the cost of effecting such transfer unless the Directors otherwise determine.

 

Holding of Shares through Direct Registration System

 

7.8 At any time any of the Shares are listed on the Designated Stock Exchange (provided that the Designated Stock Exchange remains an approved stock exchange (as defined in the Exemption Order)), a transfer of such Shares is exempt from the provisions of Article 42(1) of the Law requiring an instrument of transfer to be delivered to the Company where the following conditions are met in respect of such transfer:

 

(a) the transfer is made:

 

(i) to or from an approved central securities depository (as defined in the Exemption Order), or

 

(ii) by means of a computer system (as defined in the Exemption Order); and

 

(b) the transfer is in accordance with the relevant laws (as defined in the Exemption Order) applicable to, and relevant rules and regulations of, the Designated Stock Exchange.

 

8 Redemption, Purchase and Surrender of Shares, Treasury Shares

 

8.1 Subject to the provisions, if any, in these Articles, the Memorandum, applicable law, including the Law, and the rules of the Designated Stock Exchange, the Company may:

 

(a) issue Shares on terms that they are to be redeemed or are liable to be redeemed at the option of the Company or the Member on such terms and in such manner as the Directors may, before the issue of such Shares, determine; and

 

  12  

 

 

(b) purchase its own Shares (including any redeemable Shares) in such manner and on such other terms as the Directors may agree with the relevant Member, provided that the manner of purchase is in accordance with any applicable requirements imposed from time to time by the Commission or the Designated Stock Exchange.

 

8.2 The Company may make a payment in respect of the redemption or purchase of Shares in any manner authorised by the Law, including out of capital, profits or the proceeds of a fresh issue of Shares.

 

8.3 The Directors may, prior to the purchase, redemption or surrender of any Share, determine that such Share shall be held as a Treasury Share.

 

8.4 The Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms as they think proper (including, without limitation, for nil consideration).

 

Power to pay for redemption or purchase in cash or in specie

 

8.5 When making a payment in respect of the redemption or purchase of Shares, the Directors may make the payment in cash or in specie (or partly in one way and partly in the other way).

 

Effect of redemption or purchase of a Share

 

8.6 Upon the date of redemption or purchase of a Share:

 

(a) the Member holding that Share shall cease to be entitled to any rights in respect of the Share other than the right to receive:

 

(i) the applicable payment for the Share; and

 

(ii) any dividend declared in respect of the Share prior to the date of redemption or purchase;

 

(b) the Member's name shall be removed from the Register of Members with respect to the Share; and

 

(c) the Share shall be cancelled or become a Treasury Share.

 

For the purpose of this Article, the date of redemption or purchase is the date when the redemption or purchase occurs.

 

  13  

 

 

9 Variation of Rights Attaching to Shares

 

9.1 If at any time the share capital of the Company is divided into different classes of Shares, all or any of the rights attached to any class (unless otherwise provided by the terms of issue of the Shares of that class) may, whether or not the Company is being wound up, be varied without the consent of the holders of the issued Shares of that class where such variation is considered by the Directors not to have a material adverse effect upon such rights; otherwise, any such variation shall be made only with the consent in writing of the holders of not less than two thirds of the issued Shares of that class, or with the sanction of a resolution passed by a majority of not less than two thirds of the votes cast at a separate meeting of the holders of the Shares of that class. For the avoidance of doubt, the Directors reserve the right, notwithstanding that any such variation may not have a material adverse effect, to obtain consent from the holders of Shares of the relevant class. To any such meeting all the provisions of these Articles relating to general meetings shall apply mutatis mutandis , except that the necessary quorum shall be one person holding or representing by proxy at least one third of the issued Shares of the class and that any holder of Shares of the class present in person or by proxy may demand a poll.

 

9.2 For the purposes of a separate class meeting, the Directors may treat two or more or all the classes of Shares as forming one class of Shares if the Directors consider that such class of Shares would be affected in the same way by the proposals under consideration, but in any other case shall treat them as separate classes of Shares.

 

9.3 The rights conferred upon the holders of the Shares of any class issued with preferred or other rights shall not, unless otherwise expressly provided by the terms of issue of the Shares of that class, be deemed to be varied by the creation or issue of further Shares ranking in priority to or pari passu therewith.

 

10 Commission on Sale of Shares

 

The Company may, in so far as the Law permits, pay a commission to any person in consideration of his subscribing or agreeing to subscribe (whether absolutely or conditionally) or procuring or agreeing to procure subscriptions (whether absolutely or conditionally) for any Shares. Such commissions may be satisfied by the payment of cash and/or the issue of fully or partly paid-up Shares. The Company may also on any issue of Shares pay such brokerage as may be lawful.

 

11 Non-Recognition of Trusts

 

Except as required by law:

 

(a) no person shall be recognised by the Company as holding any Share on any trust; and

 

(b) no person other than the Member shall be recognised by the Company as having any right in a Share.

 

  14  

 

 

12 Transmission of Shares

 

Persons entitled on death of a Member

 

12.1 If a Member dies, the survivor or survivors (where he was a Joint Holder) or his legal personal representatives (where he was a sole holder), shall be the only persons recognised by the Company as having any title to his Shares. The estate of a deceased Member is not thereby released from any liability in respect of any Share, for which he was a joint or sole holder.

 

Registration of transfer of a Share following death or bankruptcy

 

12.2 Any person becoming entitled to a Share in consequence of the death or bankruptcy, liquidation or dissolution of a Member (or in any other way than by transfer) may, upon such evidence being produced as may be required by the Directors, elect, by a notice in writing sent by him to the Company, either to become the holder of such Share or to have some person nominated by him registered as the holder of such Share. If he elects to have another person registered as the holder of such Share he shall sign an instrument of transfer of that Share to that person. The Directors shall, in either case, have the same right to decline registration as they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy, liquidation or dissolution, as the case may be.

 

Indemnity

 

12.3 The Directors may require a person registered as a Member by reason of the death or bankruptcy of another Member to indemnify the Company and the Directors against any loss or damage suffered by the Company or the Directors as a result of that registration.

 

Rights of person entitled to a Share following death or bankruptcy

 

12.4 A person becoming entitled to a Share by reason of the death or bankruptcy or liquidation or dissolution of a Member (or in any other case than by transfer) shall be entitled to the same Dividends, other distributions and other advantages to which he would be entitled if he were the holder of such Share. However, he shall not, before becoming a Member in respect of a Share, be entitled in respect of it to exercise any right conferred by membership in relation to general meetings of the Company and the Directors may at any time give notice requiring any such person to elect either to be registered himself or to have some person nominated by him be registered as the holder of the Share (but the Directors shall, in either case, have the same right to decline registration as they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or dissolution or any other case than by transfer, as the case may be). If the notice is not complied with within ninety days of being received or deemed to be received (as determined pursuant to these Articles) the Directors may thereafter withhold payment of all Dividends, other distributions, bonuses or other monies payable in respect of the Share until the requirements of the notice have been complied with.

 

  15  

 

 

13 Alteration of capital

 

Increasing, consolidating, converting, dividing and cancelling share capital

 

13.1 To the fullest extent permitted by the Law, the Company may by Special Resolution do any of the following (and amend its Memorandum and its Articles for that purpose):

 

(a) increase or reduce the number of Shares that it is authorised to issue;

 

(b) consolidate all or any of the Shares (whether issued or not) into fewer shares; or

 

(c) divide all or any of the Shares (whether issued or not) into more shares.

 

13.2 All new Shares created hereunder shall be subject to the same provisions with reference to the payment of liens, transfer, transmission, forfeiture and otherwise as the Shares in the original share capital.

 

Reducing share capital

 

13.3 Subject to the Law and to any rights for the time being conferred on the Members holding a particular class of Shares, the Company may, by Special Resolution, reduce its share capital in any way.

 

Sale of fractions of Shares

 

13.4 Whenever, as a result of a consolidation or division of Shares, any Members would become entitled to fractions of a Share, the Directors may, in their absolute discretion, on behalf of those Members, sell the Shares representing the fractions for (i) the Market Price on the date of such consolidation or division, in the case of any shares listed on a Designated Stock Exchange, and (ii) the best price reasonably obtainable by the Company, in the case of any shares not listed on a Designated Stock Exchange, and distribute the net proceeds of sale in due proportion among those Members, and the Directors may authorise (and the relevant Member hereby authorises) any person to execute an instrument of transfer of the Shares to, or in accordance with the directions of, the purchaser. The transferee shall not be bound to see to the application of the purchase money nor shall his title to the Shares be affected by any irregularity in or invalidity of the proceedings in reference to the sale.

 

14 Closing Register of Members or Fixing Record Date

 

14.1 The Directors shall prepare, or cause to be prepared, at least ten (10) days before every general meeting, a complete list of the Members entitled to vote at such meeting, arranged in alphabetical order, and showing the address of each Member and the number of Shares registered in the name of each Member. Such list shall be open to the examination of any Member, for any purpose germane to the meeting, during ordinary business hours, for a period of at least ten (10) days prior to the meeting, either at a place within the city where the meeting is to be held, which place shall be specified in the notice of the meeting, or, if not so specified, at the principal executive office of the Company. The list shall also be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any Member who is present.

 

  16  

 

 

14.2 The Directors, in accordance with the Law, may fix in advance or arrears a date as the record date for any such determination of Members entitled to notice of, attend or to vote at a meeting of the Members or any adjournment thereof, or for the purpose of determining those Members that are entitled to receive payment of any Dividend or other distribution, or in order to make a determination of Members for any other purpose.

 

14.3 If no record date is fixed for the determination of Members entitled to receive notice of, attend or to vote at a meeting of Members or those Members that are entitled to receive payment of a Dividend or other distribution, the record date for such determination of Members shall be, subject to the Law, at the close of business on the Business Day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the Business Day next preceding the day on which the meeting is held. When a determination of those Members that are entitled to receive notice of, attend or vote at a meeting of Members has been made as provided in this Article, such determination shall apply to any adjournment thereof.

 

15 General Meetings

 

Power to call meetings

 

15.1 The Directors may call a general meeting at any time.

 

15.2 If there are insufficient Directors to constitute a quorum and the remaining Directors are unable to agree on the appointment of additional Directors, the Directors must call a general meeting for the purpose of appointing additional Directors.

 

15.3 The Directors must also call a general meeting if requisitioned in the manner set out in the next two Articles.

 

15.4 The requisition must be in writing and given by one or more Members who together hold at least 10% of the rights to vote at such general meeting.

 

15.5 The requisition must also:

 

(a) specify the objects of the meeting;

 

(b) be signed by or on behalf of the requisitioners. The requisition may consist of several documents in like form signed by one or more of the requisitioners; and

 

(c) be deposited at the Company's registered office in accordance with the notice provisions.

 

  17  

 

 

15.6 Should the Directors fail to call a general meeting within 21 days from the date of deposit of a requisition to be held within 2 months of that date, the requisitioners or any of them representing more than one half of the total voting rights of all of them, may call a general meeting to be held within three months from that date.

 

15.7 Without limitation to the foregoing, if there are insufficient Directors to constitute a quorum and the remaining Directors are unable to agree on the appointment of additional Directors, any one or more Members who together hold at least 10% of the rights to vote at a general meeting may call a general meeting for the purpose of considering the business specified in the notice of meeting which shall include as an item of business the appointment of additional Directors.

 

15.8 If the Members call a meeting under the above Articles, the Company shall reimburse their reasonable expenses.

 

Annual general meetings

 

15.9 The Company shall hold annual general meetings unless otherwise dispensed with in accordance with the Law. The first annual general meeting shall be held within a period of 18 months of the Company’s incorporation and thereafter at least once in every calendar year. Not more than 18 months may elapse between one annual general meeting and the next.

 

Content of notice

 

15.10 Notice of a general meeting shall specify each of the following:

 

(a) the place, the date and the time of the meeting;

 

(b) if the meeting is to be held in two or more places, the technology that will be used to facilitate the meeting;

 

(c) subject to Articles 15.10(d) and 15.20, the general nature of the business to be transacted;

 

(d) if a resolution is proposed as a Special Resolution, the text of that resolution; and

 

(e) in the case of an annual general meeting, that the meeting is an annual general meeting.

 

15.11 In each notice, there shall appear with reasonable prominence the following statements:

 

(a) that a Member who is entitled to attend and vote is entitled to appoint one or more proxies to attend and vote instead of that Member; and

 

(b) that a proxy need not be a Member.

 

  18  

 

 

Period of notice

 

15.12 A general meeting, including an annual general meeting, shall be called by at least 14 clear days' notice (but not more than sixty (60) calendar days’ notice). A meeting, however, may be called on shorter notice if it is so agreed:

 

(a) in the case of an annual general meeting, by all the Members entitled to attend and vote at that meeting; and

 

(b) in the case of any other meeting, by a majority in number of the Members having a right to attend and vote at that meeting, being a majority together holding not less than:

 

(i) 95% where a Special Resolution is to be considered; or

 

(ii) 90% for all other meetings;

 

of the total voting rights of the Members who have that right.

 

Persons entitled to receive notice

 

15.13 Subject to the provisions of these Articles and to any restrictions imposed on any Shares, the notice shall be given to the following people:

 

(a) the Members;

 

(b) persons entitled to a Share in consequence of the death or bankruptcy of a Member;

 

(c) the Directors;

 

(d) the Company's auditor (if any); and

 

(e) persons entitled to vote in respect of a Share in consequence of the incapacity of a Member.

 

Publication of notice on a website

 

15.14 Subject to the Law, a notice of a general meeting may be published on a website providing the recipient is given separate notice of:

 

(a) the publication of the notice on the website;

 

(b) the address of the website;

 

(c) the place on the website where the notice may be accessed;

 

(d) how it may be accessed; and

 

  19  

 

 

(e) the place, date and time of the general meeting.

 

15.15 If a Member notifies the Company that he is unable for any reason to access the website, the Company must as soon as practicable give notice of the meeting to that Member in writing or by any other means permitted by these Articles but this will not affect when that Member is deemed to have been given notice of the meeting.

 

Time a website notice is deemed to be given

 

15.16 A website notice is deemed to be given when the Member is given notice of its publication.

 

Required duration of publication on a website

 

15.17 Where the notice of meeting is published on a website, it shall continue to be published in the same place on that website from the date of the notification until the conclusion of the meeting to which the notice relates.

 

Accidental omission to give notice or non-receipt of notice

 

15.18 Proceedings at a meeting shall not be invalidated by the following:

 

(a) an accidental failure to give notice of the meeting or an instrument of proxy to any person entitled to notice; or

 

(b) non-receipt of notice of the meeting or an instrument of proxy by any person entitled to notice.

 

15.19 In addition, where a notice of meeting is published on a website, proceedings at the meeting shall not be invalidated merely because it is accidentally published:

 

(a) in a different place on the website; or

 

(b) for only part of the period from the date of the notification until the conclusion of the meeting to which the notice relates.

 

Notice of other business

 

15.20 No business may be transacted at any general meeting, other than business that is either (A) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Directors (or any duly authorised committee thereof) or pursuant to a requisition of a meeting by Members in accordance with Article 15.3, (B) otherwise properly brought before an annual general meeting by or at the direction of the Directors (or any duly authorised committee thereof) or (C) otherwise properly brought before an annual general meeting by any Member of the Company who (1) is a Member of record on both (x) the date of the giving of the notice by such Member provided for in this Article and (y) the record date for the determination of Members entitled to vote at such annual general meeting and (2) complies with the notice procedures set forth in this Article.

 

  20  

 

 

(a) In addition to any other applicable requirements, for business to be brought properly before an annual general meeting by a Member, such Member must have given timely notice thereof in proper written form to the Secretary of the Company and comply with Article 15.20(c) and (f).

 

(b) All notices of general meetings shall be sent or otherwise given in accordance with this Article not less than fourteen (14) nor more than sixty (60) days before the date of the meeting. The notice shall specify the place, date and hour of the meeting and (i) in the case of an extraordinary general meeting, the purpose or purposes for which the meeting is called (no business other than that specified in the notice may be transacted) or (ii) in the case of the annual general meeting, those matters which the Directors, at the time of giving the notice, intend to present for action by the members (but any proper matter may be presented at the meeting for such action). The notice of any meeting at which Directors are to be elected shall include the name of any nominee or nominees who, at the time of the notice, the Directors intend to present for election.

 

(c) For matters other than for the nomination for election of a Director to be made by a Member, to be timely such Member’s notice shall be delivered to the Company at the principal executive offices of the Company not less than ninety (90) days and not more than one hundred twenty (120) days prior to the one-year anniversary of the preceding year’s annual general meeting; provided, however, that if the Company’s annual general meeting occurs on a date more than thirty (30) days earlier or later than the Company’s prior year’s annual general meeting, then the Directors shall determine a date a reasonable period prior to the Company’s annual general meeting by which date the Members notice must be delivered and publicise such date in a filing pursuant to the Exchange Act, or via press release. Such publication shall occur at least fourteen (14) days prior to the date set by the Directors. Subject to the terms of the Shareholders Agreement and the Director Nomination Agreement, as applicable, the Onex Shareholders, the Baring Shareholders and the Designated Shareholder shall have the right (but not the obligation) to nominate at any time the persons to be elected to the board of Directors which the Onex Shareholders, the Baring Shareholders or the Designated Shareholder, as applicable, are entitled to nominate to the board of Directors pursuant to the terms of the Shareholders Agreement or the Director Nomination Agreement, as applicable, in accordance with the provisions of these Articles for the election of Directors.

 

(d) To be in proper written form, a Member’s notice to the Company must set forth as to such matter such Member proposes to bring before the annual general meeting:

 

  21  

 

 

(i) a reasonably brief description of the business desired to be brought before the annual general meeting, including the text of the proposal or business, and the reasons for conducting such business at the annual general meeting;

 

(ii) the name and address, as they appear on the Company’s Register of Members, of the Member proposing such business and any Member Associated Person (as defined below);

 

(iii) the class or series and number of Shares of the Company that are held of record or are beneficially owned by such Member or any Member Associated Person and any derivative positions held or beneficially held by the Member or any Member Associated Person;

 

(iv) whether and the extent to which any hedging or other transaction or series of transactions has been entered into by or on behalf of such Member or any Member Associated Person with respect to any securities of the Company, and a description of any other agreement, arrangement or understanding (including any short position or any borrowing or lending of shares), the effect or intent of which is to mitigate loss to, or to manage the risk or benefit from share price changes for, or to increase or decrease the voting power of, such Member or any Member Associated Person with respect to any securities of the Company;

 

(v) any material interest of the Member or a Member Associated Person in such business, including a reasonably detailed description of all agreements, arrangements and understandings between or among any of such Members or between or among any proposing Members and any other person or entity (including their names) in connection with the proposal of such business by such Member; and

 

(vi) a statement as to whether such Member or any Member Associated Person will deliver a proxy statement and form of proxy to holders of at least the percentage of the Company’s voting Shares required under applicable law and the rules of the Designated Stock Exchange to carry the proposal.

 

For purposes of this Article 15.20(d), a Member Associated Person of any Member shall mean (x) any Affiliate of, or person acting in concert with, such Member; (y) any beneficial owner of Shares of the Company owned of record or beneficially by such Member and on whose behalf the proposal or nomination, as the case may be, is being made; or (z) any person controlling, controlled by or under common control with such person referred to in the preceding clauses (x) and (y).

 

  22  

 

 

(e) In addition to any other applicable requirements and subject to Article 1.4, for a nomination for election of a Director to be made by a Member of the Company (other than Directors to be nominated by any series of Preferred Shares, voting separately as a class), such Member must (i) be a Member of record on both (x) the date of the giving of the notice by such Member provided for in this Article and (y) the record date for the determination of Members entitled to vote at such annual general meeting; (ii) on each such date beneficially own more than 15% of the issued Ordinary Shares (unless otherwise provided in the Exchange Act or the rules and regulations of the Commission); and (iii) have given timely notice thereof in proper written form to the Secretary of the Company. If a Member is entitled to vote only for a specific class or category of Directors at a meeting of the Members, such Member’s right to nominate one or more persons for election as a Director at the meeting shall be limited to such class or category of Directors.

 

(f) To be timely for purposes of Article 15.20(e), a Member’s notice shall be delivered to or mailed and received at the principal executive offices of the Company not less than ninety (90) nor more than one hundred twenty (120) days prior to the meeting; provided, however, that in the event less than one hundred thirty (130) days’ notice or prior public disclosure of the date of the meeting is given or made to Members, notice by the Member to be timely must be so received not later than the close of business on the tenth (10 th ) day following the earlier of the day on which such notice of the date of the meeting was mailed or such public disclosure was made.

 

(g) To be in proper written form for purposes of Article 15.20(f), a Member’s notice to the Secretary must set forth:

 

(i) as to each Nominating Member:

 

(A) the information that is requested in Article 15.20(d)(ii)-(d)(vi); and

 

(B) any other information relating to such Member that would be required to be disclosed pursuant to any applicable law and rules of the Commission or of the Designated Stock Exchange; and

 

(ii) as to each person whom the Member proposes to nominate for election as a Director:

 

(A) all information that would be required by Article 15.20(d)(ii)-(d)(vi) if such nominee was a Nominating Member, except such information shall also include the business address and residence address of the person;

 

(B) the principal occupation or employment of the person;

 

(C) all information relating to such person that is required to be disclosed in solicitations of proxies for appointment of Directors in an election contest, or is otherwise required, in each case pursuant to Regulation 14A under the Exchange Act or any successor provisions thereto, and any other information relating to the person that would be required to be disclosed pursuant to any applicable law and rules of the Commission or of the Designated Stock Exchange; and

 

  23  

 

 

(D) a description of all direct and indirect compensation and other material monetary arrangements and understandings during the past three years, and any other material relationship, between or among any Nominating Member and its Affiliates and associates, on the one hand, and each proposed nominee, his respective Affiliates and associates, on the other hand, including, without limitation, all information that would be required to be disclosed pursuant to Item 404 under Regulation S-K of the Exchange Act if such Nominating Member were the “registrant” for purposes of such rule and the proposed nominee were a director or executive officer of such registrant.

 

Such notice must be accompanied by a written consent of each proposed nominee to being named as a nominee and to serve as a Director if elected. The Company may require any proposed nominee to furnish such other information as may be reasonably required by the Company to determine the eligibility of such proposed nominee to serve as an independent Director of the Company in accordance with the rules of the Designated Stock Exchange.

 

(h) Unless otherwise provided by (i) the terms of these Articles, (ii) any series of Preferred Shares or (iii) the agreements set forth in Article 15.20(c) or (iv) any other agreement among Members or other agreement, in the case of this clause (iv), approved by the Directors, only persons who are nominated in accordance with the procedures set forth above, shall be eligible to serve as Directors. If the chairman of a general meeting determines that a proposed nomination was not made in compliance with these Articles, he or she shall declare to the general meeting that nomination is defective and such defective nomination shall be disregarded. Notwithstanding the foregoing provisions of these Articles, if the Nominating Member (or a qualified representative of the Nominating Member) does not appear at the general meeting to present the nomination, such nomination shall be disregarded.

 

(i) Notwithstanding anything herein to the contrary, the Onex Shareholders, the Baring Shareholders and the Designated Shareholder, as applicable, shall not be required to comply with the advance notice or 15% ownership threshold requirements, as applicable, set forth in Articles 15.20(c) and 15.20(e) for so long as the Onex Shareholders, the Baring Shareholders or the Designated Shareholder, as applicable, are entitled to nominate one or more Directors pursuant to the Shareholders Agreement or the Board Nomination Agreement, as applicable, but shall provide any such notice to the Company at least fourteen (14) days prior to the applicable general meeting.

 

15.21 The Directors will ensure that the Onex Shareholder Designees, the Baring Shareholder Designees and the Designated Shareholder Designees nominated in accordance with Article 1.4 are included in the notice of meeting for the next available annual general meeting or any extraordinary general meeting at which Directors are to be elected, noting that a general meeting will only be the next available annual general meeting if the advance notice requirements of these Articles can be complied with.

 

  24  

 

 

15.22 Subject to the other provisions of these Articles, the Company may by Ordinary Resolution appoint any person to be a Director.

 

15.23 Subject to these Articles, a Director shall hold office until the expiry of his or her term as contemplated by Article 20.2 or, until such time as he or she vacates office in accordance with Article 26.1.

 

15.24 No person shall be eligible for election as a Director of the Company unless nominated in accordance with the procedures set forth in this Article. If the chairman of an annual general meeting determines that a nomination was not made in accordance with the foregoing procedures, the chairman shall declare to the meeting that the nomination was defective and such defective nomination shall be disregarded. This Article 15 shall not apply to any nomination of a Director (a) in an election in which only the holders of one or more series of Preferred Shares of the Company are entitled to vote (unless otherwise provided in the terms of such series of Preferred Shares) or (b) pursuant to Article 21.4.

 

16 Proceedings at meetings of Members

 

Quorum

 

16.1 No business shall be transacted at any general meeting unless a quorum of Members is present at the time when the meeting proceeds to business. Members holding in aggregate not less than a simple majority of all voting share capital of the Company in issue present in person or by proxy and entitled to vote shall be a quorum, provided that the minimum quorum for any meeting shall be two Members entitled to vote.

 

Use of technology

 

16.2 A person may not participate at a general meeting by conference telephone or other communications equipment.

 

Lack of quorum

 

16.3 If a quorum is not present within 15 minutes of the time appointed for the meeting, or if at any time during the meeting it becomes inquorate, then the following provisions apply:

 

(a) if the meeting was requisitioned by Members entitled to vote, it shall be cancelled; or

 

(b) in any other case, the meeting shall stand adjourned to the same time and place seven days hence, or to such other time or place as is determined by the Directors.

 

  25  

 

 

Adjournment

 

16.4 When a meeting is adjourned to another time and place, unless these Articles otherwise require, notice need not be given of the adjourned meeting if the time and place thereof are announced at the meeting at which the adjournment is taken. At the adjourned meeting the Company may transact any business that might have been transacted at the original meeting. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each Member of record entitled to vote at the meeting.

 

16.5 A determination of the Members of record entitled to notice of or to vote at a general meeting shall apply to any adjournment of such meeting unless the Directors fix a new record date for the adjourned meeting, but the Directors shall fix a new record date if the meeting is adjourned for more than thirty (30) days from the date set for the original meeting.

 

Chairman

 

16.6 The chairman of the board of Directors shall preside as chairman at every general meeting of the Company. If at any meeting the chairman of the board of Directors is not present within fifteen minutes after the time appointed for holding the meeting or is unwilling to act as chairman, the Directors present shall elect one of their number as chairman of the meeting or if all the Directors present decline to take the chair, the Members present shall choose one of their own number to be the chairman of the meeting.

 

Right of a director or auditor's representative to attend and speak

 

16.7 Even if a Director or a representative of the auditor (if any) is not a Member, he shall be entitled to attend and speak at any general meeting and at any separate meeting of Members holding a particular class of Shares.

 

Method of voting

 

16.8 All resolutions put to the vote of the meeting shall be decided on a poll. Each Member shall have one vote for each Share he holds which confers the right to receive and vote on a resolution put to the vote of a meeting, unless any Share carries special voting rights.

 

Taking of a poll

 

16.9 A poll on any question shall be taken immediately.

 

16.10 A poll shall be taken in such manner as the chairman directs. He may appoint scrutineers (who need not be Members) and fix a place and time for declaring the result of the poll.

 

  26  

 

 

Chairman does not have casting vote

 

16.11 In the case of an equality of votes, the chairman of the meeting shall not be entitled to a second or casting vote.

 

Written resolutions

 

16.12 For so long as the Onex Shareholders and the Baring Shareholders, collectively, beneficially own (directly or indirectly) Shares representing a majority of the issued and outstanding Shares, Members may pass a resolution in writing without holding a meeting if the following conditions are met:

 

(a) all Members entitled to vote must receive (including by way of electronic communication):

 

(i) a copy of the resolution; and

 

(ii) a statement informing the Members:

 

(A) how to signify agreement to the resolution; and

 

(B) as to the date by which the resolution must be passed if it is not to lapse (or if no date is given the resolution shall lapse 28 days after the circulation date);

 

(b) the specified majority of Members entitled to vote (for which purpose, and for the purposes of Article 95(1C) of the Law, specified majority shall mean the majority of Members who would be required to pass the relevant resolution at a duly convened and held meeting of Members at which all Members were present and voting on a poll):

 

(i) sign a document; or

 

(ii) sign several documents in the like form each signed by one or more of those Members; and

 

(c) the signed document or documents is or are delivered to the Company at the place and by the time nominated by the Company in the notice of the resolution including, if the Company so nominates, by delivery of an Electronic Record by Electronic means to the address specified for that purpose.

 

Such written resolution shall be as effective as if it had been passed at a meeting of all Members entitled to vote duly convened and held.

 

16.13 Each Member shall have one vote for each Share he holds which confers the right to receive and vote on a written resolution and unless the resolution in writing signed by the Member is silent, in which case all Shares held are deemed to have been voted, the number of Shares specified in the resolution in writing shall be deemed to have been voted.

 

  27  

 

 

16.14 If a written resolution is described as a Special Resolution or as an Ordinary Resolution, it has effect accordingly.

 

17 Voting rights of members

 

Right to vote

 

17.1 Unless their Shares carry no right to vote, or unless an amount presently payable has not been paid, all Members are entitled to vote at a general meeting and all Members holding Shares of a particular class are entitled to vote at a meeting of the holders of that class of Shares (whether present in person or by proxy).

 

17.2 Members may vote in person or by proxy.

 

17.3 A Member who is entitled to vote shall have one vote for each Share he holds, unless any Share carries special voting rights.

 

17.4 A fraction of a Share carrying the right to vote shall entitle its holder to an equivalent fraction of one vote.

 

17.5 No Member is bound to vote all its Shares or any of them, nor is he bound to vote each of his Shares in the same way.

 

17.6 No Member shall be entitled to vote at any general meeting unless all sums presently payable by such Member in respect of Shares in the Company have been paid.

 

Rights of Joint Holders

 

17.7 If Shares are held jointly, only one of the Joint Holders may vote. If more than one of the Joint Holders tenders a vote, the vote of the holder whose name in respect of those Shares appears first in the register of members shall be accepted to the exclusion of the votes of the other Joint Holders.

 

Member with mental disorder

 

17.8 A Member in respect of whom an order has been made by any court having jurisdiction (whether in the Island or elsewhere) in matters concerning mental disorder may vote by that Member's receiver, curator bonis or other person authorised or appointed by that court.

 

17.9 For the purpose of the preceding Article, evidence to the satisfaction of the Directors of the authority of the person claiming to exercise the right to vote must be received not less than 24 hours before holding the relevant meeting or the adjourned meeting in any manner specified for the delivery of forms of appointment of a proxy, whether in writing or by Electronic means. In default, the right to vote shall not be exercisable.

 

  28  

 

 

Objections to admissibility of votes

 

17.10 An objection to the validity of a person's vote may only be raised at the meeting or at the adjourned meeting at which the vote is sought to be tendered. Any objection duly made shall be referred to the chairman whose decision shall be final and conclusive.

 

Form of proxy

 

17.11 An instrument appointing a proxy shall be in any common form or in any other form approved by the Directors. A Member may appoint more than one proxy to attend on the same occasion.

 

17.12 The instrument must be in writing and signed in one of the following ways:

 

(a) by the Member;

 

(b) by the Member's authorised attorney; or

 

(c) if the Member is a corporation or other body corporate, under seal or signed by a duly authorised signatory (including an authorised officer, secretary or attorney).

 

If the Directors so resolve, the Company may accept an Electronic Record of that instrument delivered in the manner specified below and otherwise satisfying the Articles about authentication of Electronic Records.

 

17.13 The Directors may require the production of any evidence which they consider necessary to determine the validity of any appointment of a proxy.

 

17.14 A Member may revoke the appointment of a proxy by notice to the Company duly signed in accordance with Article 17.12 prior to the time specified by the Company for the revocation of proxies for the meeting or adjourned meeting, but no earlier than 48 hours prior to the meeting; (for which purpose no account shall be taken of any part of a day that is not a working day); but such revocation will not affect the validity of any acts carried out by the proxy before the Directors of the Company had actual notice of the revocation.

 

How and when proxy is to be delivered

 

17.15 Subject to the following Articles, the form of appointment of a proxy and any authority under which it is signed, or a copy of the authority certified notarially or in any other way approved by the Directors, must be delivered so that it is received by the Company prior to the time specified by the Company for voting by proxy at the meeting. They must be delivered in either of the following ways:

 

  29  

 

 

(a) in the case of an instrument in writing, it must be left at or sent by post:

 

(i) to the registered office of the Company; or

 

(ii) to such other place within the Island specified in the notice convening the meeting or in any form of appointment of proxy sent out by the Company in relation to the meeting; or

 

(b) if, pursuant to the notice provisions, a notice may be given to the Company in an Electronic Record, an Electronic Record of an appointment of a proxy must be sent to the address specified pursuant to those provisions unless another address for that purpose is specified:

 

(i) in the notice convening the meeting;

 

(ii) in any form of appointment of a proxy sent out by the Company in relation to the meeting; or

 

(iii) in any invitation to appoint a proxy issued by the Company in relation to the meeting.

 

17.16 Where a poll is taken, the form of appointment of a proxy and any accompanying authority (or an Electronic Record of the same) must be delivered as required under Article 17.15.

 

17.17 If the form of appointment of proxy is not delivered on time, it is invalid.

 

Voting by proxy

 

17.18 A proxy shall have the same voting rights at a meeting or adjourned meeting as the Member would have had except to the extent that the instrument appointing him limits those rights. Notwithstanding the appointment of a proxy, a Member may attend and vote at a meeting or adjourned meeting. If a Member votes on any resolution, a vote by his proxy on the same resolution, unless in respect of different Shares, shall be invalid.

 

18 Corporations Acting by Representatives at Meeting

 

18.1 Save where otherwise provided, a corporate Member must act by one or more duly authorised representatives.

 

18.2 A corporate Member wishing to act by a duly authorised representative must identify that person to the Company by notice in writing.

 

18.3 The authorisation may be for any period of time, and must be delivered to the Company before the commencement of the meeting at which it is first used.

 

  30  

 

 

18.4 The Directors of the Company may require the production of any evidence which they consider necessary to determine the validity of the notice.

 

18.5 Where a duly authorised representative is present at a meeting that Member is deemed to be present in person, and the acts of the duly authorised representative are personal acts of that Member.

 

18.6 A corporate Member may revoke the appointment of a duly authorised representative at any time by notice to the Company, but such revocation will not affect the validity of any acts carried out by the duly authorised representative before the Directors of the Company had actual notice of the revocation.

 

19 Clearing Houses

 

If a clearing house or depository (or its nominee) is a Member it may, by resolution of its Directors, other governing body or authorised individual(s) or by power of attorney, authorise such person or persons as it thinks fit to act as its representative or representatives at any general meeting of the Company or at any general meeting of any class of Members; provided that, if more than one person is so authorised, the authorisation shall specify the number and class of Shares in respect of which each such person is so authorised. A person so authorised pursuant to this provision shall be entitled to exercise the same powers on behalf of the clearing house (or its nominee) which he represents as that clearing house (or its nominee) could exercise if it were an individual member of the Company holding the number and class of Shares specified in such authorisation.

 

20 Directors

 

20.1 The minimum number of Directors shall be two and the maximum number of Directors shall be fourteen, unless increased or decreased from time to time by the Directors or the Company in general meeting. So long as Shares are listed on the Designated Stock Exchange, the board of Directors shall include such number of “independent directors” as the relevant rules applicable to the listing of any Shares on the Designated Stock Exchange require (subject to any applicable exceptions for Controlled Companies).

 

20.2 The Directors shall be divided into three (3) classes designated as Class I, Class II and Class III, respectively. Directors shall initially be assigned to each class in accordance with the Shareholders Agreement and the Director Nomination Agreement. At the first annual general meeting of Members, the term of office of the Class I Directors shall expire and Class I Directors shall be elected for a full term of three (3) years. At the second annual general meeting of Members, the term of office of the Class II Directors shall expire and Class II Directors shall be elected for a full term of three (3) years. At the third annual general meeting of Members, the term of office of the Class III Directors shall expire and Class III Directors shall be elected for a full term of three (3) years. At each succeeding annual general meeting of Members, Directors shall be elected for a full term of three (3) years to succeed the Directors of the class whose terms expire at such annual general meeting. Notwithstanding the foregoing provisions of this Article, each Director shall hold office until the expiration of his term, until his successor shall have been duly elected and qualified or until his earlier death, resignation or removal. No decrease in the number of Directors constituting the Directors shall shorten the term of any incumbent Director.

 

  31  

 

 

21 Appointment, disqualification and removal of directors

 

First directors

 

21.1 The first Directors shall be appointed in writing by the subscriber or subscribers to the Memorandum.

 

No age limit

 

21.2 There is no age limit for Directors save that they must be aged at least 18 years.

 

No corporate directors

 

21.3 A Director must be a natural person.

 

Appointment of directors

 

21.4 The Directors shall, subject to the terms of the Shareholders Agreement and the Director Nomination Agreement, applicable law and the listing rules of the Designated Stock Exchange, ensure that all individuals (i) nominated by the Barings Shareholders to be Baring Shareholder Designees, (ii) nominated by the Onex Shareholders to be Onex Shareholder Designees and (iii) nominated by the Designated Shareholder to be Designated Shareholder Designees are nominated for election as Directors at the next annual general meeting or extraordinary general meeting called for that purpose and they shall be appointed if approved by way of Ordinary Resolution at such general meeting.

 

21.5 With respect to any Director seat which the Baring Shareholders, Onex Shareholders and the Designated Shareholder are not entitled to nominate an individual for such seat pursuant to the Shareholders Agreement or the Director Nomination Agreement, the Directors shall have the right to nominate an individual for election as a Director at the next annual general meeting or extraordinary general meeting called for that purpose and they shall be appointed if approved by way of Ordinary Resolution at such general meeting.

 

21.6 No appointment can cause the number of Directors to exceed the maximum, and any such appointment shall be invalid.

 

  32  

 

 

Removal of directors

 

21.7 A Director may be removed from office by the Members by Special Resolution only for cause (“cause” for removal of a Director shall be deemed to exist only if (a) the Director whose removal is proposed has been convicted of a felony by a court of competent jurisdiction and such conviction is no longer subject to direct appeal; (b) such Director has been found by the affirmative vote of a majority of the Directors then in office at any regular or special meeting of the board of Directors called for that purpose, or by a court of competent jurisdiction, to have been guilty of wilful misconduct in the performance of such Director’s duties to the Company in a matter of substantial importance to the Company; or (c) such Director has been adjudicated by a court of competent jurisdiction to be mentally incompetent, (which mental incompetency directly affects such Director’s ability to perform his or her obligations as a Director) at any time before the expiration of his term notwithstanding anything in these Articles or in any agreement between the Company and such Director (but without prejudice to any claim for damages under such agreement); provided that any Director who was nominated for election by the Onex Shareholders, the Baring Shareholders or the Designated Shareholder may be removed with or without cause only by the Onex Shareholders, the Baring Shareholders or the Designated Shareholder (as applicable) that have/has the right to remove such Director pursuant to the Shareholders Agreement or the Director Nomination Agreement (as applicable). In addition, a Director may be removed from office by the board of Directors by resolution made by the Directors for cause.

 

Filling of vacancies

 

21.8 A vacancy on the board of Directors may be filled only by the affirmative vote of a simple majority of the remaining Directors present and voting at a meeting of the Directors, subject to these Articles, applicable law and the listing rules of the Designated Stock Exchange, provided that if any vacancy was created by the death, resignation or removal of an Onex Shareholder Designee, Baring Shareholder Designee or Designated Shareholder Designee, then such Director shall only be replaced by the Onex Shareholders, Baring Shareholders or Designated Shareholder (as applicable) that has/have the right to replace such Director pursuant to the Shareholders Agreement or Director Nomination Agreement, and the Directors shall, subject to the terms of the Shareholders Agreement and the Director Nomination Agreement, applicable law and the listing rules of the Designated Stock Exchange, cause the vacancy caused by such death, resignation or removal to be filled, as soon as possible, by a new designee of the Onex Shareholders, the Baring Shareholders or the Designated Shareholder (as applicable) pursuant to the rights set forth in Article 1.4. A Director appointed to fill a vacancy in accordance with this Article shall be of the same Class of Director as the Director he or she replaced and the term of such appointment shall terminate in accordance with that Class of Director.

 

Resignation of directors

 

21.9 A Director may at any time resign the office by giving to the Company notice in writing or, if permitted pursuant to the notice provisions, in an Electronic Record delivered in either case in accordance with those provisions.

 

  33  

 

 

21.10 Unless the notice specifies a different date, the Director shall be deemed to have resigned on the date on which the notice is delivered to the Company.

 

Corporate governance policies

 

21.11 The Directors may, from time to time, and except as required by applicable law or the listing rules of the Designated Stock Exchange, adopt, institute, amend, modify or revoke the corporate governance policies or initiatives, which shall be intended to set forth the policies of the Company and the Directors on various corporate governance related matters, as the Directors shall determine by resolution from time to time.

 

No shareholding qualification

 

21.12 A Director shall not be required to hold any Shares in the Company by way of qualification. A Director who is not a member of the Company shall nevertheless be entitled to receive notice of and to attend and speak at general meetings of the Company and all classes of Shares of the Company.

 

22 Reserved

 

23 Directors’ Fees and Expenses

 

23.1 The Directors may receive such remuneration as the Directors may from time to time determine. The Directors may be entitled to be repaid all traveling, hotel and incidental expenses reasonably incurred or expected to be incurred by him in attending meetings of the Directors or committees of the Directors or general meetings or separate meetings of any class of securities of the Company or otherwise in connection with the discharge of his duties as a Director.

 

23.2 Any Director who performs services which in the opinion of the Directors go beyond the ordinary duties of a Director may be paid such extra remuneration (whether by way of salary, commission, participation in profits or otherwise) as the Directors may determine and such extra remuneration shall be in addition to or in substitution for any ordinary remuneration provided for, by or pursuant to any other Article.

 

24 Powers and duties of directors

 

24.1 Subject to the provisions of the Law, the Memorandum, these Articles and any resolutions made in a general meeting, the business of the Company shall be managed by the Directors, who may pay all expenses incurred in setting up and registering the Company and may exercise all powers of the Company.

 

24.2 No prior act of the Directors shall be invalidated by any subsequent alteration of the Memorandum or these Articles or any direction given by Special Resolution. However, to the extent allowed by the Law, Members may in accordance with the Law validate any prior or future act of the Directors which would otherwise be in breach of their duties.

 

  34  

 

 

25 Delegation of powers

 

Power to delegate any of the directors' powers to a committee

 

25.1 The Directors may delegate any of their powers to committees consisting of such member or members of their body as they think fit, subject to Article 25.3; provided that any committee so formed shall include amongst its members at least two Directors unless otherwise required by applicable law or the rules of the Designated Stock Exchange; provided further that no committee shall have the power or authority to (a) recommend to the Members an amendment of these Articles (except that a committee may, to the extent authorised in the resolution or resolutions providing for the issuance of Shares adopted by the Directors as provided under the laws of Jersey, fix the designations and any of the preferences or rights of such Shares relating to dividends, redemption, dissolution, any distribution of assets of the Company or the conversion into, or the exchange of such Shares for, Shares of any other class or classes or any other series of the same or any other class or classes of Shares of the Company); (b) adopt an agreement of merger or consolidation; (c) recommend to the Members the sale, lease or exchange of all or substantially all of the Company’s property and assets; (d) recommend to the Members a dissolution of the Company or a revocation of a dissolution; (e) recommend to the Members an amendment of the Memorandum; or (f) declare a dividend or authorise the issuance of Shares unless the resolution establishing such committee (or the charter of such committee approved by the Directors) permits the committee to so declare or authorize. Any committee so formed shall in the exercise of the powers so delegated conform to any regulations that may be imposed on it by the Directors.

 

25.2 Unless otherwise permitted by the Directors, a committee must follow the procedures prescribed for the taking of decisions by Directors.

 

25.3 To the extent requested by the Onex Shareholders, the Baring Shareholders or the Designated Shareholder, each committee of the board of Directors shall include at least one Onex Shareholder Designee, Baring Shareholder Designee and/or Designated Shareholder Designee (as applicable) to the extent required pursuant to the Shareholders Agreement or the Director Nomination Agreement to be appointed as a member of each such committee of the board of Directors unless such designation would violate any legal restrictions on such committee’s composition or the rules of the Designated Stock Exchange (subject in each case to any applicable exceptions, including those for Controlled Companies and any applicable phase-in periods).

 

Power to appoint an agent of the Company

 

25.4 The Directors may appoint any person, either generally or in respect of any specific matter, to be the agent of the Company with or without authority for that person to delegate all or any of that person's powers. The Directors may make that appointment:

 

(a) by causing the Company to enter into a power of attorney or agreement; or

 

  35  

 

 

(b) in any other manner they determine.

 

Power to appoint an attorney or authorised signatory of the Company

 

25.5 The Directors may from time to time and at any time by power of attorney appoint any company, firm or person or body of persons, whether nominated directly or indirectly by the Directors, to be the attorney or attorneys of the Company for such purposes and with such powers, authorities and discretion (not exceeding those vested in or exercisable by the Directors under these Articles) and for such period and subject to such conditions as they may think fit, and any such power of attorney may contain such provisions for the protection and convenience of persons dealing with any such attorney as the Directors may think fit, and may also authorise any such attorney to delegate all or any of the powers, authorities and discretion vested in him.

 

25.6 Any power of attorney or other appointment may contain such provision for the protection and convenience of persons dealing with the attorney or authorised signatory as the Directors think fit. Any power of attorney or other appointment may also authorise the attorney or authorised signatory to delegate all or any of the powers, authorities and discretions vested in that person.

 

Management

 

25.7 The Directors may from time to time provide for the management of the affairs of the Company in such manner as they shall think fit and the provisions contained in the following paragraphs shall be without prejudice to the general powers conferred by this paragraph.

 

25.8 The Directors from time to time and at any time may establish any advisory committees, local boards or agencies for managing any of the affairs of the Company and may appoint any persons to be members of such advisory committees or local boards and may appoint any agents of the Company and may fix the remuneration of any of the aforesaid.

 

25.9 The Directors from time to time and at any time may delegate to any such advisory committee, local board or agent any of the powers, authorities and discretions for the time being vested in the Directors and may authorise the members for the time being of any such local advisory committee or board, or any of them to fill up any vacancies therein and to act notwithstanding vacancies and any such appointment or delegation may be made on such terms and subject to such conditions as the Directors may think fit and the Directors may at any time remove any person so appointed and may annul or vary any such delegation, but no person dealing in good faith and without notice of any such annulment or variation shall be affected thereby.

 

  36  

 

 

25.10 Any such delegates as aforesaid may be authorised by the Directors to sub-delegate all or any of the powers, authorities, and discretions for the time being vested to them.

 

25.11 The Directors shall elect, by the affirmative vote of a majority of the Directors then in office, a chairman. The chairman of the board of Directors shall be a Director or an officer of the Company. Subject to the provisions of these Articles and the direction of the Directors, the chairman of the board of Directors shall perform all duties and have all powers which are commonly incident to the position of chairman of a board or which are delegated to him or her by the Directors, preside at all general meetings and meetings of the Directors at which he or she is present and have such powers and perform such duties as the Directors may from time to time prescribe.

 

26 Disqualification of Directors

 

26.1 Subject to these Articles, the office of Director shall be vacated, if the Director:

 

(a) becomes bankrupt or makes any arrangement or composition with his creditors;

 

(b) dies or is found to be or becomes, in the opinion of a registered medical practitioner by whom he is being treated, physically or mentally incapable of acting as a Director;

 

(c) resigns his office by notice to the Company in accordance with Articles 21.9 and 21.10;

 

(d) is prohibited by applicable law or the Designated Stock Exchange from being a Director;

 

(e) without special leave of absence from the Directors, is absent from meetings of the Directors for six consecutive months and the Directors resolve that his office be vacated; or

 

(f) is removed from office pursuant to these Articles or any other agreement between the Director and the Company or any of its subsidiaries.

 

26.2 If the office of Director is terminated or vacated for any reason, he shall thereupon cease to be a member of any committee of the board of Directors of the Company.

 

27 Meetings of directors

 

Regulation of directors' meetings

 

27.1 Subject to the provisions of these Articles, the Directors may regulate their proceedings as they think fit.

 

  37  

 

 

Calling meetings

 

27.2 (a) The chairman of the board of Directors, a majority of the Directors or the Secretary on request of a Director or (b) for so long as there are at least four (4) Onex Shareholder Designees, a majority of the Onex Shareholder Designees may at any time summon a meeting of the Directors by twenty-four (24) hour notice to each Director in person, by telephone, facsimile, electronic email, or in such other manner as the Directors may from time to time determine, which notice shall set forth the general nature of the business to be considered unless notice is waived by all the Directors either at, before or after the meeting is held. Notice of a meeting need not be given to any Director (i) who signs a waiver of notice or a consent to holding the meeting or an approval of the minutes thereof, whether before or after the meeting, or (ii) who attends the meeting without protesting, prior thereto or at its commencement, the lack of notice to such Directors. All such waivers, consents, and approvals shall be filed with the corporate records or made part of the minutes of the meeting. A waiver of notice need not specify the purpose of any regular or special meeting of the Directors.

 

Use of technology

 

27.3 A Director or Directors may participate in any meeting of the Directors, or of any committee appointed by the Directors of which such Director or Directors are members, by means of telephone or similar communication equipment by way of which all persons participating in such meeting can hear each other and such participation shall be deemed to constitute presence in person at the meeting.

 

Quorum

 

27.4 The quorum for the transaction of business at a meeting of Directors (including any adjourned meeting) shall be a majority of the authorised number of Directors, but shall not be less than two. Every act or decision done or made by a majority of the Directors present at a duly held meeting at which a quorum is present shall be regarded as the act of the Directors, subject to the provisions of these Articles and other applicable law.

 

27.5 If a quorum is not present within 15 minutes from the time specified for a meeting of Directors, or if, during a meeting, a quorum ceases to be present, then the meeting shall be adjourned to the same day in the next week at the same time and place or such other day, time and place as the Director(s) calling such meeting may determine.

 

Voting

 

27.6 A question which arises at a board meeting shall be decided by a majority of votes. If votes are equal the chairman shall not have a casting vote.

 

27.7 The continuing Directors may act notwithstanding any vacancy in their body but if and so long as their number is reduced below the number fixed by or pursuant to these Articles as the necessary quorum of Directors, the continuing Directors may act for the purpose of increasing the number, or of summoning a general meeting of the Company, but for no other purpose.

 

  38  

 

 

Validity

 

27.8 Anything done at a meeting of Directors is unaffected by the fact that it is later discovered that any person was not properly appointed, or had ceased to be a Director, or was otherwise not entitled to vote.

 

28 Permissible directors' interests and disclosure

 

28.1 Subject to these Articles and the Law, a Director who is in any way, whether directly or indirectly, interested in a contract or proposed contract with the Company shall declare the nature of his interest at a meeting of the Directors. A general notice given to the Directors by any Director to the effect that he is a member of any specified company or firm and is to be regarded as interested in any contract which may thereafter be made with that company or firm shall be deemed a sufficient declaration of interest in regard to any contract so made. A Director may vote in respect of any contract or proposed contract or arrangement notwithstanding that he may be interested therein and if he does so his vote shall be counted and he may be counted in the quorum at any meeting of the Directors at which any such contract or proposed contract or arrangement shall come before the meeting for consideration.

 

28.2 A Director may hold any other office or place of profit under the Company (other than the office of auditor) in conjunction with his office of Director for such period and on such terms (as to remuneration and otherwise) as the Directors may determine and no Director or intending Director shall be disqualified by his office from contracting with the Company either with regard to his tenure of any such other office or place of profit or as vendor, purchaser or otherwise, nor shall any such contract or arrangement entered into by or on behalf of the Company in which any Director is in any way interested, be liable to be avoided, nor shall any Director so contracting or being so interested be liable to account to the Company for any profit realised by any such contract or arrangement by reason of such Director holding that office or of the fiduciary relation thereby established. A Director, notwithstanding his interest, may be counted in the quorum present at any meeting whereat he or any other Director is appointed to hold any such office or place of profit under the Company or whereat the terms of any such appointment are arranged and he may vote on any such appointment or arrangement. Any Director who enters into a contract or arrangement or has a relationship that is reasonably likely to be implicated under this Article 28.2 or that would reasonably be likely to affect a Director’s status as an “Independent Director” under applicable law or the rules of the Designated Stock Exchange shall disclose the nature of his or her interest in any such contract or arrangement in which he is interested or any such relationship. Without limiting the generality of the foregoing:

 

(a) the Baring Shareholder Designee, the Onex Shareholder Designees and any Designated Shareholder Designee may hold any position of any kind whatsoever with the Baring Shareholders, the Onex Shareholders or any member of the Shareholder Group (as applicable) and/or any of their respective Affiliates and may maintain any interest of any kind whatsoever, whether directly or indirectly, in the Baring Shareholders, the Onex Shareholders or any member of the Shareholder Group (as applicable) and/or any of their respective Affiliates and/or any Owner Opportunity (as defined below) (such positions and/or interests, as the case may be, hereinafter, together, Owner Interests );

 

  39  

 

 

(b) no Owner Interests shall disqualify any Baring Shareholder Designee, Onex Shareholder Designee or Designated Shareholder Designee from the office of Director, nor shall any contract, transaction or arrangement entered into by or on behalf of the Company in respect of which any Owner Interests may subsist, whether directly or indirectly, be or be liable to be avoided, nor shall any Baring Shareholder Designee, Onex Shareholder Designee or Designated Shareholder Designee be liable to account to the Company for any profit or other gain arising by reason of any Owner Interest and/or any contract, transaction or arrangement entered into by or on behalf of the Company in respect of which any Owner Interest may subsist, whether directly or indirectly;

 

(c) each Baring Shareholder Designee, Onex Shareholder Designee and Designated Shareholder Designee shall be at liberty to vote in respect of any contract, transaction or arrangement in which any applicable Owner Interest may subsist, whether directly or indirectly; and

 

(d) the Owner Interests shall be deemed to have been disclosed by each Baring Shareholder Designee, Onex Shareholder Designee and Designated Shareholder Designee upon his or her appointment as a Director of the Company and shall be deemed to be sufficient disclosure of the Owner Interests as required under these Articles. Thereafter, it shall not be necessary for a Baring Shareholder Designee, Onex Shareholder Designee or Designated Shareholder Designee to give special or particularized notice of any Owner Interests in respect of any transaction which may involve the Company.

 

28.3 To the maximum extent permitted by applicable law:

 

(a) the Company renounces and waives:

 

(i) any interest or expectancy in, or in being offered or presented with an opportunity to participate in; or

 

(ii) any right to be informed of:

 

any business or corporate opportunity that may from time to time be of interest to or known to or be or have been presented to the Baring Shareholders, the Onex Shareholders or any member of the Shareholder Group (as applicable) and/or any of their respective Affiliates and/or any of their officers, directors, agents, stockholders, members, partners and subsidiaries (including specifically, without limiting the generality of the foregoing, each Baring Shareholder Designee, Onex Shareholder Designee and Designated Shareholder Designee (other than the Chief Executive Officer of the Company, the Executive Chairman of the Company (if any) and any other officer or executive officer of the Company)) (each such opportunity, hereinafter, an Owner Opportunity ) whether or not such Owner Opportunity is or may be pursued by any Baring Shareholder, any Onex Shareholder or any member of the Shareholder Group (as applicable) and or their respective Affiliates and whether or not such Owner Opportunity may be a business or corporate opportunity the Company might reasonably have pursued or had the ability or desire to pursue if granted the opportunity to do so;

 

  40  

 

 

(b) no Onex Shareholder Designee, Baring Shareholder Designee or Designated Shareholder Designee (other than the Chief Executive Officer of the Company, the Executive Chairman of the Company (if any) and any other officer or executive officer of the Company) (each of such persons, hereinafter, a Relevant Person ) shall:

 

(i) be required or be under any duty (whether fiduciary or otherwise) to present to or make known to the Company any Owner Opportunity or refrain from, whether directly or indirectly, pursuing, participating in the pursuit of, exploiting or acquiring, any Owner Opportunity; or

 

(ii) be liable to the Company for any breach of any fiduciary or other duty, whether as a Director or otherwise, by reason of the fact that such Relevant Person, whether directly or indirectly, acting in good faith, pursues, participates in the pursuit of, exploits or acquires any Owner Opportunity, directs any Owner Opportunity to another person or fails to present any Owner Opportunity, or information regarding any Owner Opportunity, to the Company;

 

unless such Owner Opportunity is, or has been, expressly offered in writing to the Relevant Person solely in their capacity as Director;

 

(c) none of the Baring Shareholders, the Onex Shareholders or any member of the Shareholder Group nor any of their respective Affiliates has any duty to refrain from engaging or investing directly or indirectly in the same or similar business activities or lines of business as the Company or any of its subsidiaries.

 

28.4 Any Director may act by himself or his firm in a professional capacity for the Company, and he or his firm shall be entitled to reasonable expense reimbursement consistent with the Company’s policies in connection with such Director’s service in his official capacity; provided that nothing herein contained shall authorise a Director or his firm to act as auditor to the Company.

 

  41  

 

 

29 Minutes

 

29.1 The Directors shall cause minutes to be made in books or loose-leaf folders provided for the purpose of recording:

 

(a) all appointments of officers made by the Directors;

 

(b) the names of the Directors present at each meeting of the Directors and of any committee of the Directors; and

 

(c) all resolutions and proceedings at all meetings of the Company, and of the Directors and of committees of Directors.

 

Written resolutions

 

29.2 The Directors may pass a resolution in writing without holding a meeting if the following conditions are met:

 

(a) all Directors are given notice of the resolution;

 

(b) the resolution is set out in a document or documents indicating that it is a written resolution;

 

(c) all of the Directors:

 

(i) sign a document; or

 

(ii) sign several documents in the like form each signed by one or more Directors; and

 

(d) the signed document or documents is or are delivered to the Company, including, if the Company so nominates by delivery of an Electronic Record, by Electronic means to the address specified for that purpose.

 

29.3 Such written resolution shall be as effective as if it had been passed at a meeting of the Directors duly convened and held; and it shall be treated as having been passed on the day and at the time that the last Director signs.

 

30 [Reserved]

 

31 Record Dates

 

Except to the extent of any conflicting rights attached to Shares, the Directors may fix any time and date as the record date for declaring or paying a dividend or making or issuing an allotment of Shares. The record date may be before or after the date on which a dividend, allotment or issue is declared, paid or made.

 

  42  

 

 

32 Dividends

 

Payment of dividends by directors

 

32.1 Subject to the provisions of the Law, the Directors may pay dividends in accordance with the respective rights of the Members. Any dividend shall not be a debt owed by the Company until such time as payment of the dividend is made.

 

32.2 In relation to Shares carrying differing rights to dividends or rights to dividends at a fixed rate, the following applies:

 

(a) if the Company has different classes of Shares, the Directors may pay dividends on Shares which confer deferred or non-preferred rights with regard to dividends as well as on Shares which confer preferential rights with regard to dividends but no dividend shall be paid on Shares carrying deferred or non-preferred rights if, at the time of payment, any preferential dividend is in arrears;

 

(b) subject to the provisions of the Law, the Directors may also pay, at intervals settled by them, any dividend payable at a fixed rate if it appears to them that there are sufficient funds of the Company lawfully available for distribution to justify the payment; and

 

(c) if the Directors act in good faith, they shall not incur any liability to the Members holding Shares conferring preferred rights for any loss those Members may suffer by the lawful payment of the dividend on any Shares having deferred or non-preferred rights.

 

Apportionment of dividends

 

32.3 Except as otherwise provided by the rights attached to Shares, all dividends shall be declared and paid according to the amounts paid up on the Shares on which the dividend is paid. All dividends shall be apportioned and paid proportionately to the amount paid up on the Shares during the time or part of the time in respect of which the dividend is paid. But if a Share is issued on terms providing that it shall rank for dividend as from a particular date, that Share shall rank for dividend accordingly.

 

Right of set off

 

32.4 The Directors may deduct from a dividend or any other amount payable to a person in respect of a Share any amount due by that person to the Company in relation to a Share.

 

  43  

 

 

Power to pay other than in cash

 

32.5 If the Directors so determine, any resolution determining a dividend may direct that it shall be satisfied wholly or partly by the distribution of assets or the issue of Shares. If a difficulty arises in relation to the distribution, the Directors may settle that difficulty in any way they consider appropriate. For example, they may do any one or more of the following:

 

(a) issue fractional Shares;

 

(b) fix the value of assets for distribution and make cash payments to some Members on the footing of the value so fixed in order to adjust the rights of Members; and

 

(c) vest some assets in trustees.

 

How payments may be made

 

32.6 A dividend or other monies payable on or in respect of a Share may be paid in any of the following ways:

 

(a) if the Member holding that Share or other person entitled to that Share nominates a bank account for that purpose, by wire transfer to that bank account; or

 

(b) by cheque or warrant sent by post to the registered address of the Member holding that Share or other person entitled to that Share.

 

32.7 For the purpose of Article 32.6(a), the nomination may be in writing or in an Electronic Record and the bank account nominated may be the bank account of another person. For the purpose of Article 32.6(b), subject to any applicable law or regulation, the cheque or warrant shall be made to the order of the Member holding that Share or other person entitled to the Share or to his nominee, whether nominated in writing or in an Electronic Record, and payment of the cheque or warrant shall be a good discharge to the Company.

 

32.8 If two or more persons are registered as Joint Holders, a dividend (or other amount) payable on or in respect of that Share may be paid as follows:

 

(a) to the registered address of the Joint Holder of the Share who is named first on the register of members or to the registered address of the deceased or bankrupt holder, as the case may be; or

 

(b) to the address or bank account of another person nominated by the Joint Holders, whether that nomination is in writing or in an Electronic Record.

 

32.9 Any Joint Holder of a Share may give a valid receipt for a dividend (or other amount) payable in respect of that Share.

 

Dividends or other monies not to bear interest in absence of special rights

 

32.10 Unless provided for by the rights attached to a Share, no dividend or other monies payable by the Company in respect of a Share shall bear interest.

 

  44  

 

 

Unclaimed Dividends

 

32.11 All dividends unclaimed for one (1) year after having been declared may be invested or otherwise made use of by the Directors for the benefit of the Company until claimed. Subject to any applicable unclaimed property or other laws, any dividend unclaimed after a period of ten (10) years from the date of declaration shall be forfeited and shall revert to the Company. The payment by the Directors of any unclaimed dividend or other sums payable on or in respect of a Share into a separate account shall not constitute the Company a trustee in respect thereof.

 

33 Accounts and audits

 

Accounting and other records

 

33.1 The Directors must ensure that proper accounting and other records are kept, and that accounts and associated reports are distributed in accordance with the requirements of the Law.

 

No automatic right of inspection

 

33.2 Except as provided in Article 14.1, the Directors shall from time to time determine whether and to what extent and at what times and places and under what conditions or regulations the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors, and no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred by applicable law or authorised by the Directors.

 

Sending of accounts and reports

 

33.3 The Company's accounts and associated Directors' report and auditor's report (if any) that are required or permitted to be sent to any person pursuant to any law shall be treated as properly sent to that person if:

 

(a) they are sent to that person in accordance with the notice provisions in Article 39; or

 

(b) they are published on a website providing that person is given separate notice of:

 

(i) the fact that the documents have been published on the website;

 

(ii) the address of the website;

 

(iii) the place on the website where the documents may be accessed; and

 

(iv) how they may be accessed.

 

33.4 If, for any reason, a person notifies the Company that he is unable to access the website, the Company must, as soon as practicable, send the documents to that person by any other means permitted by these Articles. This, however, will not affect when that person is taken to have received the documents under Article 33.5.

 

  45  

 

 

Time of receipt if documents are published on a website

 

33.5 Documents sent by being published on a website in accordance with the preceding two Articles are only treated as sent at least 14 clear days before the date of the meeting at which they are to be laid if:

 

(a) the documents are published on the website throughout a period beginning at least 14 clear days before the date of the meeting and ending with the conclusion of the meeting; and

 

(b) the person is given at least 14 clear days' notice of the meeting.

 

Validity despite accidental error in publication on website

 

33.6 If, for the purpose of a meeting, documents are sent by being published on a website in accordance with the preceding Articles, the proceedings at that meeting are not invalidated merely because by accident:

 

(a) those documents are published in a different place on the website to the place notified; or

 

(b) they are published for only part of the period from the date of notification until the conclusion of that meeting.

 

When accounts are to be audited

 

33.7 The accounts relating to the Company’s affairs shall be audited in such manner and with such financial year end as may be determined from time to time by the Directors or failing any determination as aforesaid shall not be audited.

 

34 Audit

 

34.1 The Directors or, if authorised to do so, the audit committee of the Directors, may appoint an auditor of the Company who shall hold office until removed from office by a resolution of the Directors and may fix his or their remuneration.

 

34.2 Every auditor of the Company shall have a right of access at all times to the books and accounts and vouchers of the Company and shall be entitled to require from the Directors and officers of the Company such information and explanation as may be necessary for the performance of the duties of the auditors.

 

  46  

 

 

35 Seal

 

Company seal

 

35.1 The Company may have a seal if the Directors so determine.

 

Official seal

 

35.2 Subject to the provisions of the Law, the Company may also have:

 

(a) an official seal or seals for use in any place or places outside the Island. Each such official seal shall be a facsimile of the original seal of the Company but shall have added on its face the name of the country, territory or place where it is to be used or the words “branch seal”; and

 

(b) an official seal for use only in connection with the sealing of securities issued by the Company and such official seal shall be a copy of the common seal of the Company but shall in addition bear the word “securities”.

 

When and how seal is to be used

 

35.3 A seal may only be used by the authority of the Directors. Unless the Directors otherwise determine, a document to which a seal is affixed must be signed in one of the following ways:

 

(a) by a Director and the Secretary; or

 

(b) by a single Director.

 

If no seal is adopted or used

 

35.4 If the Directors do not adopt a seal, or a seal is not used, a document may be executed in the following manner:

 

(a) by a Director and the Secretary; or

 

(b) by a single Director; or

 

(c) by any other person authorised by the Directors; or

 

(d) in any other manner permitted by the Law.

 

Power to allow non-manual signatures and facsimile printing of seal

 

35.5 The Directors may determine that either or both of the following applies:

 

(a) that the seal or a duplicate seal need not be affixed manually but may be affixed by some other method or system of reproduction; and/or

 

  47  

 

 

(b) that a signature required by these Articles need not be manual but may be a mechanical or Electronic Signature.

 

Validity of execution

 

35.6 If a document is duly executed and delivered by or on behalf of the Company, it shall not be regarded as invalid merely because, at the date of the delivery, the Secretary, or the Director, or other Officer or person who signed the document or affixed the seal for and on behalf of the Company ceased to be the Secretary or hold that office and authority on behalf of the Company.

 

36 Officers

 

36.1 Subject to these Articles, the Directors may from time to time appoint any person, whether or not a Director of the Company, to hold the office of the chairman of the board of Directors (which, pursuant to the Director Nomination Agreement, shall be the Executive Chairman of the Company except as otherwise provided therein), the Chief Executive Officer, the President, the Chief Financial Officer, one or more Vice Presidents or such other Officers as the Directors may think necessary for the administration of the Company, for such term and at such remuneration (whether by way of salary or commission or participation in profits or partly in one way and partly in another), and with such powers and duties as the Directors may think fit.

 

36.2 The appointee must consent in writing to holding that office.

 

36.3 Any appointment of a Director to an executive office shall terminate if he ceases to be a Director but without prejudice to any claim for damages for breach of any agreement relating to the provision of the services of such Director.

 

36.4 Where a chairman is appointed he shall, unless unable to do so, preside at every meeting of Directors.

 

36.5 If there is no chairman, or if the chairman is unable to preside at a meeting, that meeting may select its own chairman or the Directors may nominate one of their number to act in place of the chairman should he ever not be available.

 

36.6 Subject to the provisions of the Law and Article 36.7, the Directors may also appoint any person, who need not be a Director, as Secretary, for such period and on such terms, including as to remuneration, as they think fit.

 

36.7 The Secretary must consent in writing to holding that office.

 

36.8 A Director, Secretary or other Officer of the Company may not hold office, or perform the services, of auditor.

 

  48  

 

 

37 Register of Directors and Officers

 

The Company shall cause to be kept in one or more books at its office a Register of Directors in which there shall be entered the full names and addresses of the Directors and such other particulars as required by the Law.

 

38 Capitalisation of profits

 

Capitalisation of profits or of any stated capital account or capital redemption reserve

 

Subject to the Law and these Articles, the Directors may capitalise any sum standing to the credit of any of the Company’s reserve accounts (including a stated capital account or a capital redemption reserve) or any sum standing to the credit of profit and loss account or otherwise available for distribution and to appropriate such sum to Members in the proportions in which such sum would have been divisible amongst them had the same been a distribution of profits by way of dividend and to apply such sum on their behalf in paying up in full unissued Shares for allotment and distribution credited as fully paid up to and amongst them in the proportion aforesaid. In such event the Directors shall do all acts and things required to give effect to such capitalisation, with full power to the Directors to make such provisions as they think fit for the case of Shares becoming distributable in fractions. The Directors may authorise any person to enter on behalf of all of the Members interested into an agreement with the Company providing for such capitalisation and matters incidental thereto and any agreement made under such authority shall be effective and binding on all concerned.

 

39 Notices

 

Form of notices

 

39.1 Except as otherwise provided in these Articles, any notice or document may be served by the Company or by the person entitled to give notice to any Member either personally, by facsimile or by sending it through the post in a prepaid letter or via a recognised courier service, fees prepaid, addressed to the Member at his address as appearing in the Register of Members or, to the extent permitted by all applicable laws and regulations, by electronic means by transmitting it to any electronic number or address or website supplied by the Member to the Company or by placing it on the Company’s Website, provided that, (i) with respect to notification via electronic means, the Company has obtained the Member’s prior express positive confirmation in writing to receive or otherwise have made available to him notices in such fashion, and (i) with respect to posting to Company’s Website, notification of such posting is provided to such Member. In the case of Joint Holders of a Share, all notices shall be given to that one of the Joint Holders whose name stands first in the Register of Members in respect of the joint holding, and notice so given shall be sufficient notice to all the Joint Holders.

 

  49  

 

 

39.2 An affidavit of the mailing or other means of giving any notice of any general meeting, executed by the Secretary, Assistant Secretary or any transfer agent of the Company giving the notice, shall be prima facie evidence of the giving of such notice.

 

39.3 Any Member present, either personally or by proxy, at any meeting of the Company shall for all purposes be deemed to have received due notice of such meeting and, where requisite, of the purposes for which such meeting was convened.

 

Signatures

 

39.4 A written notice shall be signed when it is autographed by or on behalf of the giver, or is marked in such a way as to indicate its execution or adoption by the giver.

 

39.5 An Electronic Record may be signed by an Electronic Signature.

 

Evidence of transmission

 

39.6 A notice given by Electronic Record shall be deemed sent if an Electronic Record is kept demonstrating the time, date and content of the transmission, and if no notification of failure to transmit is received by the giver.

 

39.7 A notice given in writing shall be deemed sent if the giver can provide proof that the envelope containing the notice was properly addressed, pre-paid and posted, or that the written notice was otherwise properly transmitted to the recipient.

 

Delivery of notices

 

39.8 Any notice or other document, if served by (a) post, shall be deemed to have been served when the letter containing the same is posted, or (b) facsimile, shall be deemed to have been served upon confirmation of successful transmission, or (c) recognised courier service, shall be deemed to have been served when the letter containing the same is delivered to the courier service and in proving such service it shall be sufficient to provide that the letter containing the notice or documents was properly addressed and duly posted or delivered to the courier, or (d) electronic means as provided herein shall be deemed to have been served and delivered on the day on which it is successfully transmitted or at such later time as may be prescribed by any applicable laws or regulations.

 

Giving notice to a deceased or bankrupt Member

 

39.9 Any notice or document delivered or sent to any Member in accordance with the terms of these Articles shall notwithstanding that such Member be then dead or bankrupt, and whether or not the Company has notice of his death or bankruptcy, be deemed to have been duly served in respect of any Share registered in the name of such Member as sole or Joint Holder, unless his name shall at the time of the service of the notice or document, have been removed from the Register of Members as the holder of the Share, and such service shall for all purposes be deemed a sufficient service of such notice or document on all persons interested (whether jointly with or as claiming through or under him) in the Share.

 

  50  

 

 

Saving provisions

 

39.10 A Member present, either in person or by proxy, at any general meeting or at any meeting of the Members holding any class of Shares shall be deemed to have received notice of the meeting and, where requisite, of the purposes for which it was called.

 

39.11 Every person who becomes entitled to a Share shall be bound by any notice in respect of that Share which, before his name is entered in the register of members, has been duly given to a person from which he derives his title.

 

39.12 None of the preceding notice provisions shall derogate from the Articles about the delivery of written resolutions of Directors and written resolutions of Members.

 

40 Authentication of Electronic Records

 

Application of Articles

 

40.1 Without limitation to any other provision of these Articles, any notice, written resolution or other document under these Articles that is sent by Electronic means by a Member, or by the Secretary, or by a Director or other Officer of the Company, shall be deemed to be authentic if either Article 40.2 or Article 40.4 applies.

 

Authentication of documents sent by Members by Electronic means

 

40.2 An Electronic Record of a notice, written resolution or other document sent by Electronic means by or on behalf of one or more Members shall be deemed to be authentic if the following conditions are satisfied:

 

(a) the Member or each Member, as the case may be, signed the original document, and for this purpose original document includes several documents in like form signed by one or more of those Members;

 

(b) the Electronic Record of the original document was sent by Electronic means by, or at the direction of, that Member to an address specified in accordance with these Articles for the purpose for which it was sent; and

 

(c) Article 40.7 does not apply.

 

40.3 For example, where a sole Member signs a resolution and sends the Electronic Record of the original resolution, or causes it to be sent, by facsimile transmission to the address in these Articles specified for that purpose, the facsimile copy shall be deemed to be the written resolution of that Member unless Article 40.7 applies.

 

  51  

 

 

Authentication of document sent by the Secretary or Officers by Electronic means

 

40.4 An Electronic Record of a notice, written resolution or other document sent by or on behalf of the Secretary or an Officer or Officers of the Company shall be deemed to be authentic if the following conditions are satisfied:

 

(a) the Secretary or the Officer or each Officer, as the case may be, signed the original document, and for this purpose original document includes several documents in like form signed by the Secretary or one or more of those Officers;

 

(b) the Electronic Record of the original document was sent by Electronic means by, or at the direction of, the Secretary or that Officer to an address specified in accordance with these Articles for the purpose for which it was sent; and

 

(c) Article 40.7 does not apply.

 

This Article applies whether the document is sent by or on behalf of the Secretary or Officer in his own right or as a representative of the Company.

 

40.5 For example, where a sole Director signs a resolution and scans the resolution, or causes it to be scanned, as a PDF version which is attached to an email sent to the address in these Articles specified for that purpose, the PDF version shall be deemed to be the written resolution of that Director unless Article 40.7 applies.

 

Manner of signing

 

40.6 For the purposes of these Articles about the authentication of Electronic Records, a document will be taken to be signed if it is signed manually or in any other manner permitted by these Articles.

 

Saving provision

 

40.7 A notice, written resolution or other document under these Articles will not be deemed to be authentic if the recipient, acting reasonably:

 

(a) believes that the signature of the signatory has been altered after the signatory had signed the original document;

 

(b) believes that the original document, or the Electronic Record of it, was altered, without the approval of the signatory, after the signatory signed the original document; or

 

(c) otherwise doubts the authenticity of the Electronic Record of the document;

 

and the recipient promptly gives notice to the sender setting the grounds of its objection. If the recipient invokes this Article, the sender may seek to establish the authenticity of the Electronic Record in any way the sender thinks fit.

 

  52  

 

 

41 Information

 

41.1 No Member, as such, shall be entitled to require discovery of any information in respect of any detail of the Company’s trading or any information which is or may be in the nature of a trade secret or other confidential or proprietary information related to the conduct of the business of the Company and which in the opinion of the Directors would not be in the interests of the members of the Company to communicate to the public.

 

41.2 The Directors shall be entitled (but not required, except as provided by law) to release or disclose any information in their possession, custody or control regarding the Company or its affairs to any of its Members including, without limitation, information contained in the Register of Members and transfer books of the Company.

 

42 Indemnity

 

Indemnity

 

42.1 To the fullest extent permitted by law, the Company shall indemnify every Director and Officer of the Company or any predecessor to the Company (which for the avoidance of doubt, shall not include auditors of the Company), together with every former Director and former Officer of the Company or any predecessor to the Company, and the successors and assigns of each of the foregoing, and may indemnify any person (other than current and former Directors and Officers) (any such Director or Officer, an Indemnified Person ), out of the assets of the Company against any liability, action, proceeding, claim, demand, costs, damages or expenses, including legal expenses, whatsoever which they or any of them may incur as a result of any act or failure to act in carrying out their functions in connection with the Company other than such liability (if any) that they may incur by reason of their own actual fraud or wilful default. No Indemnified Person shall be liable to the Company for any loss or damage incurred by the Company as a result (whether direct or indirect) of the carrying out of their functions unless that liability arises through the actual fraud or wilful default of such Indemnified Person. No person shall be found to have committed actual fraud or wilful default under this Article unless or until a court of competent jurisdiction shall have made a finding to that effect. Each Member agrees to waive any claim or right of action he or she might have, whether individually or by or in the right of the Company, against any Indemnified Person on account of any action taken by such Indemnified Person, or the failure of such Indemnified Person to take any action in the performance of his duties with or for the Company; provided that such waiver shall not extend to any matter in respect of any actual fraud or wilful default which may attach to such Indemnified Person.

 

42.2 The Company shall advance to each Indemnified Person reasonable attorneys’ fees and other costs and expenses incurred in connection with the defence of any action, suit, proceeding or investigation involving such Indemnified Person for which indemnity will or could be sought. In connection with any advance of any expenses hereunder, the Indemnified Person shall execute an undertaking to repay the advanced amount to the Company if it shall be determined by final judgment or other final adjudication that such Indemnified Person was not entitled to indemnification pursuant to this Article. If it shall be determined by a final judgment or other final adjudication that such Indemnified Person was not entitled to indemnification with respect to such judgment, costs or expenses, then such party shall not be indemnified with respect to such judgment, costs or expenses and any advancement shall be returned to the Company (without interest) by the Indemnified Person.

 

  53  

 

 

42.3 The Directors, on behalf of the Company, may purchase and maintain insurance for the benefit of any Director or other Officer of the Company against any liability which, by virtue of any rule of law, would otherwise attach to such person in respect of any negligence, default, breach of duty or breach of trust of which such person may be guilty in relation to the Company.

 

42.4 Neither any amendment nor repeal of these Articles set forth under this heading of Indemnity (the Indemnification Articles ), nor the adoption of any provision of these Articles or Memorandum of Association inconsistent with the Indemnification Articles, shall eliminate or reduce the effect of the Indemnification Articles, in respect of any matter occurring, or any action or proceeding accruing or arising or that, but for these Indemnification Articles, would accrue or arise, prior to such amendment, repeal or adoption of an inconsistent provision.

 

43 Financial Year

 

Unless the Directors otherwise prescribe, the financial year of the Company shall begin on January 1 in each year and shall end on December 31 in such year.

 

44 Winding up

 

Distribution of assets in specie

 

44.1 If the Company is wound up, the liquidator or the Directors, as the case may be, shall, subject to these Articles and any other sanction required by the Law, apply the assets of the Company in satisfaction of creditors’ claims in such manner and order as such liquidator thinks fit. Subject to the rights attaching to any Shares, in a winding up:

 

(a) if the assets available for distribution amongst the Members shall be insufficient to repay the whole of the Company’s issued share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the Members in proportion to the number of Shares held by them; or

 

(b) if the assets available for distribution amongst the Members shall be more than sufficient to repay the whole of the Company’s issued share capital at the commencement of the winding up, the surplus shall be distributed amongst the Members in proportion to the number of Shares held by them at the commencement of the winding up subject to a deduction from those Shares in respect of which there are monies due, of all monies payable to the Company.

 

  54  

 

 

44.2 If the Company is wound up, the liquidator or the Directors, as the case may be, subject to the rights attaching to any Shares and with the sanction of a Special Resolution of the Company and any other sanction required by the Law, divide amongst the Members in kind the whole or any part of the assets of the Company (whether such assets shall consist of property of the same kind or not) and may for that purpose value any assets and determine how the division shall be carried out as between the Members or different classes of Members. The liquidator or the Directors, as the case may be, may, with the like sanction, vest the whole or any part of such assets in trustees upon such trusts for the benefit of the Members as the liquidator, with the like sanction, shall think fit, but so that no Member shall be compelled to accept any asset upon which there is a liability.

 

  55  

 

 

Dated the 13 th day of May 2019.

 

Signed for and on behalf of Onex Partners IV LP of 190 Elgin Avenue,
George Town, KY1-9005, Cayman Islands

By: Onex Partners IV GP LP, its general partner

By: Onex Partners Manager LP, its agent

By: Onex Partners Manager GP ULC, its general partner

 

/s/ Joshua Hausman   /s/ Matthew Ross
Signature of authorised signatory   Signature of authorised signatory
     
Joshua Hausman        Matthew Ross
Print name   Print name

 

Signed for and on behalf of Onex Partners IV GP LP of 190 Elgin Avenue,
George Town, KY1-9005, Cayman Islands

By: Onex Partners Manager LP, its agent

By: Onex Partners Manager GP ULC, its general partner

 

/s/ Joshua Hausman   /s/ Matthew Ross
Signature of authorised signatory   Signature of authorised signatory
     
Joshua Hausman   Matthew Ross
Print name   Print name

 

Witness to above signatures /s/ Lisa Kim
  Signature
   
[Address] Lisa Kim
  Print name

 

  56  

 

 

 

 

Exhibit 4.6

 

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “ Agreement ”), dated as of May 13, 2019, is made and entered into by and among Clarivate Analytics Plc, a public limited company organized under the laws of the Island of Jersey (the “ Company ”), Churchill Capital Corp, a Delaware corporation (“ Acquiror ”), Churchill Sponsor LLC, a Delaware limited liability company (the “ Sponsor ”), and the undersigned parties listed under Holder on the signature page hereto (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to  Section 8.2  of this Agreement, a “ Holder ” and collectively the “ Holders ”).

 

RECITALS

 

WHEREAS , the Company, Acquiror, Camelot Holdings (Jersey) Limited, a private limited company organized under the laws of the Island of Jersey, CCC Merger Sub, Inc., a Delaware corporation, and Camelot Merger Sub (Jersey) Limited, a private limited company organized under the laws of the Island of Jersey, are party to that certain Agreement and Plan of Merger, dated January 14, 2019 (the “ Merger Agreement ”);

 

WHEREAS , as a result of the consummation of the transactions contemplated by the Merger Agreement, the Holders will hold Company Shares (as defined below) and/or warrants to purchase Company Shares;

 

WHEREAS , Acquiror and certain of the Sponsor Holders (as defined below) are a party to a Registration Rights Agreement, dated as of September 6, 2018 (the “ Prior Agreement ”);   and

 

WHEREAS , in connection with the consummation of the transactions contemplated by the Merger Agreement, Acquiror and the Sponsor Holders desire to amend and restate the Prior Agreement in its entirety as set forth herein, and the Company and the Holders (other than the Sponsor Holders) desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement.

 

NOW , THEREFORE , in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

Article I.
DEFINITIONS

 

1.1          Definitions . The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

 

Acquiror ” shall have the meaning given in the Preamble.

 

 

 

 

Adverse Disclosure ” shall mean public disclosure of material non-public information which, in the Board’s good faith judgment, after consultation with independent outside counsel to the Company, (i) would be required to be made in any Registration Statement filed with the SEC by the Company so that such Registration Statement would not be materially misleading, (ii) would not be required to be made at such time but for the filing of such Registration Statement and (iii) the Company has a bona fide business purpose for not disclosing publicly.

 

Affiliate ” shall mean, with respect to any specified Person, any other Person that directly or indirectly controls, is controlled by, or is under common control with, such specified Person. As used in this definition, the term “control” shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. “Affiliates” with respect to the Onex Shareholders and the Baring Shareholders, respectively, shall not include the Company or its Subsidiaries.

 

Agreement ” shall have the meaning given in the Preamble.

 

Automatic Shelf Registration Statement ” shall have the meaning specified in Section 3.1 .

 

Baring Shareholders ” shall have the meaning specified in the Shareholders Agreement.

 

Blue Sky ” shall mean state securities regulation and requirements.

 

Board ” shall mean the Board of Directors of the Company.

 

Company ” shall have the meaning given in the Preamble.

 

Company Shares ” shall mean the ordinary shares of no par value in the capital of the Company and any shares or other securities into or for which such shares are hereafter converted or exchanged.

 

Demand Notice ” shall have the meaning specified in Section 2.1.6 .

 

Demand Period ” shall have the meaning specified in Section 2.1.5 .

 

Demand Registration ” shall have the meaning specified in Section 2.1.1 .

 

Demand Registration Statement ” shall have the meaning specified in Section 2.1.1 .

 

Demand Suspension ” shall have the meaning specified in Section 2.1.8 .

 

Exchange Act ” shall mean the U.S. Securities Exchange Act of 1934, as amended, or any similar federal statute then in effect, and a reference to a particular section thereof shall include a reference to the comparable section, if any, of such similar federal statute and the rules and regulations thereunder.

 

FINRA ” shall mean the Financial Industry Regulatory Authority, Inc.

 

  2  

 

 

Founder Shares Lock-up Period ” shall have the meaning specified in the Sponsor Agreement.

 

Holders ” shall have the meaning given in the Preamble.

 

Investor Shareholders ” shall have the meaning specified in the Shareholders Agreement.

 

Investor Shareholder Lock-up Period ” shall mean the period commencing on the date hereof and ending on the one hundred eightieth (180 th ) day after the date hereof.

 

Loss ” shall have the meaning specified in Section 6.1 .

 

Management Shareholders ” shall have the meaning specified in the Shareholders Agreement.

 

Merger Agreement ” shall have the meaning given in the Recitals hereto.

 

Onex Shareholders ” shall have the meaning specified in the Shareholders Agreement.

 

Permitted Transferees ” shall mean (a) in the case of any Sponsor Holder, any permitted transferee as provided in paragraph 7(c) of the Sponsor Agreement, (b) in the case of any Holder (other than any Sponsor Holder) that is not an individual, any Affiliate of such Holder (including existing affiliated investment funds or vehicles that at all times remain Affiliates) and (c) in the case of any Holder (other than any Sponsor Holder) who is an individual, (i) any successor by death or (ii) any trust, partnership, limited liability company or similar entity solely for the benefit of such individual or such individual’s spouse or lineal descendants, provided that such individual acts as trustee, general partner or managing member and retains the sole power to direct the voting and disposition of the transferred Company Shares.

 

Piggyback Registration ” shall have the meaning specified in Section 2.2.1 .

 

Preemption Notice ” shall have the meaning specified in Section 2.1.7 .

 

Prior Agreement ” shall have the meaning given in the Recitals hereto.

 

Prospectus ” shall mean the prospectus included in any Registration Statement, all amendments and supplements to such prospectus, including post effective amendments, and all other material incorporated by reference in such prospectus.

 

Public Offering ” shall mean a public offering and sale of Company Shares pursuant to an effective Registration Statement under the Securities Act.

 

  3  

 

 

Registrable Securities ” shall mean (a) all Company Shares owned of record by the Holders and (b) warrants to purchase Company Shares held by the Holders (including any Company Shares issued or issuable upon the exercise of any such warrant); provided , however , that only the Company Shares and warrants to purchase Company Shares, in each case, held by the Sponsor Holders that have vested in accordance with the terms of paragraph 7(d) of the Sponsor Agreement shall be deemed Registrable Securities, except (x) with respect to such Company Shares subject only to time-based vesting under paragraph 7(d) of the Sponsor Agreement, such Company Shares shall be deemed Registrable Securities if such Company Shares will vest within sixty (60) days of the effective date of the applicable Registration Statement and (y) with respect to Company Shares and warrants to purchase Company Shares subject to performance vesting under paragraph 7(d) of the Sponsor Agreement, such Company Shares and warrants to purchase Company Shares shall be deemed Registrable Securities if the Company, upon the written request of the Sponsor Representative, reasonably determines that such Company Shares or warrants to purchase Company Shares are reasonably likely to vest within sixty (60) days of the effective date of the applicable Registration Statement; provided , further , that no such Company Shares or warrants to purchase Company Shares may be sold under any Registration Statement until such Company Shares or warrants to purchase Company Shares shall have vested in accordance with the terms of paragraph 7(d) of the Sponsor Agreement. As to any particular Registrable Securities that have been issued, such securities shall cease to be Registrable Securities when (i) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been disposed of under such Registration Statement, (ii) in the case of such securities held by the Investor Shareholders or the Sponsor Holders, they shall have been distributed to the public pursuant to Rule 144 under the Securities Act (or any similar rule that may be adopted by the SEC), (iii) in the case of such securities held by the Management Shareholders, they shall have become eligible for distribution to the public pursuant to Rule 144 under the Securities Act (or any similar rule that may be adopted by the SEC), or (iv) they shall have ceased to be outstanding.

 

Registration ” shall mean the registration of securities with the SEC pursuant to a Registration Statement.

 

Registration Expenses ” shall have the meaning specified in Section 5.1 .

 

Registration Statement ” shall mean any registration statement of the Company filed with, or to be filed with, the SEC under the rules and regulations promulgated under the Securities Act, including the related Prospectus, amendments and supplements to such registration statement, including post-effective amendments, and all exhibits to and all material incorporated by reference in such registration statement other than a registration statement (and related Prospectus) filed on Form S-8 or any successor form thereto.

 

SEC ” shall mean the U.S. Securities and Exchange Commission.

 

Securities Act ” shall mean the U.S. Securities Act of 1933, as amended, or any similar federal statute then in effect, and in reference to a particular section thereof shall include a reference to the comparable section, if any, of any such similar federal statute and the rules and regulations thereunder.

 

Shareholders Agreement ” shall mean the Amended and Restated Shareholders Agreement of the Company, dated as of January 14, 2019, by and among the Company, the Onex Shareholders, the Baring Shareholders, and the other Persons party thereto from time to time, as the same may be amended, restated or modified from time to time.

 

  4  

 

 

Shelf Period ” shall have the meaning specified in Section 2.1.5 .

 

Shelf Registration Statement ” shall mean a Registration Statement filed with the SEC on either (a) Form S-3 or Form F-3 (or any successor form or other appropriate form under the Securities Act) or (b) if the Company is not permitted to file a Registration Statement on Form S-3 or Form F-3, an evergreen Registration Statement on Form S-1 or Form F-1 (or any successor form or other appropriate form under the Securities Act), in each case, for an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act (or any similar rule that may be adopted by the SEC) covering the Registrable Securities, as applicable.

 

Shelf Takedown Notice ” shall have the meaning specified in Section 2.1.6 .

 

Shelf Takedown Request ” shall have the meaning specified in Section 2.1.2(a) .

 

Sponsor ” shall have the meaning given in the Preamble hereto.

 

Sponsor Agreement ” means the Sponsor Agreement, dated as of January 14, 2019, by and among the Company, Acquiror, the Sponsor Holders and the other parties thereto, as the same may be amended, restated or modified from time to time.

 

Sponsor Holders ” means the Sponsor, Garden State Capital Partners LLC, M. Klein Associates, Inc., Michael S. Klein, Martin Broughton, Balakrishnan S. Iyer, Karen G. Mills, Sheryl von Blucher, Jerre Stead, the Iyer Family Trust dated 1/25/2001, Mills Family I, LLC, K&BM LP and JMJS Group – II, LP.

 

Sponsor Representative ” means (a) Jerre Stead or (b) following the death of Jerre Stead, the disqualification, resignation or removal of Jerre Stead as a director of the Company or the date on which Jerre Stead no longer beneficially owns any Company Shares, (i) Michael Klein or (ii) if Michael Klein has died, been disqualified, resigned or removed as a director of the Company or no longer beneficially owns any Company Shares, then the Person selected by the Sponsor Holders then holding a majority of the Company Shares held by the Sponsor Holders and reasonably acceptable to the Investor Shareholders. “Beneficially owns” for purposes of this definition shall include securities held by Churchill Sponsor LLC for the benefit of a Sponsor Holder other than Sponsor.

 

Subsidiary ” shall mean, with respect to any specified Person, any other Person of which (a) a majority of shares of stock or other equity or economic interests are owned or controlled, directly or indirectly, through one or more intermediaries, by such specified Person or (b) the outstanding shares of stock or other equity interests having voting power at such time to elect a majority of the board of directors or other comparable governing body of such Person, or to otherwise control such Person, are at the time owned or controlled by, directly or indirectly, one or more intermediaries, or both, by such specified Person.

 

Underwritten Offering ” shall mean a Public Offering in which Company Shares are sold to an underwriter or underwriters on a firm commitment basis for reoffering to the public.

 

Underwritten Shelf Takedown ” means an underwritten Public Offering pursuant to an effective Shelf Registration Statement.

 

  5  

 

 

WKSI ” shall have the meaning specified in Section 3.1 .

 

Article II.
REGISTRATIONS

 

2.1          Demand Registrations .

 

2.1.1          Demand by Holders . At any time and from time to time, any Investor Shareholder or the Sponsor Representative, on behalf of the Sponsor Holders, may make a written request to the Company for Registration of Registrable Securities held by such Investor Shareholder or the Sponsor Holders, as applicable, and any other Holders of Registrable Securities; provided, that the Baring Shareholders, collectively, may only make three (3) such written requests; provided, further that (x) for so long as the Investor Shareholders beneficially own, in the aggregate, at least two hundred thousand (200,000) Company Shares, the Sponsor Representative may only make one (1) such written request and only if the Company is eligible to file a Registration Statement on Form S-3 or Form F-3 at the time of such written request and (y) after such time as the Investor Shareholders cease to beneficially own, in the aggregate, at least two hundred thousand (200,000) Company Shares, the Sponsor Representative may only make three (3) such written requests (including any such request pursuant to the foregoing clause (x)). Any such requested Registration shall hereinafter be referred to as a “ Demand Registration .” Any Demand Registration may request that the Company register Registrable Securities on an appropriate form, including a Shelf Registration Statement and, if the Company is a WKSI, an automatic shelf registration statement. The Company shall promptly provide to the Investor Shareholders or the Sponsor Representative, as applicable, the information necessary to determine the Company’s status as a WKSI upon reasonable request. Each request for a Demand Registration shall specify the aggregate number of Registrable Securities to be registered. As soon as reasonably practicable following a request for a Demand Registration, the Company shall file a Registration Statement relating to such Demand Registration (a “ Demand Registration Statement ”), and shall use its reasonable best efforts to cause such Demand Registration Statement to promptly be declared effective under the Securities Act.

 

2.1.2          Shelf Takedown .

 

(a)          At any time the Company has an effective Shelf Registration Statement with respect to an Investor Shareholder’s Registrable Securities, by notice to the Company, an Investor Shareholder may make a written request (a “ Shelf Takedown Request ”) to the Company to effect a Public Offering, including an Underwritten Shelf Takedown, of all or a portion of such Investor Shareholder’s Registrable Securities that may be registered under such Shelf Registration Statement, and as soon as practicable the Company shall amend or supplement the Shelf Registration Statement as necessary for such purpose.

 

  6  

 

 

(b)          At any time the Company has an effective Shelf Registration Statement with respect to a Sponsor Holder’s Registrable Securities, by at least seven (7) business days’ advance written notice to the Company and the Investor Shareholders, the Sponsor Representative may make a Shelf Takedown Request to the Company to effect a Public Offering, including an Underwritten Shelf Takedown, of all or a portion of such Sponsor Holder’s Registrable Securities that may be registered under such Shelf Registration Statement, and as soon as practicable the Company shall amend or supplement the Shelf Registration Statement as necessary for such purpose, in each case, unless, within four (4) business days of receipt of such notice, an Investor Shareholder delivers a Shelf Takedown Request to the Company, in which case, the Sponsor Representative’s Shelf Takedown Request shall be automatically withdrawn and Section 2.1.6 shall apply with respect to the Investor Shareholder’s Shelf Takedown Request.

 

2.1.3          Limitation on Demand Registration and Underwritten Shelf Takedowns . The Company shall not be obligated to (x) file a Demand Registration Statement under this Section 2.1 unless the aggregate purchase price of the Registrable Securities to be included in the requested Registration (determined by reference to the offering price on the cover of the registration statement proposed to be filed, or, in the case of a Shelf Registration Statement, reasonably expected to be sold pursuant thereto from time to time) is greater than $100,000,000 (or, in the case of a Demand Registration initiated by the Sponsor Representative, either (i) $75,000,000 or (ii) 7,500,000 Company Shares), or (y) effect any Underwritten Shelf Takedown unless the aggregate purchase price of the Registrable Securities to be sold is greater than $50,000,000 (or, in the case of a Demand Registration initiated by the Sponsor Representative, either (i) $50,000,000 or (ii) 5,000,000 Company Shares).

 

2.1.4          Demand Withdrawal . Any Holder may withdraw its Registrable Securities from a Demand Registration at any time prior to the effectiveness of the applicable Demand Registration Statement. Upon receipt of notices from the Investor Shareholder(s) or the Sponsor Representative, as applicable, requesting a withdrawal of its Registrable Securities from a Demand Registration, the Company shall cease all efforts to secure effectiveness of the applicable Demand Registration Statement unless otherwise requested by the Onex Shareholders to the extent an Onex Shareholder has Registrable Securities in such Demand Registration; provided that, if the Baring Shareholder or the Sponsor Representative, as applicable, requests such withdrawal, and the Onex Shareholders request that such withdrawal not be effected, then (x) the withdrawing Baring Shareholder or the Sponsor Holders, as applicable, shall not be required to continue participating in such Demand Registration and (y) such Demand Registration will not count as one of the Baring Shareholders’ or the Sponsor Representative’s, as applicable, Demand Registrations. Any Demand Registration initiated by the Baring Shareholder or the Sponsor Representative that is withdrawn by such initiating shareholder in accordance with this Section 2.1.4 due to adverse market conditions shall not be considered a request for a Demand Registration by such party under Section 2.1.1 .

 

  7  

 

 

2.1.5          Effective Registration . A registration request pursuant to Section 2.1.1 shall not be deemed a Demand Registration unless the Demand Registration Statement is declared effective by the SEC and remains effective for not less than 180 days (or such shorter period when all Registrable Securities covered by such Demand Registration Statement have been sold), or if such Registration Statement relates to an Underwritten Offering, then such longer period as in the opinion of counsel for the underwriter or underwriters a Prospectus is required by law to be delivered in connection with sales of Registrable Securities by an underwriter or dealer (the applicable period, the “ Demand Period ”). No Demand Registration shall be deemed to have been effected if (a) during the Demand Period such registration is interfered with by any stop order, injunction or other order or requirement of the SEC or other governmental agency or court or (b) the conditions to closing specified in the underwriting agreement, if any, entered into in connection with such registration are not satisfied other than by reason of a wrongful act, misrepresentation or breach of such applicable underwriting agreement by a participating Holder. The Company shall use its reasonable best efforts to keep any Shelf Registration Statement continuously effective under the Securities Act in order to permit the Prospectus forming part of the Shelf Registration Statement to be usable by Holders until the earlier of: (i) the date as of which all Registrable Securities have been sold pursuant to the Shelf Registration Statement or another Registration Statement filed under the Securities Act (but in no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder); and (ii) the date as of which no Holder holds Registrable Securities (such period of effectiveness, the “ Shelf Period ”).

 

2.1.6          Demand Notice . Promptly upon receipt of any request for a Demand Registration pursuant to Section 2.1.1 (other than in connection with an Underwritten Offering effected pursuant to a Shelf Registration Statement) but in no event more than two (2) business days thereafter, the Company shall deliver a written notice (a “ Demand Notice ”) of such Demand Registration request to all Holders of Registrable Securities, and the Company shall include in such Demand Registration all such Registrable Securities with respect to which the Company has received written requests for inclusion therein within three (3) business days after the date that the Demand Notice has been delivered. Promptly upon receipt of any Shelf Takedown Request for an Underwritten Shelf Takedown, but in no event more than two (2) business days thereafter (or such shorter period as may be reasonably requested in connection with an underwritten “block trade”), the Company shall deliver a written notice (a “ Shelf Takedown Notice ”) of such Shelf Takedown Request to all Holders of Registrable Securities registered pursuant to such Shelf Registration Statement (other than to Management Shareholders), and the Company shall include in such Underwritten Shelf Takedown all such Registrable Securities with respect to which the Company has received written requests for inclusion therein within two (2) business days (or such shorter period as may be reasonably requested in connection with an underwritten “block trade”) after the date that the Shelf Takedown Notice has been delivered.

 

  8  

 

 

2.1.7          Preemption . If not more than thirty (30) days prior to receipt of any request for a Demand Registration pursuant to Section 2.1.1 , the Company shall have (a) circulated to prospective underwriters and their counsel a draft of a Registration Statement for a primary offering of equity securities on behalf of the Company, (b) solicited bids for a primary offering of Company Shares or (c) otherwise reached an understanding with an underwriter with respect to a primary offering of Company Shares, the Company may preempt the Demand Registration with such primary offering by delivering written notice of such intention (the “ Preemption Notice ”) to the Holders making a request for a Demand Registration within five (5) days after the Company has received the request. The period of preemption may be up to forty-five (45) days following the date of the Preemption Notice or such longer period as the Company is subject to a lock-up pursuant to Section 7.3 . Notwithstanding anything to the contrary herein, the Company shall not be entitled to exercise its right to preempt a Demand Registration pursuant to this Section 2.1.7 more than once during any 12 month period.

 

2.1.8          Delay in Filing; Suspension of Registration . If the filing, initial effectiveness or continued use of a Demand Registration Statement at any time would require the Company to make an Adverse Disclosure, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, the Demand Registration Statement (a “ Demand Suspension ”); provided , however , that the Company shall not be permitted to exercise a Demand Suspension (a) more than once during any twelve (12) month period or (b) for a period exceeding forty-five (45) days. In the case of a Demand Suspension, the Holders agree to suspend use of the applicable Prospectus in connection with any sale or purchase, or offer to sell or purchase, Registrable Securities, upon receipt of the notice referred to above. The Company shall immediately notify the Holders upon the termination of any Demand Suspension, amend or supplement the Prospectus, if necessary, so it does not contain any untrue statement or omission and furnish to the Holders such numbers of copies of the Prospectus as so amended or supplemented as the Holders may reasonably request. The Company agrees, if necessary, to supplement or make amendments to the Demand Registration Statement, if required by the registration form used by the Company for the Demand Registration or by the instructions applicable to such registration form or by the Securities Act or as may be requested by the Holders of a majority of the Registrable Securities that are included in such Demand Registration Statement.

 

2.1.9          Underwritten Offering . If the Holders of not less than a majority of the Registrable Securities requesting a Demand Registration so elect, such offering of Registrable Securities shall be in the form of an Underwritten Offering. The Holders initiating the underlying Demand Registration for such Underwritten Offering shall have the right to select the managing underwriter or underwriters to administer the offering; provided , that (i) any such managing underwriter or underwriters shall be reasonably acceptable to the Company and (ii) in the event that an Investor Shareholder is participating in such Underwritten Offering and did not initiate the underlying Demand Registration, such managing underwriter or underwriters shall be reasonably acceptable to the applicable Investor Shareholder, such consent not to be unreasonably withheld, conditioned or delayed.

 

  9  

 

 

2.1.10          Priority of Securities Registered Pursuant to Demand Registrations . If the managing underwriter or underwriters of a proposed Underwritten Offering of the Registrable Securities included in a Demand Registration (or, in the case of a Demand Registration not being underwritten, the Holders of a majority of the Registrable Securities included therein) or an Underwritten Shelf Takedown advise the Company in writing (which, for the avoidance of doubt, may be via e-mail) that, in its or their opinion, the number of securities requested to be included in such Demand Registration or Underwritten Shelf Takedown exceeds the number which can be sold in such offering without being likely to have a significant adverse effect on the price, timing or distribution of the securities offered or the market for the securities offered, then the Company will include in such offering, (a) first , the number of Registrable Securities requested by all Holders of Registrable Securities to be included in such offering that, in the opinion of such managing underwriter(s) (or, in the case of a Demand Registration not being underwritten, the Holders of a majority of the Registrable Securities included therein), can be sold without having such significant adverse effect, such amount to be allocated among all such Holders of Registrable Securities pro rata on the basis of the respective number of Registrable Securities then held by each such Holder, (b) second , only if all of the Registrable Securities referred to in clause (a) have been included in such offering, the securities the Company proposes to sell and (c) third , only if all of the securities referred to in clauses (a) and (b) have been included in such offering, any other securities eligible for inclusion in such Registration.

 

2.2          Piggyback Registration .

 

2.2.1          Participation . If the Company proposes to file a Registration Statement under the Securities Act or to conduct a Public Offering with respect to any offering of Company Shares for its own account or for the account of any other Persons (other than (a) a Registration under Section 2.1 , (b) a Registration on Form S-4 or S-8 or any successor form thereto, (c) a Registration of securities solely relating to an offering and sale to employees, directors or consultants of the Company or any of its Subsidiaries pursuant to any benefit or incentive plan or (d) a Registration Statement relating to the registration of Company Shares in connection with a payment under the Tax Receivable Agreement (as defined in the Merger Agreement)), then, as soon as practicable (but in no event less than ten (10) days prior to the initial filing of such Registration Statement or, in the case of a Public Offering under a Shelf Registration Statement, three (3) days prior to the anticipated pricing date), the Company shall give written notice of such proposed filing or Public Offering to all Holders of Registrable Securities (other than Management Shareholders in connection with a registration effected pursuant to a Shelf Registration Statement (including any Underwritten Shelf Takedown)), and such notice shall offer such Holders of Registrable Securities the opportunity to register under such Registration Statement, or to sell in such Public Offering, such number of Registrable Securities as each such Holder may request in writing (a “ Piggyback Registration ”). Subject to Section 2.2.2 , the Company shall include in such Registration Statement or in such Public Offering all such Registrable Securities which are requested to be included therein within ten (10) days after the Company has given such notice or, in the case of a Public Offering under a Shelf Registration Statement, one (1) day prior to the pricing date; provided , however , that if at any time after giving written notice of its intention to register or sell any securities and prior to the effective date of the Registration Statement filed in connection with such Registration, the Company shall determine for any reason not to register or sell or to delay Registration of such securities, the Company shall give written notice of such determination to each Holder of Registrable Securities and, thereupon, (i) in the case of a determination not to register or sell, shall be relieved of its obligation to register any Registrable Securities in connection with such Registration or Public Offering (but not from its obligation to pay the Registration Expenses in connection therewith), without prejudice, however, to the rights of any Holders under Section 2.1 , and (ii) in the case of a determination to delay registering or selling, in the absence of a request for a Demand Registration or an Underwritten Shelf Takedown, shall be permitted to delay registering or selling any Registrable Securities, for the same period as the delay in registering or selling such other securities. If such Public Offering is to be underwritten, then each Holder making a request for a Piggyback Registration pursuant to this Section 2.2.1 must, and the Company shall make such arrangements with the managing underwriter or underwriters so that each such Holder may, participate in such Underwritten Offering. If the offering pursuant to such Registration Statement is to be on any other basis, then each Holder making a request for a Piggyback Registration pursuant to this Section 2.2.1 must, and the Company shall make such arrangements so that each such Holder may, participate in such offering on such basis. Each Holder of Registrable Securities shall be permitted to withdraw all or part of such Holder’s Registrable Securities from a Piggyback Registration at any time prior to the pricing of such Registration.

 

  10  

 

 

2.2.2          Priority of Piggyback Registration . If the managing underwriter or underwriters of any proposed Underwritten Offering of Registrable Securities included in a Piggyback Registration informs the Company in writing (which, for the avoidance of doubt, may be via e-mail) that, in its or their opinion, the number of securities which such Holders and any other Persons intend to include in such offering exceeds the number which can be sold in such offering without being likely to have a significant adverse effect on the price, timing or distribution of the securities offered or the market for the securities offered, then the securities to be included in such Piggyback Registration shall be (a) first , the number of Registrable Securities that the Company proposes to sell, that, in the opinion of such managing underwriter(s), can be sold without having such significant adverse effect, (b) second , only if all securities referred to in clause (a) have been included in such registration, the number of Registrable Securities requested by all Investor Shareholders to be included in such offering that, in the opinion of such managing underwriter(s), can be sold without having such significant adverse effect, pro rata on the basis of the respective number of Registrable Securities then held by each such Investor Shareholder, (c) third , only if all securities referred to in clauses (a) and (b) have been included in such offering, the number of Registrable Securities requested by all Management Shareholders and Sponsor Holders to be included in such offering that, in the opinion of such managing underwriter(s), can be sold without having such significant adverse effect, pro rata on the basis of the respective number of Registrable Securities then held by each such Management Shareholder and Sponsor Holder and (d) fourth , only if all securities referred to in clauses (a), (b) and (c) have been included in such Registration, the number of Company Shares that any other Person exercising a contractual right to demand Registration proposes to sell that, in the opinion of such managing underwriter(s), can be sold without having such significant adverse effect, pro rata on the basis of the respective number of Company Shares then held by each such Person.

 

2.2.3          No Effect on Demand Registrations or Shelf Takedowns . No Registration of Registrable Securities effected pursuant to this Section 2.2 shall be deemed to have been effected pursuant to Section 2.1 or shall relieve the Company of its obligations under Section 2.1 .

 

2.3          Restrictions on Registration Rights . Notwithstanding anything to the contrary contained in this Agreement, no Registration Statement shall become effective, (a) with respect to any Registrable Securities held by any Sponsor Holder, until after the expiration of the Founder Shares Lock-up Period, and (b) with respect to any Registrable Securities held by any Investor Shareholder, until after the expiration of the Investor Shareholder Lock-up Period.

 

  11  

 

 

Article III.
REGISTRATION PROCEDURES

 

3.1          General Procedures . In connection with the Company’s Registration obligations under Sections 2.1 and 2.2 , the Company shall use its reasonable best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended method or methods of distribution thereof as expeditiously as reasonably practicable, and in connection therewith the Company shall, among other things:

 

3.1.1         prepare the required Registration Statement including all exhibits and financial statements required under the Securities Act to be filed therewith, and before filing a Registration Statement or Prospectus, or any amendments or supplements thereto, (x) furnish to the underwriters, if any, and to the Holders of the Registrable Securities covered by such Registration Statement, copies of all documents prepared to be filed and (y) except in the case of a Registration under Section 2.2 , not file any Registration Statement or Prospectus or amendments or supplements thereto or any free writing prospectus related thereto to which the Investor Shareholder(s) or the Sponsor Representative, as applicable, requesting a Demand Registration or an Underwritten Shelf Takedown, as applicable, or the underwriters, if any, shall reasonably object;

 

3.1.2         as soon as reasonably practicable file with the SEC a Registration Statement relating to the Registrable Securities, including all exhibits and financial statements required by the SEC to be filed therewith, and use its reasonable best efforts to cause such Registration Statement to become effective under the Securities Act as soon as practicable thereafter;

 

3.1.3         prepare and file with the SEC such pre- and post-effective amendments to such Registration Statement and supplements to the Prospectus or any free writing prospectus related thereto as may be (a) reasonably requested by any participating Investor Shareholder, (b) reasonably requested by any participating Holder to the extent such request relates to information relating to such Holder, or (c) necessary to keep such Registration effective for the period of time required by this Agreement, and comply with provisions of the Securities Act with respect to the sale or other disposition of all securities covered by such Registration Statement during such period in accordance with the intended method or methods of disposition by the sellers thereof set forth in such Registration Statement;

 

  12  

 

 

3.1.4         notify the participating Holders of Registrable Securities and the managing underwriter or underwriters, if any, and (if requested) confirm such advice in writing (which, for the avoidance of doubt, may be via e-mail) and provide copies of the relevant documents, as soon as practicable after notice thereof is received by the Company (a) when the applicable Registration Statement or any amendment thereto has been filed or becomes effective, and when the applicable Prospectus or any amendment or supplement to such Prospectus or any free writing prospectus related thereto has been filed and/or used, (b) of any written comments by the SEC or any request by the SEC for amendments or supplements to such Registration Statement or such Prospectus or for additional information, (c) of the issuance by the SEC of any stop order suspending the effectiveness of such Registration Statement or any order by the SEC or any other regulatory authority preventing or suspending the use of any preliminary or final Prospectus or the initiation or threatening of any proceedings for such purposes, (d) if, at any time, the representations and warranties of the Company in any applicable underwriting agreement cease to be true and correct in all material respects, and (e) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable Securities for offering or sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose;

 

3.1.5         promptly notify each selling Holder of Registrable Securities and the managing underwriter or underwriters, if any, when the Company becomes aware of the happening of any event as a result of which the applicable Registration Statement or the Prospectus included in such Registration Statement (as then in effect) or any free writing prospectus related thereto or the information conveyed to any purchaser at the time of sale to such purchaser contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements therein (in the case of such Prospectus, any preliminary Prospectus, any free writing prospectus and any information conveyed to any purchaser at the time of the sale to such purchaser, in light of the circumstances under which they were made) not misleading or, if for any other reason it shall be necessary during such time period to amend or supplement such Registration Statement or Prospectus, any free writing prospectus related thereto or any information conveyed to any purchaser at the time of the sale to such purchaser in order to comply with the Securities Act and, in either case as promptly as reasonably practicable thereafter, prepare and file with the SEC, and furnish without charge to the selling Holders and the managing underwriter or underwriters, if any, an amendment or supplement to such Registration Statement or Prospectus, any free writing prospectus related thereto or any information conveyed to any purchaser at the time of the sale to such purchaser which shall correct such misstatement or omission or effect such compliance;

 

3.1.6         use its reasonable best efforts to prevent, or obtain the withdrawal of, any stop order or other order suspending the use of any Registration Statement, preliminary or final Prospectus;

 

3.1.7         use its reasonable best efforts to incorporate in a Prospectus supplement or post-effective amendment such information as (x) the managing underwriter or underwriters, (y) the participating Investor Shareholder(s) and (z) in the case of a Demand Registration by the Sponsor Representative, the Sponsor Representative agree should be included therein relating to the plan of distribution with respect to such Registrable Securities; and make all required filings of such Prospectus supplement or post-effective amendment as soon as reasonably practicable after being notified of the matters to be incorporated in such Prospectus supplement or post-effective amendment;

 

  13  

 

 

3.1.8         furnish to each selling Holder of Registrable Securities and each underwriter, if any, without charge, as many conformed copies as such Holder or underwriter may reasonably request of the applicable Registration Statement and any amendment or post-effective amendment thereto, including financial statements and schedules, all documents incorporated therein by reference and all exhibits (including those incorporated by reference) and any free writing prospectus utilized in connection therewith;

 

3.1.9         deliver to each selling Holder of Registrable Securities and each underwriter, if any, without charge, as many copies of the applicable Prospectus (including each preliminary prospectus) and any amendment or supplement thereto or any free writing prospectus relating thereto as such Holder or underwriter may reasonably request (it being understood that the Company consents to the use of such Prospectus or any amendment or supplement thereto or any free writing prospectus relating thereto by each of the selling Holders of Registrable Securities and the underwriters, if any, in connection with the offering and sale of the Registrable Securities covered by such Prospectus or any amendment or supplement thereto) and such other documents as such selling Holder or underwriter may reasonably request in order to facilitate the disposition of the Registrable Securities by such Holder or underwriter;

 

3.1.10         on or prior to the date on which the applicable Registration Statement is declared effective, use its reasonable best efforts to register or qualify, and cooperate with the selling Holders of Registrable Securities, the managing underwriter or underwriters, if any, and their respective counsel, in connection with the registration or qualification of such Registrable Securities for offer and sale under the securities or Blue Sky laws of each state and other jurisdiction of the United States as any such selling Holder or managing underwriter or underwriters, if any, or their respective counsel reasonably request in writing and do any and all other acts or things reasonably necessary or advisable to keep such registration or qualification in effect for such period as required by Section 2.1.5 ;

 

3.1.11         cooperate with the selling Holders of Registrable Securities and the managing underwriter or underwriters, if any, to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold and not bearing any restrictive legends, and cause such Registrable Securities to be issued in such denominations and registered in such names in accordance with the underwriting agreement prior to any sale of Registrable Securities to the underwriters or, if not an underwritten offering, in accordance with the instructions of the selling Holders of Registrable Securities at least two (2) business days prior to any sale of Registrable Securities and instruct any transfer agent and registrar of Registrable Securities to release any stop transfer orders in respect thereof;

 

3.1.12         use its reasonable best efforts to (a) cause the Registrable Securities covered by the applicable Registration Statement to be registered with or approved by such other governmental agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter or underwriters, if any, to consummate the disposition of such Registrable Securities and (b) keep such registration or qualification in effect for so long as such registration statement remains in effect;

 

3.1.13         deliver promptly to counsel to the Holders of Registrable Securities and each underwriter, if any, participating in the offering of the Registrable Securities copies of all comment letters from the SEC or its staff with respect to such Registration Statement;

 

  14  

 

 

3.1.14         not later than the effective date of the applicable Registration Statement, provide a CUSIP number for all Registrable Securities and provide the applicable transfer agent with printed certificates, if applicable, for the Registrable Securities which are in a form eligible for deposit with The Depository Trust Company;

 

3.1.15         make such representations and warranties to the Holders of Registrable Securities being registered, and the underwriters or agents, if any, in form, substance and scope as are customarily made by issuers in secondary underwritten public offerings;

 

3.1.16         enter into and perform its obligations under such customary agreements (including underwriting agreements in customary form) and take all such other actions as (x) the participating Investor Shareholder(s), (y) in the case of a Demand Registration by the Sponsor Representative, the Sponsor Representative or (z) the managing underwriter or underwriters, if any, reasonably request in order to expedite or facilitate the registration and disposition of such Registrable Securities;

 

3.1.17         use its reasonable best efforts to obtain for delivery to the underwriter or underwriters, if any, an opinion or opinions from counsel for the Company (including outside counsel) dated the date of the closing(s) under the underwriting agreement, in customary form, scope and substance, which opinions shall be reasonably satisfactory to such underwriters and their respective counsel;

 

3.1.18         use its reasonable best efforts to, in the case of an Underwritten Offering, obtain for delivery to the Company and the managing underwriter or underwriters, a comfort letter from the Company’s independent certified public accountants (and, if necessary and to the extent that the Company or any business acquired after the date hereof has previously engaged such independent certified public accountants or independent auditors, any other independent certified public accountants or independent auditors of any Subsidiary of the Company or any business acquired by the Company for which financial statements and financial data are required to be included in the Registration Statement) in customary form and covering such matters of the type customarily covered by comfort letters as the managing underwriter or underwriters reasonably request, dated the date of execution of the underwriting agreement and brought down to the closing under the underwriting agreement;

 

3.1.19         use commercially reasonably efforts to cooperate with each seller of Registrable Securities and each underwriter, if any, participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA or any securities exchange on which such Registrable Securities are traded or will be traded;

 

3.1.20         use commercially reasonably efforts to, to the extent required by the rules and regulations of FINRA, retain a Qualified Independent Underwriter (as such term is defined in FINRA Rule 5121(f)(12));

 

  15  

 

 

3.1.21         use its reasonable best efforts to comply with the Securities Act and, if applicable, make available to its securityholders, as soon as reasonably practicable, an earnings statement satisfying the provisions of Section 11(a) of the Securities Act and the rules and regulations promulgated thereunder;

 

3.1.22         use its reasonably best efforts to provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by the applicable Registration Statement from and after a date not later than the effective date of such Registration Statement;

 

3.1.23         use its reasonable best efforts to cause all Registrable Securities covered by the applicable Registration Statement to be listed on each securities exchange on which similar securities issued by the Company are then listed or quoted;

 

3.1.24         subject to appropriate confidentiality arrangements, make available upon reasonable notice at reasonable times and for reasonable periods for inspection by a representative appointed by the participating Investor Shareholder(s) or the Sponsor Representative, by any underwriter participating in any disposition to be effected pursuant to such Registration Statement and by any attorney, accountant or other agent retained by such Investor Shareholder(s), Sponsor Representative or any such underwriter, all pertinent financial and other records, pertinent corporate documents and properties of the Company, and cause all of the Company’s officers, directors, employees, agents and representatives to, and use its reasonable best efforts to cause the independent public accountants who have certified its financial statements to, make themselves available to discuss the business of the Company and to supply all information requested by any such Person in connection with such Registration Statement as shall be necessary to enable them to exercise their due diligence responsibility;

 

3.1.25         in the case of an Underwritten Offering, cause the senior executive officers of the Company and its Subsidiaries to participate in the customary “road show” presentations that may be reasonably requested by the managing underwriter or underwriters in any such Underwritten Offering and otherwise to facilitate, cooperate with, and participate in each proposed offering contemplated herein and customary selling efforts related thereto;

 

3.1.26         take all reasonable action to ensure that any free writing prospectus utilized in connection with any registration covered by Section 2.1 or Section 2.2 complies in all material respects with the Securities Act, is filed in accordance with the Securities Act to the extent required thereby, is retained in accordance with the Securities Act to the extent required thereby and, when taken together with the related Prospectus, Prospectus supplement and related documents, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading;

 

3.1.27         in connection with any Underwritten Offering, if at any time the information conveyed to a purchaser at the time of sale to such purchaser includes any untrue statement of a material fact or omits to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, promptly file with the SEC such amendments or supplements to such information as may be necessary so that the statements as so amended or supplemented will not, in light of the circumstances, be misleading;

 

  16  

 

 

3.1.28         provide all such other certificates, letters, opinions and other requested documents customarily provided in public offerings similar to the offering then being undertaken; and

 

3.1.29         take all such other reasonable actions as are necessary or advisable in order to expedite or facilitate the disposition of such Registrable Securities in accordance with the terms of this Agreement.

 

To the extent the Company is a well-known seasoned issuer (as defined in Rule 405 under the Securities Act) (a “ WKSI ”) at the time any Demand Registration is submitted to the Company, and such Demand Registration requests that the Company file an automatic shelf registration statement (as defined in Rule 405 under the Securities Act) (an “ Automatic Shelf Registration Statement ”) on Form S-3 or Form F-3, the Company shall file an Automatic Shelf Registration Statement which covers those Registrable Securities which are requested to be registered by the Investor Shareholders or the Sponsor Representative. If the Company does not pay the filing fee covering the Registrable Securities at the time the Automatic Shelf Registration Statement is filed, the Company agrees to pay such fee at such time or times as the Registrable Securities are to be sold. To the extent required in order to maintain an effective Automatic Shelf Registration Statement covering the Registrable Securities, the Company shall file a new Automatic Shelf Registration Statement covering the Registrable Securities. If at any time when the Company is required to re-evaluate its WKSI status the Company determines that it is not a WKSI, the Company shall use its reasonable best efforts to file a new Shelf Registration Statement and keep such Shelf Registration Statement effective during the period during which such registration statement is required to be kept effective.

 

If the Company files any Shelf Registration Statement for the benefit of the holders of any securities other than the Investor Shareholders, the Company agrees that it shall include in such Shelf Registration Statement such disclosures as may be required by Rule 430B (referring to the unnamed selling security holders in a generic manner by identifying the initial offering of the securities to the Holders) in order to ensure that the Investor Shareholders may be added to such Shelf Registration Statement at a later time through the filing of a Prospectus supplement rather than a post-effective amendment.

 

3.2          Obligations of the Holders . The Company may require each seller of Registrable Securities as to which any Registration is being effected to furnish to the Company such information regarding the distribution of such securities and such other information relating to such Holder and its ownership of Registrable Securities as the Company may from time to time reasonably request in writing. Each Holder of Registrable Securities agrees to furnish such information to the Company and to cooperate with the Company as reasonably necessary to enable the Company to comply with the provisions of this Agreement.

 

  17  

 

 

3.3          Suspension of Use of Prospectus . Each Holder of Registrable Securities agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3.1.5 , such Holder will forthwith discontinue disposition of Registrable Securities pursuant to such Registration Statement until such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 3.1.5 , or until such Holder is advised in writing by the Company that the use of the Prospectus may be resumed, and if so directed by the Company, such Holder shall deliver to the Company (at the Company’s expense) all copies, other than permanent file copies then in such Holder’s possession, of the Prospectus covering such Registrable Securities current at the time of receipt of such notice. In the event the Company shall give any such notice, the period during which the applicable Registration Statement is required to be maintained effective shall be extended by the number of days during the period from and including the date of the giving of such notice to and including the date when each seller of Registrable Securities covered by such Registration Statement either receives the copies of the supplemented or amended Prospectus contemplated by Section 3.1.5 or is advised in writing by the Company that the use of the Prospectus may be resumed.

 

3.4          Blue Sky Laws . If any such Registration Statement or comparable statement under Blue Sky laws refers to any Holder by name or otherwise as the Holder of any securities of the Company, then such Holder shall have the right to require (a) the insertion therein of language, in form and substance reasonably satisfactory to such Holder and the Company, to the effect that the holding by such Holder of such securities is not to be construed as a recommendation by such Holder of the investment quality of the Company’s securities covered thereby and that such holding does not imply that such Holder will assist in meeting any future financial requirements of the Company or (b) in the event that such reference to such Holder by name or otherwise is not in the judgment of the Company, as advised by counsel, required by the Securities Act or any state Blue Sky law then in force, the deletion of the reference to such Holder.

 

Article IV.
UNDERWRITTEN OFFERINGS

 

4.1          Demand Registrations . If requested by the underwriters for any Underwritten Offering requested by Holders of Registrable Securities pursuant to Section 2.1 , the Company shall enter into an underwriting agreement with such underwriters for such offering, such agreement to be reasonably satisfactory in substance and form to the Company, the Investor Shareholder(s) requesting such Demand Registration or Underwritten Shelf Takedown and the underwriters, and to contain such representations and warranties by the Company and such other terms as are generally prevailing in agreements of that type, including indemnities no less favorable to the recipient thereof than those provided in Article VI . The Holders of the Registrable Securities proposed to be distributed by such underwriters shall cooperate with the Company in the negotiation of such underwriting agreement. Such Holders of Registrable Securities to be distributed by such underwriters shall be parties to such underwriting agreement, which underwriting agreement shall (a) contain such representations and warranties by such Holders of Registrable Securities and such other terms as are generally prevailing in agreements of that type, including indemnities, and the aggregate amount of liability of any Holder shall not exceed such Holder’s net proceeds from such Underwritten Offering, and (b) provide that any or all of the conditions precedent to the obligations of such underwriters under such underwriting agreement also shall be conditions precedent to the obligations of such Holders of Registrable Securities.

 

  18  

 

 

4.2          Piggyback Registrations . If the Company proposes to register any of its securities under the Securities Act as contemplated by Section 2.2 and such securities are to be distributed in an Underwritten Offering through one or more underwriters, the Company shall, if requested by any Holder pursuant to Section 2.2 and subject to the provisions of Section 2.2.2 , use its reasonable best efforts to arrange for such underwriters to include on the same terms and conditions that apply to the other sellers in such Registration, all the Registrable Securities to be offered and sold by such Holder among the securities of the Company to be distributed by such underwriters in such Registration. The Holders of the Registrable Securities to be offered in such Registration shall be parties to the underwriting agreement between the Company and such underwriters, which underwriting agreement shall (a) contain such representations and warranties by such Holders of Registrable Securities and such other terms as are generally prevailing in agreements of that type, including indemnities, and the aggregate amount of liability of any Holder shall not exceed such Holder’s net proceeds from such Underwritten Offering, and (b) provide that any or all of the conditions precedent to the obligations of such underwriters under such underwriting agreement also shall be conditions precedent to the obligations of such Holders of Registrable Securities.

 

4.3          Participation in Underwritten Registrations . Subject to Sections 4.1 and 4.2 , no Person may participate in any Underwritten Offering hereunder unless such Person (a) agrees to sell such Person’s securities on the basis provided in, and agrees to become a party to, any underwriting arrangements approved by the Persons entitled to approve such arrangements and (b) completes and executes all questionnaires, powers of attorney, medallion guarantees, indemnities and other documents required under the terms of such underwriting arrangements or otherwise reasonably requested by the underwriters.

 

4.4          Price and Underwriting Discounts . In the case of an Underwritten Offering under Section 2.1 , the price, underwriting discount and other financial terms for the Registrable Securities shall be determined by the Holders of a majority of the Registrable Securities included in the Underwritten Offering.

 

  19  

 

 

Article V.
REGISTRATION EXPENSES

 

5.1          Registration Expenses . All expenses incident to the Company’s performance of or compliance with this Agreement, and all reasonable out-of-pocket costs and expenses incurred by the Holders in connection with any registration and sale of Registrable Securities pursuant to this this Agreement (excluding (x) any underwriters’ or brokerage discounts or commissions payable in respect of the sale of Registrable Securities by any Holder and (y) except as set forth in clauses (g) and (h) below, fees and expenses of legal counsel to any Holder) shall be paid by the Company, including (a) all registration and filing fees, and any other fees and expenses associated with filings required to be made with the SEC, FINRA or other applicable governmental entity (including reasonable fees and disbursements of counsel for the underwriters in connection with the FINRA qualification of the Registrable Securities), (b) all fees and expenses in connection with compliance with any securities or Blue Sky laws and determination of the eligibility of the Registrable Securities for investment under the laws of the various jurisdictions (including reasonable fees and disbursements of counsel for the underwriters in connection with Blue Sky qualification of the Registrable Securities), (c) all printing, duplicating, word processing, messenger, telephone, facsimile and delivery expenses (including expenses of printing certificates for the Registrable Securities in a form eligible for deposit with The Depository Trust Company and of printing prospectuses), (d) all fees and disbursements of counsel for the Company and of all independent certified public accountants of the Company (including the expenses of any special audit and cold comfort letters required by or incident to such performance) or its Subsidiaries or any business acquired by the Company for which financial statements and financial data are, or are required to be, included in the Registration Statement, (e) Securities laws liability insurance or similar insurance if the Company so desires or the underwriters so require in accordance with then-customary underwriting practice, (f) all fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange or quotation of the Registrable Securities on any inter-dealer quotation system, (g) all reasonable fees and disbursements of one law firm or other counsel selected by the Holders of a majority of the Registrable Securities owned by the Onex Shareholders and their Affiliates being registered, one law firm or other counsel selected by the Holders of a majority of the Registrable Securities owned by the Baring Shareholders and their Affiliates being registered and, in the case of a Demand Registration by the Sponsor Representative, one law firm or other counsel selected by the Holders of a majority of the Registrable Securities owned by the Sponsor Holders being registered, and, in the case of a Registration Statement which is not a Demand Registration Statement by the Sponsor Representative, all reasonable fees and disbursements of lead counsel designated by the holders of a majority of the Registrable Securities owned by the Onex Shareholders and their Affiliates or the Baring Shareholders and their Affiliates, as the case may be, (h) all reasonable fees and disbursements of such local or special legal counsel as may reasonably be required by the Holders of a majority of the Registrable Securities participating in such Registration, (i) any reasonable fees and disbursements of underwriters (excluding any underwriters’ or brokerage discounts or commissions payable in respect of the sale of Registrable Securities by any Holder) customarily paid by issuers or sellers of securities, (j) all fees and expenses of any special experts or other Persons retained by the Company in connection with any Registration, (k) fees and expenses of a Qualified Independent Underwriter (as such term is defined in FINRA Rule 5121(f)(12)) and its counsel, if any, (l) all of the Company’s internal expenses (including all salaries and expenses of its officers and employees performing legal or accounting duties), (m) all expenses incurred in connection with promotional efforts or “roadshows” for any Underwritten Offering, including all travel (including any aircraft chartered for such purpose), meals and lodging, and (n) fees and disbursements of transfer agents, registrars and custodians. All such expenses are referred to herein as “ Registration Expenses ”.

 

  20  

 

 

Article VI.
INDEMNIFICATION

 

6.1          Indemnification by the Company . The Company agrees to indemnify and hold harmless, to the fullest extent permitted by law, each Holder of Registrable Securities, each member, limited or general partner thereof, each member, limited or general partner of each such member, limited or general partner, each of their respective Affiliates, officers, directors, security holders, employees, advisors, and agents and each Person who controls (within the meaning of the Securities Act) such Persons and each of their respective Representatives from and against any and all losses, penalties, judgments, suits, costs, claims, damages, liabilities and expenses, joint or several (including reasonable costs of investigation and legal expenses) (each, a “ Loss ” and collectively “ Losses ”) arising out of or based upon (a) any untrue or alleged untrue statement of a material fact contained in any Registration Statement under which such Registrable Securities were registered under the Securities Act (including any final, preliminary or summary Prospectus contained therein or any amendment thereof or supplement thereto or any documents incorporated by reference therein) or contained in any free writing prospectus utilized in connection therewith or in any information conveyed to any purchaser at the time of the sale to such purchaser, or any other disclosure document produced by or on behalf of the Company or any of its Subsidiaries including, without limitation, reports and other documents filed under the Exchange Act, (b) any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, preliminary Prospectus, free writing prospectus related thereto or the information conveyed to any purchaser at the time of the sale to such purchaser, in light of the circumstances under which they were made) not misleading, (c) any actions or inactions or proceedings in respect of the foregoing whether or not such indemnified party is a party thereto or (d) any registration or qualification of securities under Blue Sky laws; provided , however , that the Company shall not be liable to any particular indemnified party to the extent that any such Loss arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in any such Registration Statement or other disclosure document in reliance upon and in conformity with written information furnished to the Company by such indemnified party expressly for use in the preparation thereof. This indemnity shall be in addition to any liability the Company may otherwise have. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Holder or any indemnified party and shall survive the transfer of such securities by such Holder. The Company shall also indemnify underwriters, selling brokers, dealer managers and similar securities industry professionals participating in the distribution, their officers and directors and each Person who controls such Persons (within the meaning of the Securities Act) to the same extent as provided above with respect to the indemnification of the indemnified parties.

 

  21  

 

 

6.2          Indemnification by the Selling Holder of Registrable Securities . Each selling Holder of Registrable Securities agrees (severally and not jointly) to indemnify and hold harmless, to the fullest extent permitted by law, the Company, its directors and officers and each Person who controls the Company (within the meaning of the Securities Act) from and against any Losses resulting from (a) any untrue statement of a material fact in any Registration Statement under which such Registrable Securities were registered under the Securities Act (including any final, preliminary or summary Prospectus contained therein or any amendment thereof or supplement thereto or any documents incorporated by reference therein) or contained in any free writing prospectus utilized in connection therewith or (b) any omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, preliminary Prospectus, free writing prospectus related thereto in light of the circumstances under which they were made) not misleading, in each case, to the extent, but only to the extent, that such untrue statement or omission is contained in any information furnished in writing by such selling holder to the Company specifically for inclusion in such Registration Statement, concerns such selling Holder or its ownership of the securities of the Company and has not been corrected in a subsequent writing prior to or concurrently with the sale of the Registrable Securities to the Person asserting the claim. In no event shall the liability of any selling Holder of Registrable Securities hereunder be greater in amount than the dollar amount of the net proceeds received by such Holder under the sale of Registrable Securities giving rise to such indemnification obligation. The Company shall be entitled to receive indemnities from underwriters, selling brokers, dealer managers and similar securities industry professionals participating in the distribution, to the same extent as provided above (with appropriate modification) with respect to information furnished in writing by such Persons specifically for inclusion in any Prospectus or Registration Statement.

 

6.3          Conduct of Indemnification Proceedings . Any Person entitled to indemnification hereunder shall (a) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification ( provided , that any delay or failure to so notify the indemnifying party shall relieve the indemnifying party of its obligations hereunder only to the extent, if at all, that it is actually and materially prejudiced by reason of such delay or failure) and (b) permit such indemnifying party to assume the defense of such claim, jointly with any other indemnifying party, with counsel reasonably satisfactory to the indemnified party; provided , however , that any Person entitled to indemnification hereunder shall have the right to select and employ separate counsel and to participate in the defense of such claim, but the fees and expenses of such counsel shall be at the expense of such Person unless (i) the indemnifying party has agreed in writing to pay such fees or expenses, (ii) the indemnifying party shall have failed to assume the defense of such claim within a reasonable time after receipt of notice of such claim from the Person entitled to indemnification hereunder and employ counsel reasonably satisfactory to such Person, (iii) the indemnified party has reasonably concluded (based upon advice of its counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party or (iv) in the reasonable judgment of any such Person (based upon advice of its counsel) a conflict of interest may exist between such Person and the indemnifying party with respect to such claims (in which case, if the Person notifies the indemnifying party in writing that such Person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such Person). If the indemnifying party assumes the defense, the indemnifying party shall not have the right to settle such action without the consent of the indemnified party. No indemnifying party shall consent to entry of any judgment or enter into any settlement unless such judgment or settlement (A) includes as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of an unconditional release from all liability in respect to such claim or litigation, (B) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party and (C) does not require any action (or consent or other restriction on action) other than the payment of money by the indemnifying party. If such defense is not assumed by the indemnifying party, the indemnifying party will not be subject to any liability for any settlement made without its prior written consent, but such consent may not be unreasonably withheld. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements or other charges of more than one separate firm admitted to practice in such jurisdiction at any one time unless (x) the employment of more than one counsel has been authorized in writing by the indemnifying party or parties, (y) an indemnified party has reasonably concluded (based on the advice of counsel) that there may be legal defenses available to it that are different from or in addition to those available to the other indemnified parties or (z) a conflict or potential conflict exists or may exist (based upon advice of counsel to an indemnified party) between such indemnified party and the other indemnified parties, in each of which cases the indemnifying party shall be obligated to pay the reasonable fees and expenses of such additional counsel or counsels.

 

  22  

 

 

6.4          Contribution . If for any reason the indemnification provided for in Sections 6.1 and 6.2 is unavailable to an indemnified party or insufficient in respect of any Losses referred to therein, then the indemnifying party shall contribute to the amount paid or payable by the indemnified party as a result of such Loss (a) in such proportion as is appropriate to reflect the relative fault of the indemnifying party, on the one hand, and the indemnified party or parties, on the other hand, in connection with the acts, statements or omissions that resulted in such losses or (b) if the allocation provided by clause (a) above is not permitted by applicable law, then such proportion as is appropriate to reflect not only the relative fault referred to in clause (a) above but also the relative benefit of the indemnifying party on the one hand and of the indemnified party or parties on the other in connection with the statement or omissions which resulted in such Losses, as well as any other relevant equitable considerations. The relative benefits of such parties shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses). In connection with any Registration Statement filed with the SEC by the Company, the relative fault of the indemnifying party on the one hand and the indemnified party on the other hand shall be determined by reference to, among other things, whether any untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would not be just or equitable if contribution pursuant to this Section 6.4 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in this paragraph. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. The amount paid or payable by an indemnified party as a result of the Losses referred to in Sections 6.1 and 6.2 shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 6.4 , in connection with any Registration Statement filed by the Company, a selling Holder of Registrable Securities shall not be required to contribute any amount in excess of the dollar amount of the net proceeds received by such Holder under the sale of Registrable Securities giving rise to such contribution obligation. If indemnification is available under this Article VI , the indemnifying parties shall indemnify each indemnified party to the fullest extent provided in Sections 6.1 and 6.2 hereof without regard to the provisions of this Section 6.4 . The remedies provided for in this Article VI are not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in equity.

 

  23  

 

 

6.5          Third Party Beneficiaries . The Company and the Holders agree that the other parties indemnified pursuant to this Article VI are express and intended third party beneficiaries of this Article VI .

 

Article VII.
ADDITIONAL REGISTRATION MATTERS

 

7.1          Reporting Obligations . The Company covenants that, at its own expense, it will use reasonable best efforts to file timely the reports required to be filed by it under the Exchange Act. Upon the request of any Holder of Registrable Securities, the Company will deliver to such Holder a written statement as to whether it has complied with such requirements and, if not, the specifics thereof (and such Holder shall be entitled to rely upon the accuracy of such written statement).

 

7.2          Waiver of Registration Rights . Notwithstanding anything to the contrary in this Agreement, the Onex Shareholders and the Baring Shareholders, acting together, may waive compliance by the Company with any provision of this Agreement with respect to the Management Shareholders, including waiving any obligation to include Registrable Securities held by the Management Shareholders in connection with any offering or Registration.

 

7.3          Holdback Agreement . If the Company at any time shall register Registrable Securities (including any registration pursuant to the terms hereof) for sale to the public, the Holders (and, in the case of a registration of Registrable Securities pursuant to Section 2.1.1 , the Company) hereby agree, at the request of the Company or any Investor Shareholder or the Sponsor Representative, as applicable, requesting registration of Registrable Securities pursuant to Section 2.1 , (a) not to sell publicly, make any short sale of, grant any option for the purchase of, or otherwise dispose publicly of, any Company Shares or other equity securities of the Company, or securities convertible into, exercisable or exchangeable for or that represent the right to receive equity securities of the Company (including any warrants to purchase Company Shares), without the prior written consent of the managing underwriters of such Public Offering, for a period designated by such managing underwriter or, in the case of a registration of Registrable Securities pursuant to Section 2.1 , any Investor Shareholder or the Sponsor Representative, as applicable, requesting such registration, which period shall not last more than 90 days after the effective date of the Registration Statement pursuant to which any Public Offering shall be made, and (b) to enter into agreements regarding the matters set forth in the foregoing clause (a) with such managing underwriters, if any, in connection with any such Public Offering. The Company shall obtain the agreement of any Person permitted to sell shares or any securities convertible into or exchangeable or exercisable for shares in a registration to be bound by and to comply with this Section 7.3 as if such Person was a Holder hereunder.

 

  24  

 

 

Article VIII.
MISCELLANEOUS

 

8.1          Notices . Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service providing evidence of delivery, or (iii) transmission by electronic mail. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered by courier service, hand delivery or electronic mail, at such time as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation. Any notice or communication under this Agreement must be addressed as follows:

 

If to the Company, to:

 

c/o Clarivate Analytics
Friars House
160 Blackfriars Road
London SE1 8EZ United Kingdom
Attention: Stephen Hartman
E-mail: stephen.hartman@lw.com

 

with a copy (which shall not constitute notice) to:

 

Latham & Watkins LLP
555 Eleventh Street, N.W.
Washington, DC 20004
Attention: Paul Sheridan and Shaun Hartley
E-mail: paul.sheridan@lw.com and shaun.hartley@lw.com

 

If to any Holder, at such Holder’s address as set forth in the Company’s books and records.

 

Any party may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30) days after delivery of such notice as provided in this Section 8.1 .

 

  25  

 

 

8.2          Assignment; No Third Party Beneficiaries .

 

8.2.1         This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.

 

8.2.2         No Holder may assign or delegate such Holder’s rights, duties or obligations under this Agreement, in whole or in part, except in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee but only if such Permitted Transferee agrees to become bound by the provisions of this Agreement.

 

8.2.3         This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and the permitted assigns of the Holders.

 

8.2.4         This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth in this Agreement and Section 6.5 hereof.

 

8.2.5         No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have received (i) written notice of such assignment as provided in Section 8.1 hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other than as provided in this Section 8.2 shall be null and void.

 

8.3          Counterparts . This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced.

 

8.4          Choice of Law; Remedies; Submission to Jurisdiction; Waiver of Jury Trial . To the greatest extent permitted by Jersey law, this Agreement and any suit, action or other proceeding arising out of or relating to this Agreement or any transaction contemplated hereby shall be governed by and construed in accordance with the internal laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of such state or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than those of the State of Delaware.

 

EACH OF THE PARTIES HERETO ACKNOWLEDGES AND AGREES THAT IN THE EVENT OF ANY BREACH OF THIS AGREEMENT, THE NON-BREACHING PARTY WOULD BE IRREPARABLY HARMED AND COULD NOT BE MADE WHOLE BY MONETARY DAMAGES, AND THAT, IN ADDITION TO ANY OTHER REMEDY TO WHICH THEY MAY BE ENTITLED AT LAW OR IN EQUITY, THE PARTIES SHALL BE ENTITLED TO SUCH EQUITABLE OR INJUNCTIVE RELIEF AS MAY BE APPROPRIATE. THE CHOICE OF FORUM SET FORTH IN THIS SECTION BELOW SHALL NOT BE DEEMED TO PRECLUDE THE ENFORCEMENT OF ANY JUDGMENT OF A COURT DESCRIBED IN CLAUSE (A) OF THIS SECTION BELOW, OR THE TAKING OF ANY ACTION UNDER THIS AGREEMENT TO ENFORCE SUCH A JUDGMENT, IN ANY OTHER APPROPRIATE JURISDICTION.

 

  26  

 

 

IN THE EVENT ANY PARTY TO THIS AGREEMENT COMMENCES ANY LITIGATION, PROCEEDING OR OTHER LEGAL ACTION IN CONNECTION WITH OR RELATING TO THIS AGREEMENT OR ANY MATTERS DESCRIBED OR CONTEMPLATED HEREIN, THE PARTIES TO THIS AGREEMENT HEREBY (A) AGREE UNDER ALL CIRCUMSTANCES ABSOLUTELY AND IRREVOCABLY TO INSTITUTE ANY SUCH LITIGATION, PROCEEDING OR OTHER LEGAL ACTION IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE LOCATED IN WILMINGTON, DELAWARE, OR, IF UNDER APPLICABLE LAW EXCLUSIVE JURISDICTION IS VESTED IN THE U.S. FEDERAL COURTS, THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE (AND APPELLATE COURTS THEREOF); (B) AGREE THAT IN THE EVENT OF ANY SUCH LITIGATION, PROCEEDING OR ACTION, SUCH PARTIES WILL CONSENT AND SUBMIT TO THE PERSONAL JURISDICTION OF ANY SUCH COURT DESCRIBED IN CLAUSE (A) OF THIS SECTION AND TO SERVICE OF PROCESS UPON THEM IN ACCORDANCE WITH THE RULES AND STATUTES GOVERNING SERVICE OF PROCESS (IT BEING UNDERSTOOD THAT NOTHING IN THIS SECTION SHALL BE DEEMED TO PREVENT ANY PARTY FROM SEEKING TO REMOVE ANY ACTION TO THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE); (C) AGREE TO WAIVE TO THE FULLEST EXTENT PERMITTED BY LAW ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE VENUE OF ANY SUCH LITIGATION, PROCEEDING OR ACTION IN ANY SUCH COURT OR THAT ANY SUCH LITIGATION, PROCEEDING OR ACTION WAS BROUGHT IN ANY INCONVENIENT FORUM; (D) AGREE, AFTER CONSULTATION WITH COUNSEL, TO WAIVE ANY RIGHTS TO A JURY TRIAL TO RESOLVE ANY DISPUTES OR CLAIMS RELATING TO THIS AGREEMENT; (E) AGREE TO SERVICE OF PROCESS IN ANY SUCH LITIGATION, PROCEEDING OR ACTION BY MAILING OF COPIES THEREOF TO SUCH PARTY AT ITS ADDRESS SET FORTH HEREIN FOR COMMUNICATIONS TO SUCH PARTY; (F) AGREE THAT ANY SERVICE MADE AS PROVIDED HEREIN SHALL BE EFFECTIVE AND BINDING SERVICE IN EVERY RESPECT; AND (G) AGREE THAT NOTHING HEREIN SHALL AFFECT THE RIGHTS OF ANY PARTY TO EFFECT SERVICE OF PROCESS IN ANY OTHER MANNER PERMITTED BY LAW.

 

8.5          Amendments and Modifications . This Agreement may be amended only by a written instrument duly executed by the Company and the Investor Shareholders (but only for so long as any Investor Shareholder holds any Company Shares); provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her or its capacity as a holder of the shares of capital stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected; provided, further, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects any Sponsor Holder, solely in his, her or its capacity as a holder of the shares of capital stock of the Company, shall require the consent of the Sponsor Representative. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party.

 

  27  

 

 

8.6          Other Registration Rights . The Company is not currently a party to, and the Company shall not hereafter enter into, any agreement with respect to its securities that is inconsistent with, or more favorable to a third party than, the rights granted to the Holders by this Agreement.

 

8.7          Term . This Agreement shall terminate upon the first date as of which (a) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by the SEC)) or (b) the Holders of all Registrable Securities are permitted to sell the Registrable Securities under Rule 144 (or any similar provision) under the Securities Act without limitation on the amount of securities sold or the manner of sale. The provisions of this Article VIII (other than Section 8.6 ) and Article VI shall survive any termination.

 

[Signature pages follow]

 

  28  

 

 

IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

 

  COMPANY :
     
  CLARIVATE ANALYTICS PLC
  a Jersey public limited company
     
  By: /s/ Paul Edwards
    Name: Paul Edwards
    Title:   Director
     
  ACQUIROR :
     
  CHURCHILL CAPITAL CORP ,
  a Delaware corporation
     
  By: /s/ Jerre L. Stead
    Name: Jerre L. Stead
    Title:   CEO
     
  HOLDERS :
     
  CHURCHILL SPONSOR LLC
     
  By: /s/ Michael Klein
    Name: Michael Klein
    Title:   
     
  GARDEN STATE CAPITAL PARTNERS LLC
     
  By: /s/ Michael Klein
    Name: Michael Klein
    Title:   
     
  M. KLEIN ASSOCIATES, INC.
     
  By: /s/ Michael Klein
    Name: Michael Klein
    Title:   
     
  THE IYER FAMILY TRUST DATED 1/25/2001
     
  By: /s/ Balakrishnan S. Iyer
    Name: Balakrishnan S. Iyer
    Title:   Trustee

 

[Signature Page to Registration Rights Agreement]

 

 

 

 

  MILLS FAMILY I, LLC
     
  By: /s/ Karen G. Mills
    Name: Karen Mills
    Title:   Managing Member
     
 

K&BM LP

By: Karen Mills, its general partner

     
  By: /s/ Karen G. Mills
    Name: Karen Mills
    Title:   Partner
     
 

JMJS GROUP II, LP

By: Jerre L. Stead, as Family trustee of the JLS-98 Trust, created July 28, 1998, its general partner

     
  By: /s/ Jerre L. Stead
    Name:
    Title:   
     
    /s/ Martin Broughton
    Name: Martin Broughton
     
    /s/ Balakrishnan S. Iyer
    Name: Balakrishnan S. Iyer
     
    /s/ Karen G. Mills
    Name: Karen G. Mills

 

    /s/ Sheryl von Blucher
    Name: Sheryl von Blucher
     
    /s/ Jerre L. Stead
    Name: Jerre Stead
     
    /s/ Michael S. Klein
    Name: Michael S. Klein

 

[Signature Page to Registration Rights Agreement]

 

 

 

 

  ONEX ADVISOR SUBCO LLC
     
  By: /s/ Joel Greenberg
    Name: Joel Greenberg
    Title:   Director 
     
  By: /s/ Marci Settle
   

Name: Marci Settle

Title: Director

 

  ONEX PARTNERS HOLDINGS LIMITED
S.À R.L.
     
  By: /s/ Joshua Hausman
    Name: Joshua Hausman
    Title:   Type A Manager
     
  By: /s/ Olivier Dorier
    Name: Olivier Dorier
    Title:   Type B Manager

 

  ONEX PARTNERS IV LP
By:  Onex Partners IV GP LP, its general partner
By:   Onex Partners Manager LP, its agent
By:   Onex Partners Manager GP ULC, its general partner
     
  By: /s/ Joshua Hausman
    Name: Joshua Hausman
    Title:   Managing Director
     
  By: /s/ Matthew Ross
   

Name: Matthew Ross

Title: Managing Director

     
  ONEX PARTNERS IV PV LP
By:  Onex Partners IV GP LP, its general partner
By:  Onex Partners IV GP LLC, its general partner
     
  By: /s/ Joshua Hausman
    Name: Joshua Hausman
    Title:   Managing Director

 

[Signature Page to Registration Rights Agreement]

 

 

 

 

  By: /s/ Matthew Ross
    Name: Matthew Ross
    Title:   Managing Director
     
 

ONEX PARTNERS IV SELECT LP
By:   Onex Partners IV GP LLC, its general partner

By:   Onex Partners Manager LP, its agent

By:   Onex Partners Manager GP ULC, its general partner

     
  By: /s/ Joshua Hausman
    Name: Joshua Hausman
    Title:   Managing Director
     
  By: /s/ Matthew Ross
    Name: Matthew Ross
    Title:   Managing Director
   
  ONEX PARTNERS IV GP LP
By:   Onex Partners Manager LP, its agent
By:   Onex Partners Manager GP ULC, its general partner
     
  By: /s/ Joshua Hausman
    Name: Joshua Hausman
    Title:   Managing Director
     
  By: /s/ Matthew Ross
    Name: Matthew Ross
    Title:   Managing Director
     
  ONEX US PRINCIPALS LP
By:   Onex US Principals GP LLC
     
  By: /s/ Joshua Hausman
    Name: Joshua Hausman
    Title:   Director

 

[Signature Page to Registration Rights Agreement]

 

 

 

 

  ONEX CAMELOT CO-INVEST LP
By:   Onex Partners IV GP LP, its general partner
By:   Onex Partners Manager LP, its agent
By:   Onex Partners Manager GP ULC, its general partner
     
  By: /s/ Joshua Hausman
    Name: Joshua Hausman
    Title:   Managing Director
     
  By: /s/ Matthew Ross
    Name: Matthew Ross
    Title:   Managing Director
     
  ELGIN INVESTMENT HOLDINGS LIMITED
     
  By: /s/ Tariq Syed Usman
    Name: Tariq Syed Usman
    Title:    Alternate Director to Caroline Baker
     
  Management Shareholders:
     
    /s/ Yasemin Agatan
    Name: Yasemin Agatan
     
    /s/ Christine Archbold
    Name: Christine Archbold
     
    /s/ Nagaraju Bandaru
    Name: Nagaraju Bandaru
     
    /s/ Rikard Bandebo
    Name: Rikard Bandebo
     
    /s/ Brian Binsfeld
    Name: Brian Binsfeld
     
    /s/ David C. Brown
    Name: David Brown
     
    /s/ Vincent Caraher
    Name: Vincent Caraher
     
    /s/ Andrea Degutis
    Name: Andrea Degutis

 

[Signature Page to Registration Rights Agreement]

 

 

 

 

    /s/ Todd Fegan
    Name: Todd Fegan
     
    /s/ Hemant Gandhi
    Name: Hemant Gandhi
     
    /s/ Richard Hanks
    Name: Richard Hanks
     
    /s/ Vicky Harris
    Name: Vicky Harris
     
    /s/ Stephen Hartman
    Name: Stephen Hartman
     
    /s/ Shawki Hassoun
    Name: Shawki Hassoun
     
    /s/ Jeffrey Huntsman
    Name: Jeffrey Huntsman
     
    /s/ Benjamin Kaube
    Name: Benjamin Kaube
     
    /s/ David Lee Kochalko
    Name: David Lee Kochalko
     
    /s/ Vijayshree Krishnan
    Name: Vijayshree Krishnan
     
    /s/ Jeremy Lawson
    Name: Jeremy Lawson
     
    /s/ Ian MacLochlainn
    Name: Ian MacLochlainn
     
    /s/ Ronda Sue Majure
    Name: Ronda Sue Majure
     
    /s/ Jeffrey Mastendino
    Name: Jeffrey Mastendino
     
    /s/ Kevin Joseph McCurry
    Name: Kevin Joseph McCurry

 

[Signature Page to Registration Rights Agreement]

 

 

 

 

    /s/ Christopher McKenna
    Name: Christopher McKenna
     
    Nadler Family Investments LLC
     
    By: /s/ Jay Nadler
    Name: Jay Nadler
    Title: Managing Member
     
    /s/ Richard Neale
    Name: Richard Neale
     
    /s/ Charles Neral
    Name: Charles Neral
     
    /s/ Francis Paleno
    Name: Francis Paleno
     
    /s/ Andrew Preston
    Name: Andrew Preston
     
    /s/ Janice Read
    Name: Janice Read
     
    /s/ Stuart Recher
    Name: Stuart Recher
     
    /s/ Jan-Eric Reichelt
    Name: Jan-Eric Reichelt
     
    /s/ Jeffrey Roy
    Name: Jeffrey Roy
     
    /s/ Kathleen Sullivan
    Name: Kathleen Sullivan
     
    /s/ Annette Thomas
    Name: Annette Thomas
     
    /s/ Daniel Videtto III
    Name: Daniel Videtto III
     
    /s/ Nikola Vujic
    Name: Nikola Vujic
     
    /s/ Biao Wang
    Name: Biao Wang
     
    /s/ Andrew Wright
    Name: Andrew Wright
     
    /s/ Eric Yan
    Name: Eric Yan

 

[Signature Page to Registration Rights Agreement]

 

 

 

 

Exhibit 15.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 ( No. 333-231405) of Clarivate Analytics Plc of our report dated February 26, 2019 relating to the financial statements of Camelot Holdings (Jersey) Limited, which appears in this Form 20-F.

 

/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
May 16, 2019